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Abstract 
 Unnatural amino acid (UAA) incorporation is an invaluable technique that is 
seeing increased use.  THG73 is an amber suppressor tRNA used to incorporate > 100 
residues at the UAG, amber stop codon, in Xenopus oocytes.  We have found that yeast 
Phe frameshift suppressors (YFFS) can incorporate UAAs at the CGGG and GGGU 
quadruplet codons in vitro and in vivo, allowing simultaneous incorporation of three 
UAAs in the nicotinic acetylcholine receptor (nAChR).  The YFFS are more 
“orthogonal” than the amber suppressor tRNA, THG73, but the frameshift suppressors 
incorporate UAAs less efficiently than THG73.  A library of tRNAs derived from THG73 
has produced an amber suppressor that is “orthogonal” and suppresses similarly to 
THG73.  An analogous opal suppressor tRNA allows incorporation of UAAs at the UGA, 
opal stop codon.  The use of the amber, opal, CGGG, and GGGU codons should allow 
for the simultaneous incorporation of four UAAs in vivo.  Bioorthogonal labeling of 
UAAs is useful for the addition of large fluorophores.  We incorporated p-AcPhe at α70 
of the nAChR and labeled with biotin and Cy5.5 hydrazide.  Biotin and Cy5.5 hydrazide 
consistently labeled three proteins on oocytes not expressing α70p-AcPhe and isn’t 
useful for site-specific labeling of ketone containing UAAs in oocytes.  We explored the 
known subunit stoichiometry of the nAChR (2α:β:γ:δ) expressed in oocytes and detected 
each subunit with the HA tag by Western blot.  The α-subunit is present in excess of the 
other subunits in a ratio of ≈ 3:1, which is expected to be 2:1.  UAAs are being sold 
commercially for detection of protein-protein interactions in eukaryotic cells.  The UAAs 
are heterogeneously incorporated and little is known about the effect on protein function 
and stability.  We heterogeneously incorporated UAAs into the nAChR and detected 
changes in function by shifts in EC50.  Many UAAs altered the function of the nAChR.  
Incorporation of photo-reactive UAAs allowed for detection of cross-linking by Western 
blot.  Heterogeneously incorporated UAAs also altered the functional nAChR expression 
on the surface of oocytes.  Site-specific and heterogeneous incorporation of multiple 
UAAs are useful techniques for novel experiments to explore protein function, FRET 
experiments, cross-linking, and protein expression. 
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Vesicle Reconstitution & Characterization 
of the Synthetic 
Mechanosensitive Channel of Large Conductance 
  
2 
1.1  Introduction 
 
 Mechanosensation is used in all three kingdoms of life for various functions.  In 
bacteria, mechanosensation is necessary to regulate osmotic pressure and prevent lysis of 
the cell wall.  Three distinct ion channels have been classified by their conductance in 
bacteria.  The mechanosensitive channel of large conductance (MscL) has a conductance 
> 1 nS, the mechanosensitive channels of small conductance (MscS and MscK) have 
conductances between 0.3–0.5 nS, and the mechanosensitive channel of mini 
conductance (MscM) has a conductance between 0.1–0.15 nS (1–4).  E. coli MscL was 
first cloned in 1994 and experiments explicitly showed that mechanosensation through 
the lipid bilayer could be performed by a single ion channel (5). 
 Rees and co-workers solved the crystal structure of MscL from Mycobacterium 
tuberculosis (Tb-MscL).  The crystal structure revealed a channel formed by a 
homopentamer, where each subunit contained two transmembrane (TM) α helices and a 
third cytoplasmic α helix (Figure 1.1).  The structure lacks the first 9 residues in the N-
terminus and 33 residues in the C-terminus (6).  Tb-MscL has sequence homology of 
37% when compared to the E. coli MscL (Ec-MscL), with highest homology in the TM 
regions (7).  MscL is thought to serve as a sensor for changes in osmolarity because the 
channel is gated by tension, through the lipid bilayer, that is near the lytic limit of most 
bacterial cells (1,8).  Upon tension gating, MscL generates a large conductance of ≈ 3 nS, 
with multiple sub-conductance states (9,10).  Synthetic MscL samples were prepared 
containing a N-terminal biotin moiety (B-Ec-MscL & B-Tb-MscL) (11) and this research 
was performed to reconstitute the channel into vesicles for characterization within the 
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Figure 1.1:  Crystal structure of Tb-MscL.  Left, the structure shows a homopentameric 
arrangement perpendicular to the lipid bilayer with a single subunit highlighted.  Each 
subunit contains two TM α helices and a cytoplasmic α helix.  N is the N-terminus and C 
is the C-terminus of a single subunit.  Right, a view from the periplasmic region.  Figure 
adapted from (12). 
 
 Synthetic MscL samples initially are dissolved in trifluoroethanol (TFE) and 
therefore must be reconstituted into a lipid bilayer in order to form functional channels.  
Lipids used in this research include: 1,2-Dioleoyl-sn-Glycero-3-Phosphocholine (DOPC) 
(Figure 1.2 A) and azolectin, an extract from soybean containing 40% phosphocholine 
lipid derivatives.  For vesicle formation, lipid is first dried in order to create a lipid film 
(Figure 1.2 B, 1).  The addition of water causes this lipid layer to swell and form bilayers.  
With agitation multilamellar vesicles (MLVs) are formed (Figure 1.2 B, 2).  MLVs can 
then be extruded through filters of specific diameters to form large unilamellar vesicles 
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(LUVs) or can be sonicated to form small unilamellar vesicles (SUVs) (Figure 1.2 B, 3 & 
4) (13).  Giant unilamellar vesicles (GUVs) are formed by the electroformation technique 
(14,15), which applies an oscillating electrical current with a geometric wave function 
(Figure 1.2 B, 5). 
 
 
Figure 1.2:  Diagram of a DOPC lipid and vesicle formation.  (A) DOPC structure is 
shown with the hydrophilic head group and hydrophobic tail groups highlighted.  (B) 
Vesicle formation. 1) The dried lipid film is shown and is the start of vesicle formation.  
2) Upon addition of water the lipid swells and forms MLV upon agitation.  3) Extrusion 
of MLVs creates LUVs.  4) Sonication of MLVs creates a homogenous population of 
SUVs.  5) Electroformation of the dry lipid film when placed in water forms GUVs.  
Figure on right adapted from (13). 
 
 
 Many methods exist for incorporation of membrane proteins into vesicles, 
including organic solvent-mediated reconstitution, mechanical reconstitution, detergent-
mediated reconstitution, and dried lipid-protein reconstitution.  Organic solvent-mediated 
reconstitution has been used to incorporate rhodopsin into LUVs (16), but the organic 
solvents quickly degrade many membrane proteins (17).  Mechanical reconstitution uses 
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force to fragment a bacterial cell and then fusion is allowed to occur with prepared 
MLVs.  This method has been used for MscL preparations (18), but is not useable for a 
completely synthetic protein.  Detergent-mediated reconstitution is the most successful 
and widely used procedure for reconstitution of membrane proteins into vesicles.  
Membrane proteins are purified, solubilized in an aqueous-detergent solution, and applied 
to a dry lipid film.  MLVs containing lipid, protein, and detergent are then subjected to 
dialysis or polystyrene beads to selectively remove detergent (17,19).  Detergent can alter 
the physical state of vesicles (20) and results in loss of reproducible gigaohm (GΩ) seals 
necessary for electrophysiological characterization (18).  Dried lipid-protein 
reconstitution involves the drying of both the lipid and protein and then forming vesicles.  
This method has been successfully used for the incorporation of gramicidin channels (21) 
and MscL (11). 
 
1.2  Results 
 
1.2.1  Vesicle Reconstitution of Synthetic MscL 
 Four different methods have been used for vesicle reconstitution of synthetic 
MscL, three of which will be discussed here.  The fourth method was published recently 
and used a modified dried lipid-protein reconstitution technique (21) of drying MscL onto 
lipid and then forming unilamellar blisters by the addition of Mg2+ (11).  The MLV 
preparation was developed by Dr. Joshua Maurer and found to have the pentameric 
oligomer state when cross-linked (Figure 1.3, A).   Briefly, solubilized B-Tb-MscL in the 
detergent n-dodecyl β-D-maltoside (DDM) was used, and MLVs were formed by 
rehydration of dry DOPC (20).  SUVs were formed upon selective removal of DDM 
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using polystyrene Bio-Beads and MLVs were then formed by the freeze-thaw technique 
(20,22).  Removal of DDM is necessary to avoid thread-like micelles, open bilayer 
structures (19), and to obtain GΩ seals for patch clamp recording (18). 
 The electroformation technique initially developed by Angelova and Dimitrov 
was used to create GUVs (14,15).  A Pt wire electrode chamber was hand made to create 
GUVs.  The MLV preparation was dried on the Pt wires and a sine wave of 2 V at a 
frequency of 10 Hz was applied for one hour as previously described (23).  A second 
indium tin oxide (ITO) coverslip chamber was also hand made, to create more uniform 
GUVs, in collaboration with Sean Gordon.  Synthetic MscL was dried onto a previously 
dried lipid film (11) and a square wave voltage of 1.5 V at 10 Hz was applied for 1 h 
(24). 
 The MLV preparation was the easiest initial route for synthetic MscL 
characterization because the procedure was previously determined, and the observation of 
pentameric channels suggested functionally reconstituted MscL (Figure 1.3 A).  The 
addition of concentrated Mg2+ to the MLVs was hoped to form blisters that could be used 
for electrophysiological recording (11,18).  While SUVs and LUVs are unilamellar, they 
can’t be used for electrophysiology because they are not large enough compared to the 
electrode opening and are not visible under a microscope (18).  The electroformation 
technique was used to create GUVs that would be readily visualized under a microscope 
and amenable to patch-clamp analysis. 
1.2.2 Electron Microscopy of B-Ec-MscL in MLVs 
 Electron microscopy (EM) on MLVs prepared with B-Ec-MscL was performed to 
visualize the membrane protein in the lipid bilayer through the binding of streptavidin-
  
7 
coated gold beads to the N-terminal biotin moiety.  MLVs were prepared containing B-
Ec-MscL and without, as a control for non-specific labeling.  Electron micrographs of 
MLVs showed many vesicles were ruptured and damaged when compared to light 
microscopy images (data not shown).  Gold particles showed a random labeling pattern 
with no statistical difference between the control MLVs (data not shown).  After two 
labeling trials, EM was abandoned because of a lack of uniform labeling required to 
demonstrate that B-Ec-MscL was reconstituted into the MLVs. 
1.2.3 Oligomeric State of MscL Analyzed by Cross-Linking in MLVs 
 The crystal structure of Tb-MscL shows a homopentameric arrangement (6).  Tb-
MscL lacks any native cysteine residues for cross-linking and mutations would be 
necessary, which could alter channel organization.  Lysines 99 and 100 form a cluster of 
charged residues in the cytoplasmic region of the structure and are ~ 7 Å from the 
neighboring subunit counterparts.  This proximity allows for the cross-linking of the 
primary amines using disuccinimidyl suberate (DSS), with a spacer arm of 11.4 Å, as 
previously described (6). 
 The MLV and cross-linking method developed by Dr. Joshua Maurer showed a 
pentamer when DSS was added to B-Tb-MscL (Figure 1.3, A Lanes 2–4) similar to the 
cross-linking experiments performed by Rees and co-workers (6).  Surprisingly, B-Tb-
MscL shows some dimeric protein without DSS (Figure 1.3, A Lane 1).  Achieving only 
a pentameric cross-linking was highly dependent on the amount of time the labeling was 
allowed to proceed (Dr. Joshua Maurer, personal communication).  Figure 1.3, B Lanes 
2–5 show cross-linking experiments using the same procedure with both B-Ec-MscL and 
Tb-MscL and show oligomer states higher than a pentamer.  While B-Ec-MscL shows 
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nearly the same cross-linking with 1.5 and 3 µg B-Ec-MscL (Figure 1.3, B Lanes 2 & 3), 
the B-Tb-MscL samples show varying cross-linking with 1.5 and 3 µg of B-Tb-MscL 
(Figure 1.3, B Lanes 4 & 5).  The variation in cross-linking shows the dependence on the 
amount of protein in the sample and shows the limitation in determining the number of 
subunits in an ion channels.  Hexameric states have been previously reported in the 
literature based on cross-linking and EM (25,26).  As a control, cross-linking was 
performed on proteins that were solubilized in DDM micelles, and no cross-linking was 




Figure 1.3:  Oligomeric analysis of MscL using DSS cross-linking in MLVs.  (A) 
Pentameric arrangement of B-Tb-MscL when incorporated into MLVs.  Lane 1, B-Tb-
MscL (2 µg) without DSS.  Lanes 2–4 are B-Tb-MscL (3 µg) with DSS.  Numbers to 
right represent number of subunits cross-linked.  (B) Increased oligomers found when 
trying to replicate A.  Lane 1, biotinylated molecular weight markers.  Lane 2, B-Ec-
MscL (1.5 µg) with DSS.  Lane 3, B-Ec-MscL (3 µg) with DSS.  Lane 4, B-Tb-MscL 
(1.5 µg) with DSS.  Lane 5, B-Tb-MscL (3 µg) with DSS.  Lanes 6 & 8, B-Ec-MscL (1 
µg) solubilized in DDM without and with DSS, respectively.  Lanes 7 & 9, B-Tb-MscL 
(1 µg) solubilized in DDM without and with DSS, respectively.  Numbers in the center 
represent number of subunits cross-linked. 
 
 Reese and co-workers previously used the same technique for both Ec-MscL (3 
µg) and Tb-MscL (10 µg), and the pentameric state was detected by staining with 
Coomassie brilliant blue (6).  Coomassie brilliant blue has a detection limit of 0.1–0.5 µg 
of protein (Amersham), while NeutrAvidin, HRP conjugated is at least 5 orders of 
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magnitude more sensitive with a detection limit of 0.05–1 pg of protein (Pierce).  
Therefore altering the detection may yield a similar pentameric oligomer state, but would 
give no definitive means for knowing the functional state of synthetic MscL within the 
MLVs. 
1.2.4 Fluorescence Imaging 
 MLV preparations containing B-Ec-MscL, TFE (no protein), and biotinylated 
lipid (B-DHPE) were used for fluorescence labeling with streptavidin conjugated to 
AlexaFluor488 (streptavidin-AlexaFluor488).  Initial fluorescence on MLV preparations 
with these three preparations failed to yield any differences between the three samples 
(data not shown).  Labeling was performed using a sevenfold excess and caused a large 
degree of background labeling on the MLVs.  The labeling procedure also involved 
removal of excess fluorophore by three freeze-thaw cycles, centrifugation, and 
resuspension, which causes the MLVs to aggregate and encapsulate non-specifically 
bound streptavidin-AlexaFluor488 (27).   
 B-Ec-MscL was then labeled with more biotin moieties using EZ-Link Sulfo-
NHS-LC-Biotin (NHS-B), which reacts with the primary amine on lysine residues.  The 
spacer arm is 22.4 Å, further than the N-terminal biotin, and would allow for multiple 
biotins on a single subunit.  MLV preparations with B-Ec-MscL, TFE, and B-DHPE were 
treated with NHS-B and labeled with streptavidin-AlexaFluor488.   
Figure 1.4 displays the results of this labeling trial and conditions are labeled 
above each column.  Figure 1.4, row A shows vesicles formed with TFE and no protein.  
The fluorescence detected after exposure times of 200 ms and 1,000 ms shows no 
intensity change, and fluorescence is due to small amounts of fluorophore present in 
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solution and/or non-specifically bound to the vesicles.  Figure 1.4, row B shows vesicles 
containing B-DHPE (same moles as B-Ec-MscL shown in Figure 1.4, C & D).  The 
image at 200 ms exposure time shows high concentration of streptavidin-AlexaFluor488 
bound to the vesicles (see Figure 1.4, B overlay) and exposure of 1,000 ms completely 
saturates the image.  B-Ec-MscL MLVs are shown in Figure 1.4, and rows C & D exhibit 
very high fluorescing points along the surface of the vesicles.  The lipid bilayer is not as 
uniformly labeled as in Clayton et al. (11), but illustrates a differential labeling among 
the controls and the vesicles containing B-Ec-MscL.  Biotinylated lipid exhibits the 
highest fluorescent intensity and illustrates that the streptavidin-AlexaFluor488 is 
specifically labeling accessible biotin (Figure 1.4, row B), but B-Ec-MscL shows less 
fluorescence, suggesting the N-terminal biotin and lysine coupled biotin are less 
accessible to the streptavidin-AlexaFluor488 and/or the proteins are localizing to specific 




Figure 1.4:  Fluorescence imagining of B-Ec-MscL in MLVs.  All MLVs were subjected 
to the same procedure for additional labeling of biotin using NHS-B.  Row A, Control 
MLVs lacking B-Ec-MscL (TFE only).  Row B, MLVs containing biotinylated lipid 
(equivalent moles to B-Ec-MscL shown in C & D).  Rows C & D, B-Ec-MscL containing 
MLVs.  The far left column is imaging in brightfield.  The two middle columns show 
fluorescence measurements with the exposure times listed above each column.  The far 
right column is an overly of the brightfield and fluorescence image (200 ms). 
 
 GUV fluorescence images were prepared using a lower concentration of 
streptavidin-AlexaFluor488 that was allowed to diffuse throughout the sample as 
described (11).  Figure 1.5, A, D, and G–I show brightfield images of GUVs created 
using a 100 Hz frequency rather than 10 Hz.  This frequency was chosen because the 
vesicles form in larger aggregates of GUVs, which are easier to locate.  Note the 
unilamellar vesicles appear to have very thick bilayers due to the diffraction of light.  
Figure 1.5, B and C show a GUV fluorescing along the lipid bilayer and also show an 
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altered structure when compared to other brightfield GUVs.  Many images showed large 
aggregates of streptavidin-AlexaFluor488 present along the vesicle surface (shown in 
Figure 1.5, E and F).  However most GUVs showed no fluorescence (Figure 1.5, G–I) 
and were similar to the TFE control (data not shown). 
 
 
Figure 1.5:  Fluorescence imaging of B-Ec-MscL GUVs prepared with Pt wire 
electrodes.  (A & D) Brightfield images of B-Ec-MscL incorporated into GUVs.  (B & E) 
Fluorescence images exposed for 100 ms. (C & F) Overlay of brightfield and 
fluorescence images.  (G–I) Brightfield images of B-Ec-MscL incorporated in GUVs that 
showed no fluorescence. 
 
 The ITO coverslip GUV preparation was done in collaboration with Sean Gordon, 
who took all fluorescent images (Figure 1.6).  DOPC GUVs were prepared by ITO 
coverslip electroformation and are shown in Figure 1.6, row A.  The GUVs are labeled 
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with a hydrophobic fluorophore, DiI, which only fluoresces when incorporated into the 
lipid bilayer.  Figure 1.6, B shows labeling of B-Ec-MscL incorporated into azolectin 
GUVs by perfusion of streptavidin-AlexaFluor488.  The streptavidin-AlexaFluor488 is 
maintained outside of the vesicles throughout the labeling process, which is similar to 
vesicles perfused with AlexaFluor488 dye alone (data not shown).  Figure 1.6, C shows 
B-Ec-MscL incorporated in azolectin GUVs washed with 1 mL of 1 X PBS.  Fluorescent 
labeling is seen across all the lipid membranes, suggesting that the protein is distributed 
uniformly in the GUVs.   
 
 
Figure 1.6:  GUVs prepared by ITO coverslips and fluorescence imaging.  (Row A) 
From left to right, DOPC GUVs under brightfield, fluorescence from DiI excitation, and 
fluorescence from DiI excitation zoomed in.  Scale bar is 50 µm.  Lower row is B-Ec-
MscL incorporated in azolectin GUVs.  (B) Perfusion with streptavidin-AlexaFluor488.  





1.2.5 Electrophysiological Characterization of Pt Wire GUVs 
 Samples were prepared using DOPC and azolectin by the MLV preparation 
method, which reconstitutes B-Ec-MscL using DDM.  After removal of the detergent 
using Bio-Beads, the samples were spread across the Pt wire and allowed to dry.  
Samples were given to Dr. George Shapovalov for single-channel patch-clamp recording.  
DOPC GUVs could not be studied because of failure to attain giga-ohm (GΩ) seals.  
Azolectin GUVs containing B-Ec-MscL were able to attain GΩ seals and had similar 
channel activity to that reported for synthetic MscL (11).  This clearly shows that B-Ec-
MscL is incorporated in a functional state within the MLVs and subsequently into GUVs 
during electroformation with Pt wire electrodes.  Interestingly the DOPC GUVs could not 
be recorded on, which is most likely due to the lipid composition of the membrane. 
 
1.3 Discussion 
 The functional reconstitution of synthetic MscL was achieved through the use of 
the DDM-mediated reconstitution in MLVs and subsequent electroformation to create 
GUVs, which was shown by single-channel patch-clamp study.  GUVs prepared by ITO 
coverslips show greater uniformity in spherical shape than GUVs prepared by a Pt wire.  
The ITO GUVs also have a higher yield, remain fixed to the translucent coverslip, and 
recording can easily be analyzed by electrophysiology performed on the giant vesicles.  
Overall, the GUV methods offer a means for reconstitution of functional MscL protein 
for electrophysiological characterization and should be amenable for the incorporation of 
other ion channels and membrane proteins. 
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  GUV preparations are an optimal method for characterization of proteins in vitro 
through single-channel recordings in the absence of other proteins present within cells.  
KcsA, a tetrameric K+ channel, translated in vitro in the presence of LUVs was found to 
incorporate selectively within the lipid bilayer of LUVs (28).  MscL and other simple 
homomeric prokaryotic ion channels may also spontaneously assemble into LUVs.  
Using this system along with nonsense suppression (29), unnatural amino acids could be 
selectively incorporated in MscL without the need for purification and GUVs could be 
made from LUVs.  Many loss of function and gain of function MscL mutants were 
identified using a high throughput assay for channel function (30), but many of these 
mutations had drastic alterations in sterics or electrostatics when compared to the native 
amino acids.  Unnatural amino acids could be incorporated at identified positions that are 
important for channel function and allowing analysis of specific interactions in more 
detail by electrophysiological characterization.  Incorporation of fluorescent unnatural 
amino acids could also be utilized for fluorescence resonance energy transfer to gain 
dynamic information of ion channel function during gating. 
 
1.4 Experimental Methods 
1.4.1 Synthetic B-Ec-MscL Samples 
B-Ec-MscL samples were chemically synthesized as described (11).  Briefly, a 
modified native-chemical ligation technique was utilized to synthesize the full-length Ec-
MscL with a biotin moiety placed at the N-terminus of the protein.  Cysteine was 
substituted for glutamine 56 and asparagine 103 for the native-chemical ligation and 
selectively modified with bromoacetamide to produce side chains similar to native amino 
  
17 
acids in sterics and containing a terminal amide group.  B-Tb-MscL was synthesized in a 
similar manner, substituting cysteine residues at glutamate 102 and serine 52 and 
masking with appropriate reagents.  All samples were synthesized at Gryphon 
Therapeutics. 
1.4.2 MLV Preparation and DDM-Mediated Reconstitution of B-Ec-MscL 
10 X Rehydration Buffer (RB) (2.5 mM KCl, 1 mM EDTA, 50 mM HEPES, pH 
7.2) was prepared and diluted as necessary.  79.8 µl DOPC in chloroform (Avanti Polar 
Lipids) was placed in a glass vial and rotoevaporated to dryness for 10 min.  5.4 mg of 
DDM (Anatrace) was added to 1 mL 1 X RB (.5% DDM solution).  20.7 µl of B-Ec-
MscL in TFE (2 mg / mL) was placed into 220 µl of .5% DDM solution and was directly 
added to the vial containing dried DOPC.  The B-Ec-MscL / .5% DDM / TFE solution 
was agitated at room temperature for 5 h to allow for MLV formation.  16 mg of 
degassed Bio-Beads SM Adsorbents (Bio-Rad) was added to the MscL / .5% DDM / TFE 
solution, to selectively remove DDM as described in (19,22), and agitated at room 
temperature for 7 h.  This preparation gave a protein-to-lipid ratio of 1:300.   
1.4.3 GUV Preparation With Pt Wire Electrodes 
GUVs were prepared by the electroformation technique as previously described 
(14,15,23).  The chamber (shown in Figure 1.7) was hand made by attaching two 5 cm X 
2 mm Pt wires (Alfa Aesar) 2 mm apart from each other with epoxy glue on a glass slide.  
Epoxy glue was placed 1 mm around the length of the Pt wires to create a reservoir.  4 µl 
of the MLV preparation (described above) was spread across the Pt wires and dried under 
vacuum for 15 min.  ~ 800 µl of 1 X RB was added to the chamber and a sine wave of 2 





Figure 1.7:  Diagram of Pt wire electrode chamber for GUV preparation. 
 
1.4.4 GUV Preparation With ITO Coverslips 
GUVs were prepared by the electroformation technique as previously described 
(14,15,24).  GUVs are produced in varying diameter from 10 to 100 µm, with a mean 
diameter of 50 µm.  The chamber (shown in Figure 1.8) was hand made by cutting a 
circle of 1.5 cm in a 35 X 10 mm plastic tissue culture dish (BD Biosciences).  Coverslips 
were covered in a 75 Å layer of ITO (gift from Jerry Pine).  4 X .5 cm copper electrical 
conducting tape was attached to the ITO layer of two coverslips.  The first coverslip was 
attached to the bottom of the tissue culture dish, centered under the circle to fully cover, 
with epoxy glue.  Vacuum grease (Dow Corning) was spread around the circle to form a 
liquid barrier and to create a spacer for the second coverslip.  4 µl of 1 µg / ml DOPC in 
chloroform (Avanti Polar Lipids) or 1 µg / ml azolectin in chloroform (Sigma-Aldrich) 
was spread across the attached coverslip and air-dried for 20 min.  For B-Ec-MscL 
reconstitution, 24 ng (1:5000 protein to lipid ratio) or 121 ng (1:1000 protein to lipid 
ratio) of B-Ec-MscL in TFE was smeared across the dried lipid on the coverslip and dried 
for 30 min under vacuum as previously described (11,21).  ~ 300 µl millipore water was 
added to the chamber (to fill) and the second coverslip placed on top (making sure full 
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water contact is made throughout the area).  A square wave voltage of 1.5 V at 10 Hz 
frequency was applied for 1 h through the copper electrical conducting tape.   
 
 
Figure 1.8:  Diagram of ITO coverslip chamber for GUV preparation. (Top coverslip is 
placed on vacuum grease when square wave is applied.) 
 
1.4.5 Electron Microscopy of B-Ec-MscL in MLVs 
Samples were prepared as previously described (31).  Copper grids were coated 
with collodion/carbon and evaporated under vacuum to be made hydrophobic (prepared 
by Pat Koen, Caltech Electron Microscope Facility).  10 µl of the MLV preparation 
(described above), with and without B-Ec-MscL, was labeled with 10 µl of AuroProbe 
EM Streptavidin G10 (Amersham Biosciences) with agitation for 12 h.   The total sample 
(20 µl) was placed on the copper grid and allowed to dry for 1 min.  #5 Whatman filter 
paper was used to dry remaining solution by touching the edge of the copper grid.  30 µl 
of a 1% phosphotungstic acid (Sigma-Aldrich) was added to the grid, left for 30 sec, and 
dried with filter paper.  30 µl of a 2% uranyl acetate (Sigma-Aldrich) solution was added 
to the grid, left for 30 sec, and dried with filter paper.  Grids were examined in a 
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transmission electron microscope (Philips 420) in the Caltech Electron Microscope 
Facility. 
1.4.6 Cross-Linking of MscL in MLVs 
8.7 µl (1.5 µg B-Ec/Tb-MscL) or 17.4 µl (3 µg B-Ec/Tb-MscL) of the MLV 
vesicle preparation (described above) was mixed with 2.5 or 5 µl of 8 mM DSS (Pierce), 
respectively.  Samples were sonicated for 5 min at room temperature and quenched with 
10 µl of urea gel loading buffer (50 mM TrisCl, pH 6.8, 2% SDS, 10% glycerol, 10 M 
urea, and .1% bromophenol blue).  Samples were boiled for 3 min and subjected to SDS-
polyacrylamide gel electrophoresis and transferred to nitrocellulose.  Biotinylated SDS-
PAGE standards (Bio-Rad) were run as a molecular weight marker.  Standard Western 
blot procedures were used and protein was visualized using 45 µl NeutrAvidin, HRP 
conjugated (Pierce).   
1.4.7 Fluorescence Imaging 
30 µl of MLV preparations (B-Ec-MscL, TFE, & N-(biotinoyl)-1,2-
dihexadecanoyl-sn-glycero-3-phosphoethanolamine (B-DHPE) (Molecular Probes) were 
prepared to pH = 8 with KOH.  0.83 µl of 10 mM EZ-Link Sulfo-NHS-LC-Biotin 
(Pierce) was added and incubated at room temperature for 3 h.  6 µl of 0.1 mg / ml 
streptavidin-AlexaFluor488 (Molecular Probes) in 1 X PBS was added and agitated for 
12 h.  Samples were sequentially freeze-thawed 3 times, centrifuged 5 min, supernatant 
was removed, and MLVs were resuspended in 35 µl of 1 X RB.  2 µl of 0.1 mg / ml 
streptavidin-AlexaFluor488 (Molecular Probes) in 1 X PBS was added to 400 µl of Pt 
wire GUV preparation containing B-Ec-MscL (made at 100 Hz) and labeling was 
allowed to proceed for 1 h.  Fluorescence was observed on an Olympus IX71 inverted 
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microscope equipped with a shuttered 175 W xenon arc lamp, 488 nm excitation filter, a 
515 nm fluorescence cube, and an Olympus Plan Apo 60X /1.4 numerical aperture oil 
immersion objective.  Images were recorded using a Photometrix CCD camera. 
ITO coverslip prepared GUVs were made with 15.7 µg of DOPC and 0.19 µg DiI 
(Molecular Probes), from 5 mM stock solution in chloroform, and B-Ec-MscL as 
described above with 1:5000 or 1:1000 protein-to-lipid ratio.  B-Ec-MscL GUVs were 
labeled by perfusion of 500 µl of 10 ng / µl streptavidin-AlexaFluor488.  Fluorescence 
images were taken at this point (Figure 1.6, B) and then vesicles were washed with 1 mL 
of 1 X PBS.  Fluorescence was observed on a Zeiss LSM Pascal Inverted confocal 
microscope equipped with an Ar Laser (488 nm, 25 mW), two-channel 
fluorescence/reflection, and motorized XY scanning stage.  Images were acquired at 12 
bit per channel and processed using Zeiss LSM v.3.0sp2. (Caltech Biological Imaging 
Center). 
1.4.8 Electrophysiological Characterization of Pt Wire GUVs 
GUVs were prepared with the Pt wire chamber (described above).  B-Ec-MscL 
GUVs were prepared with either DOPC or azolectin lipids.  Single-channel recordings 
were made by Dr. George Shapovalov as described in Clayton et al. (11). 
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Evaluating Aminoacylation and Suppression 
Efficiency of Nonsense and Frameshift  
Suppressor tRNAs In Vitro 
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2.1  Introduction 
 Site-specific incorporation of unnatural amino acids (UAAs) into proteins 
biosynthetically is a valuable technique that is seeing increased use (1–4).  UAAs are 
site-specifically incorporated into proteins translated in vitro and in vivo either by 
nonsense suppression or frameshift suppression (Figure 2.1).  The primary site-specific 
incorporation technique is known as stop codon (nonsense) suppression and requires a 
suppressor tRNA, with a modified anticodon, that recognizes the stop codon.  The amber 
stop codon (UAG) is primarily utilized for UAA incorporation (Figure 2.1 A), but the 
opal stop codon (UGA) has been utilized in eukaryotic cells to incorporate a single UAA 
(5,6).  The suppressor tRNA can be chemically aminoacylated with an UAA (2,3,7–9) or 
enzymatically aminoacylated with an UAA using tRNA/aminoacyl-synthetase pairs 
(4,5,10,11).  Currently over 100 UAAs or residues (five times greater than the 20 
naturally occurring amino acids (aas)) have been incorporated by chemically 
aminoacylated tRNAs (12), but at the onset of this research only a single UAA could be 
incorporated into a protein. 
The Dougherty group uses nonsense suppression of the amber codon (UAG) to 
incorporate a single UAA to probe a wide array of structural and functional properties of 
the mouse muscle nicotinic acetylcholine receptor (nAChR) in vivo (2,13–15).  A 
modified Tetrahymena thermophila tRNAGln, containing the mutation U73G and the 
CUA anticodon, (THG73) (16) is chemically aminoacylated in vitro with an UAA and 
injected into Xenopus oocytes with ion channel mRNA (with the stop codon, UAG, at the 
suppression site).  To obtain full-length protein, the UAA must be incorporated at the 
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amber codon or the protein is truncated (Figure 2.1 A) (16).  This technique has also been 
extended to incorporate UAAs in mammalian cells using THG73 (13). 
 
Figure 2.1:  UAA incorporation techniques.  (A) Nonsense suppression: a stop codon 
recognizing tRNA suppresses a stop codon and incorporates an UAA.  (B) Frameshift 
suppression: a frameshift suppressor tRNA recognizes a quadruplet codon and 
incorporates an UAA.  Initially this was the only technique that could incorporate 
multiple UAAs in vitro (17).  Figure adapted from (1). 
 
Pioneering work developed by Sisido and coworkers used quadruplet codons to 
incorporate UAAs, which is a technique known as frameshift suppression (18).  Using 
two unique quadruplet codons allowed for the simultaneous incorporation of two UAAs 
into a single protein translated in vitro (17) (Figure 2.1 B).  The technique was viable in 
prokaryotic (18,19) and eukaryotic (20,21) in vitro translation systems.  Intriguingly, 
five-base codons could also be utilized to incorporate UAAs, but the suppression 
efficiency was much less than with four-base codons (22).  However, frameshift 
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suppression was limited to in vitro translation systems and in vivo UAA incorporation by 
frameshift suppression had not been shown at the start of this project. 
While a single UAA incorporation allows for many useful structure-function 
studies, incorporation of multiple UAAs would allow for a more diverse experiments; 
including FRET pairs (23), fluorescence quenching (24), unnatural sulfur derivatives for 
disulfide cross-linking, and alteration of the sterics and electrostatic properties of more 
than one amino acid within a protein.  Frameshift suppression allows for the 
incorporation of multiple UAAs in vitro, either through the use of two four-base codons 
(17,24) (Figure 2.1 B) or through the use of one quadruplet codon and the amber codon 
(UAG) (23,25).  These UAA incorporation experiments are typically performed on small, 
cytoplasmic proteins, such as streptavidin, and it was therefore unknown if large, multi-
subunit proteins, such as ion channels, would be feasible for multiple UAA incorporation 
in vivo. 
The mechanism of nonsense and frameshift suppression is shown in Figure 2.2.  
UAA incorporation by nonsense suppression is performed by a tRNA aminoacylated with 
an UAA that recognizes the stop codon placed at the suppression site (Figure 2.2 A).  
Competition for UAA incorporation arises from the protein release factor (RF1 and/or 
RF2, depending on the stop codon, in prokaryotes and eRF1 in eukaryotes) and 
recognition of the stop codon results in truncation of the protein, which is typically non-
functional, unfolded, and degraded in vivo (Figure 2.2 B).  Frameshift suppression 
requires a modified frameshift suppressor tRNA, containing a four-base anticodon, and 
incorporation of the UAA occurs by suppression at the quadruplet codon (18,25) (Figure 
2.2 C).  Competition for recognition of the suppression site arises from an endogenous 
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triplet recognizing tRNA, which causes a –1 frameshift and results in the presentation of 
an altered amino acid sequence and multiple stop codons (Figure 2.2 D).  Another 
undesired suppression can result when the frameshift suppressor tRNA recognizes a 
triplet and the adjacent nucleotide (same sequence as the suppression site), resulting in a 
+1 frameshift.  This undesired suppression results in loss of the UAA and results in 
truncation of the protein (Figure 2.2 E).  Due to this undesirable suppression event, 
mutation of quadruplet codons that are recognized by the frameshift suppressor tRNA can 
be performed using the degeneracy of the genetic code to increase incorporation 




Figure 2.2:  Mechanism of nonsense and frameshift suppression.  (A) Nonsense 
suppression, an amber suppressor tRNA recognizes the desired UAG stop codon and 
incorporates an UAA.  (B) Competition for nonsense suppression arises from a protein 
release factor (RF1, for UAG, in prokaryotes and eRF1 in eukaryotes) and causes 
termination of the protein sequence.  (C) Frameshift suppression, a frameshift suppressor 
tRNA recognizes the desired four-base codon and incorporates an UAA.  The CGGG 
codon is shown, but any four- or five-base codon is considered frameshift suppression.  
(D) Competition arises from endogenous tRNA that recognizes the first three bases of the 
quadruplet codon, which results in a –1 frameshift (at the same position shown in C) and 
results in truncation by stop codons (shown in green) presented after the -1 frameshift.  
(E) An undesired suppression event can occur where the frameshift suppressor tRNA 
recognizes another cognate four-base codon in the mRNA sequence, which results in the 
incorporation of an UAA and a +1 frameshift.  The +1 frameshift causes truncation by 
stop codons (shown in green) presented after the +1 frameshift.  mRNAs are written from 
5’ to 3’ going from right to left.  tRNAs are adapted from (1). 
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 The development of frameshift suppression for the in vivo incorporation of 
multiple UAAs was initially analyzed in vitro to ensure that the eukaryotic ribosome 
would tolerate the extended anticodon of the frameshift suppressor tRNAs and/or four-
base codons at the suppression site, which was unknown at the start of this research.  
Initial suppression experiments were performed on the mouse muscle nAChR α-subunit 
containing an N-terminal hemagglutinin epitope (αNHA), which allows for analysis of 
truncated and full-length protein by Western blotting (14).  The four-base codons 
analyzed in this study were CGGG (shown to suppress efficiently in previous studies 
(17,26)), CGUG, and CGUU.  CGUG and CGUU were chosen because CGU is the least-
used Arg triplet in rabbit (27), which should have less competition with endogenous 
triplet-recognizing tRNAArg during translation (Figure 2.2 D) and may increase the 
suppression efficiency (17,26,28).  The human Ser amber suppressor (HSAS) (29), 
Tetrahymena thermophila Gln amber suppressor (THG73) (16), and yeast Phe amber 
suppressor (YFAS) (18) were used to prepare the frameshift suppressor tRNAs (shown in 
Figure 2.3).  HSAS is aminoacylated by the seryl-tRNA synthetase (SerRS) in 
mammalian cells (13,29) and was chosen to create frameshift suppressor tRNAs because 
the E. coli SerRS crystal structure reveals no recognition of the anticodon loop (30) and 
mammalian cells also don’t recognize the anticodon (31).  THG73 is an orthogonal amber 
suppressor in Xenopus oocytes, in that it is not extensively aminoacylated by the 
endogenous aminoacyl-tRNA synthetases (aaRSs).  THG73 has been used extensively for 
the incorporation of UAAs (18).  YFAS has been modified by the Sisido group and 
shown to incorporate UAAs by suppressing quadruplet codons (17–19).  To create the 
frameshift suppressor tRNAs, the appropriate anticodons (CCCG, CACG, AACG; 
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written 5’-3’) were placed on HSAS, THG73, and YFAS (Figure 2.3).  The frameshift 
suppressor tRNAs were analyzed in vitro by suppressing quadruplet codons in the αNHA 
and suppression efficiency was evaluated by Western blots and densiometric analysis. 
 
 
Figure 2.3:  Nucleotide sequences and cloverleaf structures of suppressor tRNAs tested 
in vitro.  On the left, the human Ser amber suppressor (HSAS) tRNA is shown and is 
aminoacylated in vitro by the SerRS (29).  In the middle, Tetrahymena thermophila Gln 
amber suppressor U73G  (THG73) is an orthogonal tRNA (not aminoacylated by aaRSs) 
used for the incorporation of UAAs primarily in Xenopus oocytes (16).  On the right, the 
yeast Phe amber suppressor (YFAS) is shown and was the first tRNA used to incorporate 
UAAs in vitro (7).  Mutations to the acceptor stem (shown in italics) of the YFAS are 
shown in the upper right and used by the Sisido group to reduce recognition of frameshift 
suppressor tRNAs by the GlyRS (19).  Below the tRNAs are the four-base anticodons 
placed on each tRNA to create frameshift suppressor (FS) tRNAs tested in vitro. 
 
2.2  Results & Discussion 
2.2.1 Experimental Design and Western Blot Analysis 
 The nAChR α−subunit with the N-terminal HA tag (αNHA) was the initial 
construct for all mutations because the N-terminal HA tag allows for detection by 
Western blot (14), all truncations could be visualized, and this was prior to any Arg 
amino acids that could cause a +1 frameshift (Figure 2.2 E).  Initially, constructs were 
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created at Ser sites because HSAS and HSFS were predicted to be aminoacylated with 
Ser by the SerRS in vitro.  Ser154 was chosen as the first suppression site because it was 
≈ 1/3 of the protein sequence.  Ser374 was chosen as the second suppression site because 
it was ≈ 2/3 of the protein sequence.  These initial suppression sites were thought to be 
useful for in vivo studies later in Xenopus oocytes. 
 The αNHA was translated using rabbit reticulocyte lysate (RRL), nuclease treated in 
vitro reactions unless otherwise noted.  Standard Western blotting procedures were 
followed and done as published (14), unless otherwise noted.  The full-length α subunit is 
predicted to run at 53 KD, but the α-subunit runs on gel as ≈ 45 KD (14).  Densiometric 
analysis was performed using NIH Image, which imports scanned exposures and analyzes 
the pixel intensity.  Bands are manually selected and the average pixel intensity for each 
band was taken.  Suppression efficiency was calculated as written in the Experimental 
Methods.  
2.2.2 HSAS Suppression on αNHA154UAG and αNHA154UAG374UAG 
 Figure 2.4 shows αNHA154UAG and αNHA154UAG374UAG suppressed with 
HSAS.  The Western blot illustrates that HSAS is aminoacylated in the RRL in vitro 
translation system by an endogenous aaRS, which was previously unknown.  The 
αNHA154UAG construct is suppressed 59% relative to αNHA by 1 µg of HSAS (Figure 2.4, 
Lane 3), but increased suppression (94%) is seen with 2 µg of HSAS (Figure 2.4, Lane 
5).  The αNHA154UAG374UAG construct contains two stop codons and requires two 
suppression events for full-length (FL) protein, and with 2 µg of HSAS the translation 
efficiency is 33% (Figure 2.4, Lane 7).  This illustrates that suppression at two positions 
is not a concerted event (where suppression of the first UAG facilitates the suppression of 
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the second UAG), but rather that each suppression is an individual event and the 
translation efficiency of two sites is equal to the probability of a single suppression event 
(17).  The single suppression efficiency is 59% with 1 µg HSAS and the double 
translation efficiency is 33% with 2 µg HSAS.  The theoretical yield of full-length 
protein for two suppression events would be equal to 59% X 59% = 35%, which is close 
to the actual value of 33%.  The Western blot in Figure 2.4 is overexposed and the 
translation efficiencies listed here are actually overestimated. 
 
 
Figure 2.4:  HSAS suppression on αNHA154UAG and αNHA154UAG374UAG (2 µg 
mRNA).  Lane 1 shows αNHA and has the highest translation in vitro.  Lanes 2 and 4, 
αNHA154UAG mRNA only.  Lanes 3 and 5, HSAS suppression on αNHA154UAG with 1 
µg and 2 µg of HSAS, respectively.  Lane 6, αNHA154UAG374UAG mRNA only.  Lane 
7, αNHA154UAG374UAG + 2 µg HSAS.  Numbers on the left are molecular weight 
markers (KD).  On the right, 154UAG is the first truncation not suppressed by HSAS, 
374UAG is the second trunctation after suppression of 154UAG (Lanes 6 and 7 only), 
and FL is full-length protein band. 
 
2.2.3 HSAS and HSFSCCCG Suppression on αNHA154UAG374CGGG 
 Figure 2.5 A shows that FL protein with αNHA154UAG374CGGG is dependent on 
the addition of both HSAS and HSFSCCCG, which has a 35% yield of full-length protein 
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relative to αNHA (Figure 2.5 A, Lane 5).  Figure 2.5 B was performed using a RRL 
coupled in vitro translation, where DNA is added and mRNA is transcribed in the system.  
This Western blot allows for a comparison of two suppression events on 
αNHA154UAG374CGGG versus one suppression event on αNHA154UAG (Figure 2.5 B).  
55% translational efficiency is seen for αNHA154UAG374CGGG with 2 µg of each HSAS 
and HSFSCCCG (Figure 2.5 B, Lane 4), while αNHA154UAG has a suppression efficiency of 
44% with 2 µg of HSAS (Figure 2.5 B, Lane 7).  Note efficiencies are exaggerated 
because the αNHA band is saturated.  The αNHA154UAG374CGGG full-length protein 
yield is also exaggerated due to difficulty in separating the truncation band at 374CGGG 




Figure 2.5:  HSAS and HSFSCCCG suppression on αNHA154UAG374CGGG.  (A) 
Suppression in RRL with 2 µg mRNA.  Lane 1, αNHA mRNA only.  Lane 2 is 
αNHA154UAG374CGGG mRNA only.  Lane 3 is αNHA154UAG374CGGG + 2 µg HSAS, 
which truncates due to the 374CGGG frameshift.  Lane 4 is αNHA154UAG374CGGG + 2 
µg HSFSCCCG and truncates at 154UAG.  Lane 5 is αNHA154UAG374CGGG with 2 µg of 
HSAS and HSFSCCCG.  (B) Suppression in TNT RRL with 1 µg DNA.  Lanes 1–4 are the 
same as Lanes 2–5 in part A.  Lane 5 is αNHA.  Lane 6 is αNHA154UAG mRNA only.  
Lane 7 is αNHA154UAG + 2 µg of HSAS.  Lane 8 is without mRNA and tRNA.  Numbers 
on the left are molecular weight markers (KD).  On the right, 154UAG is the first 
truncation not suppressed by HSAS, 374CGGG is the second trunctation after 
suppression of 154UAG (not seen for part B Lanes 6–8), and FL is full-length protein 
band. 
 
 At this point in the research, it was determined that frameshift suppression 
efficiency was too low to proceed with UAAs.  Even though HSAS and HSFSCCCG are 
aminoacylated in vitro and should act similarly to endogenous tRNAs, there was not a 
significant amount of FL protein (Figure 2.5 A, Lane 5, and Figure 2.5 B, Lanes 4 & 7) 
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compared to the wild-type, αNHA (Figure 2.5 A, Lane 1, and Figure 2.5 B, Lane 5).  Also, 
the 374CGGG truncation was difficult to distinguish from the FL protein (Figure 2.5 A, 
Lanes 3 & 5, and Figure 2.5 B, Lanes 2 & 4) and an accurate translation efficiency could 
not be determined.  Therefore, single quadruplet codon constructs were created to analyze 
frameshift suppression accurately and without the dependence of having 154UAG being 
suppressed prior to the 374CGGG site. 
2.2.4 HSAS/HSFS and THG73/THG73FS-Ala Suppression on αNHA154XXX(X) 
 Figure 2.6 A shows HSAS and HSFS experiments on single suppression 
constructs at αNHASer154XXX(X).  αNHA154UAG suppression by HSAS showed 
suppression efficiency of 49% (Figure 2.6 A, Lane 3), while αNHA154CGGG suppression 
efficiency by HSFSCCCG was 36% (Figure 2.6 A, Lane 5).  The other two quadruplet 
codons, CGUG and CGUU, show negligible suppression and are within background 
intensity (Figure 2.6 A, Lanes 6–9).  These efficiencies are exaggerated because the αNHA 
band is saturated (Figure 2.6 A, Lane 1).  Figure 2.6 B shows the same experiments as in 
Figure 2.6 A, but using THG73 and the THG73 frameshift suppressors, which were 
chemically aminoacylated with Ala.  In Figure 2.6 B, no noticeable FL protein is seen for 
any of the THG73 suppressor tRNAs.  Intriguingly the truncated protein band (UAG and 
four-base codons) was significantly reduced with the addition of tRNA (Figure 2.6 B, 
Lanes 3, 5, 7 & 9) (reproducible many times).  Therefore it is possible that a contaminant 
may be present within the tRNA samples, even though similar results were continuously 
seen using newly transcribed tRNA, multiple precipitations with ethanol to remove salt 




Figure 2.6:  HSAS/HSFS and THG73/THG73FS-Ala suppression at αNHA154XXX(X).  1 
µg mRNA and 2 µg tRNA were used for both gels.  (A) HSAS and HSFS suppression at 
αNHA154XXX(X).  Lane 1 is αNHA.  Lane 2 is αNHA154UAG.  Lane 3 is αNHA154UAG + 
HSAS.  Lane 4 is αNHA154CGGG.  Lane 5 is αNHA154CGGG + HSFSCCCG.  Lane 6 is 
αNHA154CGUG.  Lane 7 is αNHA154CGUG + HSFSCACG.  Lane 8 is αNHA154CGUU.  Lane 
9 is αNHA154CGUU + HSFSAACG.  (B) THG73-Ala and THG73FS-Ala suppression at 
αNHA154XXX(X).  Lane 1 shows αNHA.  Lane 2 is αNHA154UAG.  Lane 3 is αNHA154UAG 
+ THG73-Ala.  Lane 4 is αNHA154CGGG.  Lane 5 is αNHA154CGGG + THG73FSCCCG-
Ala.  Lane 6 is αNHA154CGUG.  Lane 7 is αNHA154CGUG + THG73FSCACG-Ala.  Lane 8 
is αNHA154CGUU.  Lane 9 is αNHA154CGUU + THG73FSAACG-Ala.  Numbers on the left 
are molecular weight markers (KD).  On the right, UAG or 4C is the truncation at the 
stop codon or four-base codon, respectively, and FL is full-length protein band. 
 
 The HSFS and THG73FS suppressor tRNAs have not been tested in the literature 
and are possibly misfolding.  Secondary structure of all the tRNAs were predicted using 
the program mfold to predict nucleic acid folding using standard ionic conditions (32).  
For HSAS and HSFSCCCG the tRNAs had a similar fold, but were not the native structure 
shown in Figure 2.3.  Interestingly the HSFSCACG and HSFSAACG had the same fold as 
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HSAS, but in the experiments they were shown to be worse suppressors (Figure 2.6 A).  
The number of structures for HSFSCACG and HSFSAACG (4 and 5, respectively) is greater 
than the two structures predicted for HSAS and HSFSCCCG.  HSFSCACG and HSFSAACG may 
therefore exist in multiple tertiary structures.  THG73 structures were inconclusive 
because the G-U pair at the base of the anticodon stem (Figure 2.3) is not recognized by 
mfold.  Therefore, the D-loop and the anticodon loop had to be constrained in order to 
obtain a similar THG73 structure shown in Figure 2.3.  THG73FSCCCG and THG73FSCACG 
showed a similar fold to THG73 with the constraints.  THG73FSAACG did not fold 
properly even with constraints.  Structure predictions using mfold are not highly accurate 
because the overall folding lacks fundamental interactions in a tertiary fold that stabilize 
the tRNA structure and therefore the folding was inconclusive at determining whether the 
tRNAs were misfolded by the extended anticodon. 
2.2.5 HSAS/HSFS and THG73/THG73FS-Ala Suppression on Single Constructs in 
Wheat Germ In Vitro Translation 
 Another possibility for loss of protein bands was RNAi, which can occur due to 
small percentage of antisense tRNA present within a sample (T7 mMessage Machine 
Transcription kit Ambion manual) or by hybridization of tRNA to the mRNA transcript 
(RRL Promega manual).  Wheat germ extract (WG) for in vitro translation of protein is 
recommended for RNA preparations that may contain low concentrations of dsRNA, 
which can inhibit the RRL protein translation (WG Promega manual).  Figure 2.7 shows 
the HSAS/HSFS and THG73/THG73FS-Ala suppression experiments (same as Figure 
2.6) run in WG reactions.  Low translation efficiency of the full-length αNHA protein is 
seen in both blots.  Surprisingly, HSAS suppression on the αNHA154UAG construct shows 
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more full-length protein than αNHA (Figure 2.7 A, Lane 2).  Only small amounts of full-
length protein can be seen upon adding HSFS tRNAs (Figure 2.7 A, Lanes 4–9).  No full-
length protein was seen with THG73/THG73FS-Ala (Figure 2.7 B, Lanes 4–9).  
Intriguingly, both HSFSCCCG and THG73FSCCCG-Ala show a decrease in the truncated 
product when tRNA is added (Figure 2.7 A & B, Lane 5).  αNHA154CGUG also shows a 
decrease in truncation product when HSFSCACG is added (Figure 2.7 A, Lane 7).  This 
result suggests that RNAi may not be a problematic for the in vitro reactions.  Therefore, 
there may be problems with tRNA samples containing a contamination, tRNAs 
suppressing other sites, and/or tRNAs inhibiting translation.  Overall, translation in WG 
is significantly impaired and yields are not as high as in RRL, which has previously been 
seen in our lab (Dr. James Petersson and Dr. Niki Zacharias, personal communication). 
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Figure 2.7:  HSAS/HSFS and THG73/THG73FS-Ala suppression at αNHA154XXX(X) in 
wheat germ in vitro translation.  1 µg mRNA and 2 µg tRNA (when added) were used for 
each lane.  (A) Lane 1 is αNHA.  Lane 2 is αNHA154UAG.  Lane 3 is αNHA154UAG + 
HSAS, which suppresses more efficiently then the translation of αNHA (Lane 1).  Lane 4 is 
αNHA154CGGG and Lane 5 is αNHA154CGGG + HSFSCCCG.  Lane 6 is αNHA154CGUG and 
Lane 7 is αNHA154CGUG + HSFSCACG.  Lane 8 is αNHA15CGUU and Lane 9 is 
αNHA154CGUU + HSFSAACG.  (B) Lane 1 is αNHA.  Lane 2 is αNHA154UAG.  Lane 3 is 
αNHA154UAG + THG73-Ala.  Lane 4 is αNHA154CGGG and Lane 5 is αNHA154CGGG + 
THG73FSCCCG-Ala.  Lane 6 is αNHA154CGUG and Lane 7 is αNHA154CGUG + 
THG73FSCACG-Ala.  Lane 8 is αNHA15CGUU and Lane 9 is αNHA154CGUU + 
THG73FSAACG-Ala.  Both Western blots show little full-length protein for αNHA and 
translation appears impaired in the wheat germ system.  Numbers on the left are 
molecular weight markers (KD).  On the right, UAG or 4C is the truncation at the stop 
codon or four-base codon, respectively, and FL is full-length protein band. 
 
 Another hypothesis was that other sites were being recognized by the FS tRNAs 
and the reduction in truncated protein was caused by a premature +1 frameshift (Figure 
2.2 E).  Attempts to detect low molecular weight proteins by Western blot using 
nitrocellulose and PVDF membranes showed no bands below the 21.3 KD band (data not 
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shown).  This means that there was no truncation present before the αNHA154XXXX 
suppression site, there is very little truncation of αNHA154XXXX in the sample 
(undetectable by Coomassie brilliant blue stain; detection limit of 0.1–0.5 µg or Ponceau 
S staining of the nitrocellulose membrane; detection limit of 1 µg), or the low molecular 
weight truncations are lost from the membrane during washes for the Western blot 
procedure. 
2.2.6 HSAS/HSFS and THG73/THG73-W Suppression on the αNHA 
 A new control was then used, which added the FS tRNAs to αNHA.  If the FS 
tRNAs were recognizing different codons, then these would be present on the wild-type 
αNHA construct and would cause a reduction in the full-length protein band by a +1 
frameshift (shown in Figure 2.2 E).  Figure 2.8 shows HSFS suppression occurs on αNHA 
and varies based on the amount of suppressor tRNA added.  Figure 2.8 A was an internal 
control and further testing of the RNAi hypothesis, which should have inhibition of 
translation with very small amounts of dsRNA.  The Western blot (Figure 2.8 A, Lanes 
1–4) shows no significant change (< 3%) in full-length protein when 0.1 µg of HSFSCCCG, 
HSFSCACG, or HSFSAACG is added, suggesting no inhibition by the RNAi mechanism.  
However, when 2 µg of FS tRNA is added to αNHA there is a decrease in full-length 
protein (Figure 2.8 B, Lanes 2–4).  HSFSCCCG has a decrease of 38%, HSFSCACG has a 
decrease of 12%, and HSFSAACG has a decrease of 46% (Figure 2.8 B, Lanes 2–4) relative 
to αNHA without tRNA (Figure 2.8 B, Lane 1).  The difference in reduction in the αNHA 
suggests that the reduction is not caused by simply the addition of tRNA or by a 
contaminant (which would be the same for all tRNAs prepared at the same time), but 
rather suggests a suppression event or events are occurring.  Suppression for HSAS on 
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αNHA154UAG was 60%, HSFSCCCG on αNHA154CGGG was 56%, HSFSCACG on 
αNHACGUG was 33%, and HSFSAACG on αNHACGUU was 43.7% (when compared to 
αNHA) (Figure 2.8 B, Lanes 5–8).  HSAS was only 4.3% more efficient at suppression 
then HSFSCCCG in this trial.  When only 0.1 µg of tRNA was added, suppression 
efficiency was much higher for HSAS than the HSFS tRNAs, this shows the importance 
of adding the appropriate amount of tRNA for increased suppression efficiency, which is 
most likely necessary to out compete endogenous triplet recognizing tRNA (shown in 




Figure 2.8:  HSAS/HSFS suppression on αNHA is dependent on the amount of tRNA 
added.  2 µg mRNA was used in each reaction.  (A) 0.1 µg of HSAS or HSFS tRNA is 
added in the listed lanes.  Lane 1 is αNHA.  Lane 2 is αNHA + HSFSCCCG.  Lane 3 is αNHA + 
HSFSCACG.  Lane 4 is αNHA + HSFSAACG.  Change in full-length protein for αNHA + HSFS 
tRNAs is < 3% (Lanes 2–4).  Lane 5 is αNHA154UAG + HSAS.  Lane 6 is αΝΗΑ154CGGG 
+ HSFSCCCG.  Lane 7 is αNHA154CGUG + HSFSCACG.  Lane 8 is αNHA154CGUU + 
HSFSAACG.  (B) 2 µg HSAS or HSFS tRNA was used.  Lanes are identical to part A, but 
with increased amount of tRNA.  Full-length αNHA protein is variable when HSFS tRNAs 
are added (Lanes 2–4) and is different for each tRNA.  αNHA154CGGG suppression by 
HSFSCCCG is comparable to αNHAUAG suppression by HSAS (Lanes 5 & 6).  Numbers on 
the left are molecular weight markers (KD).  On the right, UAG or 4C is the truncation at 
the stop codon or four-base codon, respectively, and FL is full-length protein band. 
 
 Figure 2.9 shows representative experiments with HSAS/HSFS and 
THG73/THG73FS-W tRNAs.  HSFS showed similar patterns of reduction on αNHA and 
suppression on αNHA154XXX(X) as seen in Figure 2.8.  However, Figure 2.9 A shows 
two unknown bands appearing at 29 KD with addition of HSFSCCCG (Figure 2.9 A, Lanes 
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2 & 6, *) and 22.5 KD for HSFSCACG with αNHACGUG (Figure 2.9 A, Lane 7).  The band 
at 22.5KD can’t be identified based on the Arg triplets in the αNHA and the cause is 
unknown.  The band at 29 KD could possibly be recognition of the Arg182CGG G and 
the result of a +1 frameshift (Figure 2.2 E).  THG73FSCCCG-W showed a significant 
decrease of full-length protein when added to αNHA (Figure 2.9 B, Lane 2), but little full-
length protein is seen when added to αNHA154CGGG (Figure 2.9 B, Lane 6).  Very little 
suppression is seen with any of the THG73FS-W tRNAs (Figure 2.9 B, Lanes 6–8). 
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Figure 2.9:  HSAS/HSFS and THG73/THG73FS-W suppression on αNHA or 
αNHA154XXX(X).  4 µg mRNA and 2 µg tRNA are used in both gels.  (A) HSAS/HSFS 
suppression on αNHA (Lanes 2-4) and on αNHA154XXX(X) (Lanes 5–8).  Lane 1 is αNHA.  
Lane 2 is αNHA + HSFSCCCG.  Lane 3 is αNHA + HSFSCACG.  Lane 4 is αNHA + HSFSAACG.  
Lane 5 is αNHA154UAG + HSAS.  Lane 6 is αNHA154CGGG + HSFSCCCG.  Lane 7 is 
αNHA154CGUG + HSFSCACG.  Lane 8 is αNHA154CGUU + HSFSAACG.  The * represents a 
novel band only seen with HSFSCCCG and thought to be caused by a +1 frameshift at 
R182CGGG (Figure 2.2 E) (Lanes 2 & 6).  (B) THG73/THG73FS-W suppression on 
αNHA (Lanes 2–4) and on αNHA154XXX(X) (Lanes 5–8).  Lane 1 is αNHA.  Lane 2 is αNHA 
+ THG73FSCCCG-W.  Lane 3 is αNHA + THG73FSCACG-W.  Lane 4 is αNHA + 
THG73FSAACG-W.  Lane 5 is αNHA154UAG + THG73-W.  Lane 6 is αNHA154CGGG + 
THG73FSCCCG-W.  Lane 7 is αNHA154CGUG + THG73FSCACG-W.  Lane 8 is 
αNHA154CGUU + THG73FSAACG-W.  Note the novel band seen (* A, Lanes 2 & 6) was 
not seen in the THG73FSCCCG-W reactions.  Numbers on the left are molecular weight 
markers (KD).  On the right, UAG or 4C is the truncation at the stop codon or four-base 
codon, respectively, and FL is full-length protein band. 
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 When looking at the average densiometric analysis of the HSAS/HSFS reduction 
or suppression trials, a clear pattern arises (Figure 2.10).  The reduction in intensity of 
HSFSCCCG added to αNHA is similar to the increase in intensity of HSFSCCCG added to the 
αNHA154CGGG, suggesting a single suppression event is occurring on αNHA (Figure 2.10).  
Addition of HSFSCCCG to αNHA causes a reduction of 32% relative to αNHA intensity 
without tRNA, or suppression efficiency of 32% for HSFSCCCG on the αNHA construct.  
When HSFSCCCG is added to the αNHA154CGGG construct, full-length protein can only be 
attained by one suppression event at the desired suppression site (suppression at two sites 
would result in a +1 frameshift and lack of full-length protein) and the suppression 
efficiency is 45%.  The truncation bands have about the same average intensity and there 
is no correlation for suppression efficiency and the intensity of the truncation band 
(Figure 2.10).  Looking at the 28 KD and 70 KD (protein bands from the RRL), the 
intensity is approximately the same for all the lanes and shows that there is no global 
change in protein concentration (Figure 2.10).   HSAS and HSFSCCCG show the highest 
suppression efficiency in RRL and amber suppression appears to be better than frameshift 
suppression with these two tRNAs. 
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Figure 2.10:  Densiometric analysis of HSAS/HSFS suppression on αNHA and 
αNHA154XXX(X) (average of 6 trials).  The αNHA shows the highest intensity of full-
length protein, but close to the αNHA + HSFSCACG and suggesting HSFSCACG does not 
suppress αNHA.  αNHA is decreased upon the addition of HSFSCCCG and HSFSAACG.  The 
intensity of αNHA + HSFSCCCG is nearly the same as αNHA154UAG + HSAS, suggesting 
one suppression event is occurring in both cases.  αNHA154CGGG + HSFSCCCG shows 
highest amount of full-length protein for the FS tRNAs.  The truncation bands are 
approximately the same for all tRNAs and show no significant decrease in intensity with 
increased FL protein.  Looking at the 28 KD and 70 KD protein intensities (proteins 
present in the RRL), there is little difference in these bands between samples and there is 
no global change in protein concentration. 
 
2.2.7 Arg Mutations, Changing CGG Triplets to CGC Triplets 
 The previous Western blots (Figure 2.9 A) suggest that the αNHA construct 
contains a site that is suppressed by HSFSCCCG.  CGX triplets code for the amino acid Arg 
and are possible sites for suppression by HSFSCCCG.  Based on the 29 KD band (Figure 
2.9 A, Lanes 2 & 6) and cognate sequence for HSFSCCCG being CGGG, Arg182 was first 
mutated from CGG to CGC.  CGC was chosen to place the same nucleotide in the mRNA 
that would be used for recognition by the HSFSCCCG anticodon (5’-CCCG-3’) and avoid 
recognition.  The Arg mutants were placed in the αNHA and αNHA154CGGG constructs.  
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These are named by the construct with Arg mutation and the appropriate number 
following. 
 Figure 2.11 shows the Western blot of the Arg182 mutants.  It was hoped the 
mutation would lead to a significant increase in the amount of full-length protein in both 
the αNHAR182 mutant (Figure 2.11, Lane 6) and αNHA154CGGGR182 mutant (Figure 
2.11, Lane 4) upon addition of HSFSCCCG.  αNHAR182 shows higher full-length protein 
(Figure 2.11, Lane 5) than αNHA (Figure 2.11, Lane 1), most likely because the αNHAR182 
mRNA was prepared after the αNHA mRNA.  Upon addition of HSFSCCCG to the αNHA and 
αNHAR182 (Figure 2.11, Lanes 2 & 6) a reduction of 41% and 35%, respectively, was 
seen when compared to the same mRNA without HSFSCCCG.  αNHA154UAG suppression 
by HSAS is either 76% relative to αNHA or 68% relative to αNHAR182 (Figure 2.11, Lane 
8).  HSFSCCCG suppression of αNHA154CGGGR182 and αNHA154CGGG (Figure 2.11, 
Lanes 4 & 7, respectively) showed efficiency of 41% and 30%, respectively.  The 
mutation at R182 shows an improvement of 7% at protecting the αNHAR182 from 
HSFSCCCG suppression (Figure 2.11, Lane 6) and an increase of 11% on the full-length 
protein for αNHA154CGGGR182 suppressed by HSFSCCCG (Figure 2.11, Lane 4).  While 
this is an improvement, the suppression wasn’t increased as much as was hoped and there 
may be other triplets that are recognized on αNHA. 
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Figure 2.11:  HSFSCCCG suppression on αNHAR182 and αNHA154CGGGR182 mutants.  2 
µg mRNA and 2 µg tRNA were used for the experiments.  Lane 1 is αNHA and Lane 2 is 
αNHA + HSFSCCCG.  Lane 3 is αNHA154CGGGR182 and Lane 4 is αNHA154CGGGR182 + 
HSFSCCCG.  Lane 5 is αNHAR182 and Lane 6 is αNHAR182 + HSFSCCCG.  Lane 7 is 
αNHA154CGGG + HSFSCCCG.  Lane 8 is αNHA154UAG + HSAS.  Numbers on the left are 
molecular weight markers (KD).  On the right, UAG or 4C is the truncation at the stop 
codon or four-base codon, respectively, and FL is full-length protein band. 
 
 Further Arg CGG triplets were mutated to CGC.  Arg19 and Arg116 were chosen 
because they were closer to the N-terminus of the protein and these mutations should 
cause greater full-length protein or possibly new bands that could be detected on the 
Western blot.  The αNHA154CGGGR19R116 mutation showed a slight increase in 
suppression when HSFSCCCG was added when compared to αNHAR182 + HSFSCCCG.  
Overall, the αNHA154CGGG constructs with the Arg mutants showed little change in 
suppression efficiency.  Therefore, it appears that only the in-frame CGGG codons need 
to be removed, such as R182.  The R182 is present on the αNHA in all experiments and is 
known as the “masked” construct (33). 
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2.2.8 Optimization of the RRL In Vitro Reactions for Increased Suppression  
Efficiencies 
 In vitro translation reactions are sensitive to organic molecules and salt that is 
added with the tRNA and mRNA (RRL Promega manual).  In order to add more mRNA 
and tRNA, desalting columns were used.  The removal of excess salt and dCA-W from 
the mRNA transcription and tRNA ligations allowed for greater concentrations of mRNA 
and tRNA-W in the reactions, which caused increased protein production.  The tRNAs 
are stored at -80 ˚C and this can cause aggregation and unfolding of the tRNA.  tRNA 
was refolded at 65 ˚C for two minutes, as was done for UAA incorporation in Xenopus 
oocytes (8,16).  Translation reactions were also allowed to proceed for 3–4 h, rather than 
1.5 h.  This allowed for increased protein, which was also seen by Dr. James Petersson 
(personal communication).  These changes all helped to increase protein production and 
were easy to implement. 
 The most important factor was reducing competition with endogenous triplet 
recognizing tRNA in order to increase the suppression efficiency of the FS tRNA.  The 
Sisido group performed UAA incorporation in E. coli in vitro translation system using 
10-fold less Arg in the reaction (34).  Removing Arg decreases the competition of the FS 
tRNAs with endogenous triplet recognizing tRNAs.  Therefore, the Arg concentration 
was reduced 10-fold and this greatly increased the suppression efficiency, as discussed 
below.  Finally, the concentration of tRNA is important for the suppression efficiency.  
The Sisido group used ≈ 6.8 µg of tRNA-dCA-UAA per 10 µl E. coli translation reaction 
(18).  Addition of more tRNA-dCA-UAA also decreases competition with endogenous 
triplet recognizing tRNA and increased the overall amount of protein.  After making 
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these optimizations, it was very easy to observe and quantify suppression in the RRL in 
vitro reactions. 
2.2.9 Choosing a New Frameshift Suppressor tRNA, YFFSCCCG 
 All three of THG73FS showed no suppression in the in vitro reactions (Figures 
2.6 & 2.9), even though THG73 could suppress the amber codon.  At the time, only the 
yeast Phe frameshift suppressor (YFFS) had been used to incorporate UAAs in vitro 
(18,19,26).  YFFSCCCG (sequence shown in Figure 2.3) was chosen as the next suppressor 
tRNA to be tested because HSFSCCCG worked well in RRL and had been used extensively 
by the Sisido group. 
 YFFSCCCG-W shows suppression in RRL and is dependent on the amount of tRNA 
added (Figure 2.12).  Figure 2.12, Lanes 2 and 3 show αNHA154CGGG + YFFSCCCG-W 
with 3.4 µg and 6.8 µg, respectively, and show a suppression efficiency of 37% and 46%, 
respectively.  This efficiency exceeded any of the THG73FS-A/W experiments.  
αNHA154CGGG + HSFSCCCG showed a suppression efficiency of 100% (Figure 2.12, Lane 
4) using the optimized conditions.  αNHA154UAG + HSAS also had a suppression 
efficiency of 100% (Figure 2.12, Lane 6), showing that both nonsense and frameshift 




Figure 2.12:  YFFSCCCG-W and HSFSCCCG suppression at αNHA154XXX(X).  4 µg mRNA 
were used in each lane.  Lane 1 is αNHA.  Lane 2 is αNHA154CGGG + 3.4 µg YFFSCCCG-W.  
Lane 3 is αNHA154CGGG + 6.8 µg YFFSCCCG-W.  Lane 4 is αNHA154CGGG + 5.5 µg 
HSFSCCCG.  Lane 5 is αNHA154CGGG.  Lane 6 is αNHA154UAG + 5.5 µg HSAS.  Lane 7 is 
αNHA154UAG.  Lane 8 is RRL without mRNA and tRNA.  Note all constructs contain the 
R182 mutation and reactions were performed using optimized conditions.  Numbers on 
the left are molecular weight markers (KD).  On the right, UAG or 4C is the truncation at 
the stop codon or four-base codon, respectively, and FL is full-length protein band. 
 
 Previously, the Sisido group had shown that the YFFSCCCG can be aminoacylated 
by endogenous aaRSs in E. coli in vitro reactions (19,35).  In E. coli in vitro reactions, 
YFFSCCCG is predominately aminoacylated by the ArgRS (35).  However, YFFSACCC is 
recognized in E. coli in vitro reactions by the GlyRS and mutations were made to the 
acceptor stem (shown in Figure 2.3) to decrease recognition (19).  These acceptor stem 
mutations were made to create YFaFSCCCG (shown in Figure 2.3).  The discriminator base 
(N73) is also an important recognition by many aaRSs in prokaryotic and eukaryotic cells 
(36,37).  Work in Xenopus oocytes established that mutation of the discriminator base 
drastically decreased aminoacylation of THG73 (16).  Therefore, A73 of YFFSCCCG was 
mutated to G73 to create YFG73FSCCCG (shown in Figure 2.3). 
 Figure 2.13 shows suppression (-Trp) and reaminoacylation experiments with 
YFFSCCCG, YFG73FSCCCG, and YFaFSCCCG.  YFFSCCCG-W had a suppression efficiency of 
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16% (Figure 2.13, Lane 2) and YFFSCCCG (74 mer) had 22% full-length protein of 
αNHA (Figure 2.13, Lane 3).  The suppression efficiency of YFFSCCCG-W was not typical.  
YFG73FSCCCG-W showed a suppression efficiency of 60% (Figure 2.13, Lane 4) and 
YFG73FSCCCG (74 mer) had 24% full-length protein of αNHA (Figure 2.13, Lane 5).  
YFFSCCCG and YFG73FSCCCG (74 mer) show approximately the same amount of 
reaminoacylation product (Figure 2.13, Lanes 3 & 5).  YFaFSCCCG-W had a suppression 
efficiency of 26% (Figure 2.13, Lane 6), but YFaFSCCCG (74 mer) had 10% full-length 
protein of αNHA (Figure 2.13, Lane 7).  This reaminoacylation is very close to the 
αNHA154CGGG mRNA only, which had 9% of αNHA (Figure 2.13, Lane 8).  HSFSCCCG 
showed a suppression efficiency of 33% (Figure 2.13, Lane 9).  This Western blot shows 
that reaminoacylation of YFFSCCCG and YFG73FSCCCG can be problematic in the RRL 
using the optimized conditions. 
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Figure 2.13:  YFFSCCCG, YFG73FSCCCG, YFaFSCCCG (-Trp), and HSFSCCCG suppression 
and reaminoacylation (74 mer) tested at αNHA154CGGG.  4 µg of mRNA, 6.8 µg of 
YFFSCCCG, YFG73FSCCCG, YFaFSCCCG (-W or 74 mer), and 5.5 µg of HSFSCCCG were used 
in each lane.  Lane 1 is αNHA.  Lane 2 is αNHA154CGGG + YFFSCCCG-W.  Lane 3 is 
αNHA154CGGG + YFFSCCCG (74 mer).  Lane 4 is αNHA154CGGG + YFG73FSCCCG-W.  
Lane 5 is αNHA154CGGG + YFG73FSCCCG (74 mer).  Lane 6 is αNHA154CGGG + 
YFaFSCCCG-W.  Lane 7 is αNHA154CGGG + YFaFSCCCG (74 mer).  Lane 8 is 
αNHA154CGGG.  Lane 9 is αNHA154CGGG + HSFSCCCG.  All constructs contain the R182 
mutation and reactions performed using optimized conditions.  Numbers on the left are 
molecular weight markers (KD).  On the right, CGGG is the truncation at the four-base 
codon and FL is full-length protein band. 
 
2.2.10 HSAS and HSFS Suppression at αNHA149XXX(X) 
 All previous work had been done suppressing at αNHA154XXX(X) and therefore 
we wanted to look at a second suppression site that would be in a similar location, but 
also useful for in vivo studies.  We chose to study α149W of the nAChR because this 
residue makes a cation-π interaction with acetylcholine and causes a noticeable shift in 
EC50 when fluorinated Trp (UAAs) are incorporated at the site (15).  Figure 2.14 shows 
suppression experiments with HSAS and HSFSCCCG at αNHA154XXX(X) and 
αNHA149XXX(X) for comparison.  HSFSCCCG suppresses comparably at both 
αNHA154CGGG (Figure 2.14, Lane 2) and αNHA149CGGG (Figure 2.14, Lane 5).  HSAS 
also shows comparable suppression at both sites (Figure 2.14, Lanes 7 & 9).  All 
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suppression was > 100% of αNHA, which appears to not have translated well (Figure 2.14, 
Lane 1).  Most intriguing is that you can see the difference in molecular weight of the 
truncation bands.  The frameshift at αNHA154CGGG is predicted to have a mass of 21.3 
KD, αNHA149CGGG is predicted to have a mass of 20.6 KD, αNHA154UAG is predicted to 
have a mass of 20.4 KD, and αNHA149UAG is predicted to have a mass of 20.2 KD.  
These were arranged on the Western blot from highest molecular weight (Figure 2.14, 
Lanes 2 & 3) to lowest molecular weight (Figure 2.14, Lanes 8 & 9).  The correlation in 
migration and predicted mass shows that the frameshift suppression has the correct 
truncation pattern and is properly truncating in RRL. 
 
 
Figure 2.14:  HSFSCCCG and HSAS suppression at αNHA154XXX(X) and 
αNHA149XXX(X).  4 µg of mRNA and 5.5 µg of tRNA were used in each lane.  Lane 1 is 
αNHA.  Lane 2 is αNHA154CGGG.  Lane 3 is αNHA154CGGG + HSFSCCCG.  Lane 4 is 
αNHA149CGGG.  Lane 5 is αNHA149CGGG + HSFSCCCG.  Lane 6 is αNHA154UAG.  Lane 7 
is αNHA154UAG + HSAS.  Lane 8 is αNHA149UAG.  Lane 9 is αNHA149UAG + HSAS.  
Lane 10 is RRL without mRNA and tRNA.  All constructs contain the R182 mutation 
and reactions performed using optimized conditions.  Numbers on the left are molecular 
weight markers (KD).  On the right, UAG or 4C is the truncation at the stop codon or 
four-base codon, respectively, and FL is full-length protein band. 
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2.2.11 Suppression Efficiencies of Suppressor tRNAs Using Optimized Conditions 
 After performing Western blots with the optimized conditions and various 
suppressor tRNAs, the average suppression efficiency relative to αNHAR182 was 
calculated to allow comparison between different batches of RRL.  Figure 2.15 shows the 
overall suppression efficiency.  mRNA only for αNHA154CGGG is 15% and 
αNHA154UAG is 12% (Figure 2.15, gray bars) and represents the read-through of the 
suppression site in vitro and endogenous protein at the same molecular weight.  
HSFSCCCG and HSAS suppress almost equivalently with the same amount of tRNA 
(Figure 2.15, blue bars).   Suppression efficiency of the HSFSCCCG is most likely 
increased because of the decreased concentration of Arg in the in vitro reactions, which 
causes less competition with endogenous triplet recognizing tRNA (Figure 2.2 D).  
Reaminoacylation of YFFSCCCG (74 mer) occurs in the RRL in vitro translation and 
appears to be increased by the amount of tRNA added and the extended reaction times 
used under the optimized conditions (Figure 2.15, green bars).  Suppression of YFFSCCCG-
W is also dependent on the amount of tRNA added and increases from 30% to 67% with 
3.4 µg to 6.8 µg of YFFSCCCG-W, respectively (Figure 2.15, red bars).  THG73-W shows 
an average suppression efficiency of 66%, but only 2 µg of tRNA was used.  Overall, 
frameshift is viable in the RRL in vitro system and should work in Xenopus oocytes. 
 60 
 
Figure 2.15:  Average suppression efficiency and reaminoacylation of suppressor tRNAs 
using optimized Western blot conditions and αNHAR182.  All tRNA were added to their 
cognate suppression site at αNHA154.  αNHA154XXX(X) alone is shown in gray and 
represents read-through of the protein and endogenous protein at the same molecular 
weight as the FL protein (background) in vitro.  The suppression efficiency was 
expressed relative to αNHA.  HSFSCCCG and HSAS show nearly the same suppression 
efficiency in vitro with this amount of tRNA.  YFFSCCCG (74 mer) is a reaminoacylation 
experiment to test if an endogenous aaRS recognizes the tRNA.  YFFSCCCG-W shows that 
expression varies with the amount of tRNA added to the RRL.  THG73FSCCCG-W shows 
no suppression and the intensity of the full-length band is actually less than the 
background of αNHA154CGGG alone, which was consistently seen.  THG73-W shows 
approximately the same suppression efficiency as YFFSCCCG-W, but there is much less 
tRNA used for the amber suppressor.  Number of Western blot lanes used is listed above 
each bar, except for αNHAR182, which was always used for normalization, and YFFSCCCG 
(3.4 µg), which was only performed once. 
 
2.3 Discussion 
The eukaryotic in vitro translation system described here was invaluable for 
gaining knowledge about the translational machinery and how the suppressor tRNAs 
suppress mRNA.  RRL appears to be much more efficient in the translation of the nAChR 
αNHA-subunit than the WG system (Figures 2.6 & 2.7, for direct comparison), which has 
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been seen by other members of our group (Dr. James Petersson and Dr. Niki Zacharias, 
personal communication).  In order to achieve reproducible protein translation that was 
much greater than background, it was essential to optimize many components of the 
mRNA and tRNA handling and purification, reduction of competition for the frameshift 
suppressors by increasing the amount of tRNA added and decreasing the concentration of 
Arg, and extending the translation reaction time to 3–4 h.  Under these conditions, 
suppression experiments gave consistent full-length protein intensities that were much 
stronger than bands with mRNA only (Figures 2.12–2.14).  This is necessary to evaluate 
the suppression efficiency and determine if a suppression event has occurred. 
The suppression sites studied here were CGGG, CGUG, and CGUU with both the 
HSFS and THG73FS tRNAs.  CGUG and CGUU were untested at the time the research 
was performed and show little or no suppression with the HSFS tRNAs in the RRL 
system.  CGGG had been previously used by the Sisido group to incorporate UAAs in E. 
coli in vitro reactions (17,34) and this work showed that CGGG also works in the RRL in 
vitro reactions.  After this research was performed, the Sisido group tested multiple 
quadruplet codons in the RRL system.  While CGUG and CGUU were not tested, CGAU 
showed no suppression efficiency and CGCU showed ≈ 26% suppression efficiency in 
RRL (21).  Therefore it is difficult to predict what quadruplet codons will be 
suppressible, but the Sisido group has performed many experiments now in E. coli and 
RRL in vitro systems to identify functional quadruplet codons (19,21). 
HSAS and HSFS tRNAs are exceedingly useful tools for suppression 
experiments.  Both the amber and frameshift suppressor tRNAs are aminoacylated in 
vitro (Figures 2.4–2.9 & 2.11–2.14) and therefore they are useful tools to test suppression 
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sites without the need to ligate aas or UAAs to the tRNA.  Intriguingly, under the 
optimized conditions there is ≈ 100% suppression efficiency for both HSAS and 
HSFSCCCG with the same amount of tRNA (Figure 2.15).  This suggests that even with the 
10-fold reduction in concentration of Arg, competition with endogenous triplet 
recognizing tRNA with HSFSCCCG (Figure 2.2 D) is comparable to the competition of 
HSAS with the protein release factor, eRF1 (Figure 2.2 B).  The HSAS and HSFS tRNAs 
can also be compared to tRNA/aminoacyl-tRNA synthetase pairs that have been 
developed for the incorporation of UAAs in vivo (4,11,38).  In both cases, the aa or UAA 
is placed on the tRNA by a protein in the translation reaction and is catalytic.  This work 
establishes that both HSAS and HSFSCCCG are accepted by the translational machinery 
equally (under the optimum conditions, Figure 2.15) and tRNA/aminoacyl-tRNA 
synthetase pairs (amber and frameshift) should be extremely useful for in vitro translation 
systems to produce high yields of protein containing multiple UAAs. 
THG73 has been used extensively for incorporating UAAs in Xenopus oocytes 
using nonsense suppression at the amber codon (2,3,8,16).  However, THG73FSCCCG does 
not suppress in the in vitro translation reactions.  Figure 2.9 B, Lane 2 shows a 
representative reaction where the addition of THG73FSCCCG is added to αNHA (wild-type) 
and there is virtually no full-length protein produced.  When THG73FSCCCG is added to 
αNHA154CGGG, there is no full-length protein (Figure 2.9 B, Lane 6) and the full-length 
band shows less intensity than read-through of the mRNA only (Figure 2.15).  
THG73FSCCCG was not only non-functional, but has a unique phenotype of nearly 
abolishing translation and/or degrading protein (as determined by the Western blot 
analysis).  Therefore, it is very unlikely that the THG73FSCCCG is simply misfolding or 
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not accepted by the translational machinery.  Rather it is more likely that the tRNA is 
stalling the ribosome, causing an RNAi response, or some other mechanism that could 
either stall translation or cause mRNA and/or protein degradation.  THG73FSCCCG is 
unique among the tested suppressor tRNAs for this reason and this information would be 
unattainable without the use of the in vitro system and Western blotting. 
The YFFSCCCG was not the original choice for a frameshift suppressor tRNA for 
the incorporation of UAAs.  Previous work had shown that a modified yeast Phe amber 
suppressor (named MN3) was much less efficient than THG73 at suppressing the amber 
codon in Xenopus oocytes (16).  MN3 was also shown to be aminoacylated in the 
Xenopus oocyte greater than THG73 (16).  These reaminoacylation experiments were 
performed at aromatic amino acid sites, which would be the most logical aaRSs that 
would recognize MN3.  YFFSCCCG-W was able to suppress in the RRL system (Figures 
2.12 & 2.13).   After this research was performed, the Sisido group performed research in 
the RRL system with YFFSCCCG-NitroPhe and obtained a suppression efficiency of 64% 
with 6.8 µg of tRNA suppressing at position 83CGGG of streptavidin (21).  This is very 
close to the suppression efficiency of 68% with YFFSCCCG-W (6.8 µg) suppressing at 
αNHA154CGGG (Figure 2.15).  This work therefore agrees with the Sisido group and 
YFFSCCCG should be useful for the incorporation of UAAs in Xenopus oocytes. 
Frameshift suppression appears to be unrealistic for use in mammalian cells and 
other cells that are dividing, because the FS tRNAs would recognize sites on endogenous 
mRNA, which is suggested by identifying FS tRNAs in vivo (28).  The recognition of 
other sites would cause a loss of the UAA and could be toxic to the cell.  The Xenopus 
oocyte system is ideal for the use of frameshift suppression because the added mRNA is 
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predominately translated in vivo.  Another advantage for the oocyte system is that the 
most used Arg triplets (AGG and AGA) (27) would not be recognized by the modified 
FS tRNAs used in this study.  Therefore all possible Arg sites could be mutated to either 
AGG or AGA in the nAChR sequence.  This would allow for only competition between 
the FS tRNAs and endogenous triplet recognizing tRNA at the suppression site.  This 
should increase the total suppression efficiency of the FS tRNAs and may also increase 
the overall translation efficiency of the nAChR.  However, the amount of mutagenesis 
required to mutate all Arg sites would be time consuming and the Western blots suggest 
that full-length protein is being produced, which should be detectable by the sensitive 
assay of electrophysiology. 
 
2.4  Experimental Methods 
2.4.1 Materials 
 Oligonucleotides were synthesized by the California Institute of Technology 
Biopolymer Synthesis facility.  NotI was purchased from Roche Applied Science 
(Indianapolis).  BamHI, EcoRI, FokI, DpnI, MluI, Bsu36I, BstXI, T4 DNA ligase, and T4 
RNA ligase were purchased from New England Biolabs (Beverly, MA).  Kinase Max, T7 
MEGAshortscript, and T7 mMessage mMachine kits were purchased from Ambion 
(Austin, TX).  HA.11 monoclonal antibody from mouse was from Covance (Berkeley, 
CA).  Peroxidase-conjugated affinipure goat anti-mouse IgG was from Jackson Immuno 
Research (Westgrove, PA). 
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2.4.2 αNHA Mutations and mRNA Preparation 
The αNHA in the pAMV vector was a gift from Dr. Gabriel Brandt.  UAG 
mutations (S154 & S374) and Arg point mutations (CGG to CGC) were made using the 
QuikChange Site-Directed Mutagenesis (Stratagene).  Plasmids were purified using the 
QIAprep Spin Miniprep Kit (Qiagen), restriction enzyme screened (if possible), and 
sequenced at the Caltech DNA Sequencing facility. 
Four-base codons were mutated by overlap-extension PCR as described (39).  
Mutagenic PCR primers were ordered with at least 20 base pairs after the mutation 
region, which consisted of 3 mismatched and 1 insertion for S154 and 5 mismatches and 
1 insertion for S374 (extra 2 mismatches to place stop codons).  The initial PCR reactions 
contained 100 ng of DNA template, 1 µg of appropriate outer primer and mutagenic 
primer, 1 µl 25 mM dNTPs, 5 µl 10X buffer, millipore water to 49 µl, and 1 µl PfuTurbo 
Hotstart DNA Polymerase (Stratagene).  The reaction was run with 30 cycles of 95 ˚C 1 
min, 55 ˚C 1 min, and 72 ˚C for 7 min.  The reaction mixture was run on a 1% agarose 
gel and the appropriate length band was purified using QiaQuick Gel Extraction kit 
(Qiagen).  4 µl of the first two PCR reactions were subjected to another round of PCR 
using 1 µg of each outer primer.  The reaction was run with 30 cycles of 95 ˚C 1 min, 55 
˚C 1 min, and 72 ˚C for 7 min, and the appropriate size band was purified by gel 
extraction.  25 µl of the PCR product was then digested with MluI and Bsu36I for S154 
or Bsu36I and BstXI for S374.  Trimmed DNA was gel purified.  The trimmed product 
was subcloned into the trimmed αNHA in the pAMV vector that was dephoshphorylated by 
shrimp alkaline phosphatase (Boehringer Mannheim Biochemicals) with T4 DNA ligase 
overnight at 16 ˚C.  The ligation reaction was electroporated into bacteria and plasmids 
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were purified using QIAprep Spin Miniprep Kit (Qiagen), restriction enzyme screened (if 
possible), and sequenced at the Caltech DNA Sequencing facility. 
25–50 µg of mutated DNA was linearized with NotI for 12 h.  Linearization was 
gel screened for completion before extracting with 25:24:1 phenol:chloroform:isoamyl 
alcohol and precipitated with ethanol for 12 h.  DNA was dissolved in 52 µl DEPC water 
and concentration determined by UV.  mRNA was transcribed in vitro using T7 
mMessage Machine kit for 3–4 h.  mRNA was purified using RNeasy kit (Qiagen) and 
quantified by UV absorption at 260 nm.  mRNA was aliquoted and stored at –80 ˚C until 
used. 
2.4.3 Frameshift Suppressor tRNA Gene Construction and tRNA Preparation 
HSAS and THG73 tRNA genes in the pUC19 plasmid were a gift from Dr. Sarah 
Monahan.  HSFS tRNAs were made by the following oligonucleotides: 5’-
AATTCGTAATACGATCACTATAGTAGTCGTGGCCGAGTGGTTAAGGCGATGG
ACT(XXXX)AATCCATTGGGGTCTCCCCGCGCAGGTTCGAATCCTGCCGACTAC
GCCATGAGACCCATCCG-3’.  THG73FS tRNAs were made by the following 
oligonucleotides: 5’-AATTCGTAATACGACTCACTATAGGTTCTATAGTATAGCG 
GTTAGTACTGGGGACT(XXXX)AATCCCTTGACCTGGGTTGAATCCCAGTAGGA
CCGCCAGAGACCCATCCG-3’.  XXXX is CCCG, CACG, and AACG (written 5’-3’) 
for both THG73 and HSAS tRNAs.  YFFSCCCG was prepared with the following 
oligonucleotides: 5’-AATTCGTAATACGACTCACTATAGCGGATTTAGCTCAGTT 
GGGAGAGCGCCAGACT(CCCG)AATCTGGAGGTCCTGTGTTCGATCCACAGAA
TTCGCACCATGAGACCCATCCG-3’.  Note, oligonucleotides contain overlapping 
ends for ligation into pUC19 with EcoRI and BamHI. 
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The oligonucleotides were phosphorylated using Kinase Max kit, annealed, 
ligated to pUC19 plasmid (linearized with EcoRI and BamHI, dephosphorylated with 
shrimp alkaline phosphatase, purified by gel, and extracted using QiaQuick Gel 
Extraction kit (Qiagen)) with T4 DNA ligase at 16 ˚C for 12 h.  Bacteria were 
electroporated, plasmids were purified using QIAprep Spin Miniprep Kit (Qiagen), 
restriction enzyme screened for insert with EcoRI and BamHI, and sequenced at the 
Caltech DNA Sequencing facility.  tRNA were prepared similarly to procedures 
previously described (16,40). 
25–50 µg DNA was linearized with Fok1 for 12 h.  The linearization was gel 
screened for completion before extracting with 25:24:1 phenol:chloroform:isoamyl 
alcohol and precipitation with ethanol for 12 h.  DNA was dissolved in 52 µl DEPC water 
and concentration determined by UV absorption at 260 nm.  tRNA was transcribed in 
vitro using T7-MEGAshortscript kit for 3–4 h, which creates a 74mer tRNA lacking the 
last two nucleotides.  The tRNA was extracted with 25:24:1 phenol:chloroform:isoamyl 
alcohol and precipitated with isopropanol for 12 h.  tRNA was dissolved in DEPC water, 
run on gel with a previously prepared tRNA sample, quantified by UV absorption at 260 
nm, and verified as the correct mass using MALDI-TOF mass spectrometry as described 
for THG73 (41).  Using optimized conditions, the tRNA was dissolved in RNAse free 
water and desalted using CHROMA SPIN™-30 DEPC-H2O columns (BD Biosciences, 
San Jose, CA).  tRNA was aliquoted and stored at –80 ˚C until used. 
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2.4.4 dCA-aa Synthesis and Ligation to Supressor tRNAs 
The synthesis of dCA and the coupling of UAAs has been described previously 
(40,42).  dCA-Ala was a gift from Amy Eastwood and dCA-Trp was a gift from Dr. 
Sarah Monahan.  Ligation to THG73, THG73FS, and YFFS tRNAs was performed as 
previously described (40,41).  Briefly, the tRNA is denatured by placing in boiling water 
and allowed to cool in an ice bath to ≈ 37 ˚C to refold the tRNA.  The tRNA is ligated to 
the dCA-aa using T4 RNA ligase for 30 min (longer times result in increased hydrolysis 
of the aa).  The reaction is then extracted using 25:24:1 phenol:chloroform:isoamyl 
alcohol at pH = 5.2 and precipitated with ethanol for 12 h (longer precipitation times can 
result in hydrolysis of the aa).  The tRNA was resuspended in DEPC ≈ 1 µg / µl.  Using 
optimized conditions, the tRNA was resuspended in RNAse-free water and desalted using 
CHROMA SPIN™-30 DEPC-H2O columns (BD Biosciences, San Jose, CA).  The 
tRNA-dCA-aa was aliquoted and placed at -80 ˚C until used.  Ligation efficiency was 
qualitatively determined by MALDI-TOF as previously described (41).  
2.4.5 In Vitro Translation 
The tRNA was normalized and more concentrated samples were diluted with 
DEPC water so the same amount of tRNA was added to each in vitro reaction.  The same 
was done for the mRNA samples. 
Rabbit reticulocyte lysate (RRL), nuclease treated (Promega), was thawed slowly 
on ice.  All reactions on a gel were run with the same tube of RRL.  For eight samples, 
3/5 reactions were run as follows:  22 µl RRL, 0.9 µl 1 mM aa mix, 0.6 µl RNAse 
Inhibitor (Roche), various amounts of mRNA and/or tRNA (noted with each figure), and 
filled to 30 µl with DEPC water.  The NVOC protecting group was removed immediately 
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before use in in vitro reactions by irradiation of the tRNA-dCA-aa-NVOC for 5 min with 
a 1,000 W Hg(Xe) arc lamp as described (40).  Translation was run at 30 ˚C for 1.5 h and 
placed at –80 ˚C.  TNT Coupled Reticulocyte Lysate (Promega) was employed the same 
as RRL with DNA, following manufacturers protocol.  The reaction was run for 1.5 h and 
placed at –80 ˚C. 
Wheat germ extract (WG) (Promega) was thawed on ice and all reactions were 
performed with the same WG tube.  3/5 reactions were performed as follows:  15 µl WG, 
1.33 µl 1 mM aa mix, 3.6 µl 1 M KOAc, 1 µl RNAse Inhibitor (Roche), various amounts 
of mRNA and/or tRNA, and filled to 30 µl with DEPC water.  Translation was run at 25 
˚C for 1.5 h and placed at –80 ˚C. 
Under optimized conditions, the RRL reaction was performed as follows.  For 
eight samples, 3/5 reactions were run as follows:  22 µl RRL, 1 µl 1 mM 19 aa mix (-
Arg), 1 µl 0.1 mM Arg, 0.6 µl RNAse Inhibitor (Roche), various amounts of mRNA 
and/or tRNA (noted with each figure and greater than un-optimized conditions), and 
filled to 30 µl with RNase free water.  The tRNA was refolding at 65 ˚C for 2 min and the 
NVOC protecting group was removed immediately before use in in vitro reactions by 
irradiation of the tRNA-dCA-aa-NVOC for 5 min with a 1,000 W Hg(Xe) arc lamp as 
described (40).  Translation was run at 30 ˚C for 3–4 h and placed at –80 ˚C. 
2.4.6 Western Blotting and Densiometric Analysis 
Western blotting was performed as previously described (14).  Briefly 5 µl of 
crude in vitro translation was added to 5 µl of 2X SDS loading buffer.  Samples were 
loaded on a 4–15% linear gradient ready gel Tris-HCl (Bio-Rad) and run at 150 V for 
1.25 h or until the hemoglobin (red band from RRL) had run off the gel.  Protein was 
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transferred to nitrocellulose (Bio-Rad) at 30 V for 30 min and 100 V for 1.5 h.  
Nitrocellulose was blocked for 1 h or overnight using non-fat dairy milk (NFDM) in 1X 
PBS / 0.1% Tween, placed in 62.5–87.5 µg 1˚ Ab anti-hemagglutinin (Covance) in 15 ml 
NFDM / 1X PBS / 0.1% Tween for 1 h, washed 4X with 30 ml 1X PBS / 0.1% Tween for 
5 min each, placed in 4 µg Peroxidase-conjugated AffiniPure Goat Anti-Mouse IgG 
(Jackson ImmunoResearch) in 30 mL NFDM / 1X PBS / 0.1% Tween for 1 h, and 
washed 4X with 30 ml 1X PBS / 0.1% Tween for 5 min each.  Nitrocellulose was 
visualized using ECL Detection Kit and Hyperfilm ECL (Amersham Biosciences).  ECL 
reagents were left on nitrocellulose for 1 min and quickly exposed for 30 sec, 15 sec, 10 
sec, and 5 sec during the highest intensity light emission (1–5 min after exposure to ECL 
reagents, Amersham Biosciences manual). 
Densiometric analysis was performed using the NIH Image program (National 
Institute of Health).  Calculation of band intensity was performed similar to the manner 
of Sisido and coworkers (34).  A calibration curve could not be generated because the 
protein is present in a very small amount, so numbers are qualitative rather than 
quantitative.  Background intensity was determined by various endogenous protein bands 
in the RRL.  Intensities of protein bands reported here are average values across the entire 
lane.  Translation (for two suppression site constructs) or suppression efficiency is 
calculated by [(Suppressed FL Protein Intensity)/(Wild-type FL Protein Intensity(or 
similar control))]*100  or for suppression of the wild-type constructs; [1-(Wild-type + 
tRNA FL Intensity)/(Wild-type FL Intensity)]*100. 
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3.1  Introduction 
The site-specific incorporation of unnatural amino acids (UAAs) into proteins 
biosynthetically is a powerful methodology that is seeing increasing use.  The primary 
approach has been stop codon (nonsense) suppression using a specially designed tRNA 
with an anticodon recognizing the stop codon.  A wide range of in vitro translation 
systems has been employed, along with expression in E. coli and, to a lesser extent, yeast.  
Nonsense suppression in higher eukaryotes has for the most part been limited to the 
Xenopus oocyte (1,2).  The incorporation of UAA(s) in Xenopus oocytes is shown in 
Figure 3.1.  The mRNA with the suppression site(s) (stop and/or quadruplet codons) 
(Figure 3.1, 1) (for the mechanism of stop codon and quadruplet codon suppression see 
Figure 2.2) and the tRNA(s) chemically aminoacylated with the UAA(s) (Figure 3.1, 2) 
are injected into a Xenopus oocyte (Figure 3.1, 3).  The oocyte is allowed to incubate for 
1–2 days to allow for UAA(s) incorporation by the endogenous translational machinery, 
protein folding and processing, ion channel assembly, and export to the surface of the cell 
(Figure 3.1, 4).  UAA(s) incorporation is then assayed using the sensitivity of 
electrophysiology (Figure 3.1, 5).  Other experiments in higher eukaryotes have relied on 
the evolution of a unique tRNA and a complementary aminoacyl-tRNA synthetase 
(aaRS) to insert an UAA in response to the UAG or UGA stop codon, but currently only 





Figure 3.1:  Multiple UAA incorporation in ion channels expressed in Xenopus oocytes.  
(1) mRNAs with the appropriate suppression sites are transcribed in vitro.  (2) Suppressor 
tRNAs are transcribed in vitro.  An UAA is synthesized and chemically aminoacylated 
onto the suppressor tRNAs.  (3) mRNAs and tRNAs are micro-injected into the Xenopus 
oocyte.  (4) Oocytes are incubated to allow for protein translation with UAAs site-
specifically incorporated.  The ion channels are folded, processed (signal sequence 
removal, glycosylation, etc.), assembled into multi-subunit channels, and transported to 
the plasma membrane.  (5) UAA incorporation is detected using the sensitive assay of 
electrophysiology.  Figure adapted from (2). 
 
A remarkable variant of this approach is the use of quadruplet codons, a process 
termed frameshift suppression, that was pioneered by Sisido and coworkers (6,7).  The 
success of this approach opens up the possibility of developing multiple new codons, and 
thus incorporating several different UAAs into a protein.  This in turn would enable novel 
biophysical approaches such as incorporating fluorescence resonance energy transfer 
(FRET) pairs, new structural probes such as novel cross-linking approaches, and more 
detailed structure-function studies. 
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To date frameshift suppression in vivo has been performed only in E. coli by 
using a unique tRNA/aaRS pair, and homoglutamine is the only UAA incorporated by 
this method (8).  It has yet to be established whether frameshift suppression by 
chemically aminoacylated tRNA can be effective in vivo in general, and in eukaryotic 
cells such as the Xenopus oocyte in particular.  In fact, a previous attempt to perform 
frameshift suppression in Xenopus oocytes showed very poor suppression efficiency (9).  
Here we show that with appropriately designed frameshift suppressor (FS) tRNAs, 
frameshift suppression is a viable approach to UAA incorporation in eukaryotic cells.  
Also, the efficiency of frameshift suppression can be substantially improved by 
“masking” the mRNA of all in-frame quadruplet sequences that match the frameshift 
suppression site.  In particular, we describe two tRNAs with 4-base anticodons that can 
deliver UAAs in response to the quadruplet codons CGGG and GGGU.  When directly 
compared to an amber suppressor (AS) tRNA (THG73) that has been used extensively in 
Xenopus oocytes, the FS tRNAs are less efficient at delivering UAAs.  However, both FS 
tRNAs are more “orthogonal” than THG73, producing much less incorporation of 
undesired natural amino acids at promiscuous sites.  We also show that suppression by 
FS tRNAs increases nonlinearly with the amount of injected tRNA.  To illustrate the 
potential of this methodology, we have successfully incorporated two and three different 




3.2  Results 
3.2.1 Testing Frameshift Suppression Viability In Vivo 
 To determine whether frameshift suppression is viable in Xenopus oocytes, we 
chose to use a tRNA that can be aminoacylated in vivo.  We selected the human serine 
amber suppressor (HSAS), because it is aminoacylated (with serine) in eukaryotic cells, 
and the seryl-tRNA synthetase does not recognize the anticodon (10–12).  The CUA 
anticodon of HSAS was replaced with CCCG and ACCC to create the human serine 
frameshift suppressors (HSFSCCCG and HSFSACCC) (cloverleaf structures shown in Figure 
3.2, A), which recognize the quadruplet codons CGGG and GGGU, respectively.  Prior 
research showed that these 4-base codons are efficient in vitro (7).  Injection of wild-type 
muscle nicotinic acetylcholine receptor (nAChR) mRNA and either HSFSCCCG or 
HSFSACCC (2.5 or 10 ng per oocyte; no amino acid ligated to the tRNA) into Xenopus 
oocytes resulted in no detectable channel expression.  The addition of the original amber 
suppressor HSAS with wild type nAChR mRNA did show channel expression with 2.5 
ng tRNA per oocyte, but not with 10 ng.  These results suggested that the HSFS tRNAs 
were causing +1 frameshifts, resulting in undesirable truncation of wild-type protein and 
thus a lack of detectable current.  Analysis of the four nAChR subunits revealed four 
CGGG and one GGGU in-frame quadruplet codons.  These were mutated to degenerate 
codons (see methods) to avoid suppression, and we refer to the resulting mRNAs as the 
“masked” constructs.  Other groups have similarly removed undesired in-frame 
quadruplets (7,9,13).  Injection of 2.5 ng per oocyte of either unligated HSFS plus the 
masked nAChR mRNAs resulted in functional channels with the same EC50 as channels 
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expressed without tRNA (data not shown).  Unless otherwise noted, all subsequent 
experiments used such masked constructs. 
 
 
Figure 3.2:  tRNAs and UAAs.  (A) The AS tRNAs are shown with the CUA anticodon 
and the FS anticodons used in this study are shown below.  YFaFS tRNA acceptor stem 
mutations are shown next to the YFFS tRNA body (italicized).  (B) The three UAAs used 
in this study. 
 
 To test whether a naturally occurring amino acid (serine) could be incorporated in 
response to a quadruplet codon, we probed a highly conserved leucine of the nAChR M2 
domain, a site designated Leu9’ (shown in Figure 3.3).  This is a promiscuous site in the 
nicotinic receptor, and replacement of the native leucine with essentially any natural 
amino acid produces a functional receptor, usually with a quite noticeable shift in EC50.  
In particular, prior research showed that a leucine-to-serine mutation in the β subunit 





Figure 3.3:  nAChR suppression sites used in this research.  (A) The α-subunit of the 
nAChR.  αW149 and αL9’ are shown in red and green, respectively.  (B) The α-, β-, and 
δ-subunits of the nAChR are shown.  αW149 and L9’ are shown in red and green, 
respectively.  These were the three subunits used to simultaneously incorporate three 
UAAs.  (C) Top view of the nAChR with αW149 and L9’ shown in red and green, 
respectively.  Due to the stoichiometry (2α:β:γ:δ), the simultaneous incorporation of 
three different UAAs at α149UAG, β9’CGGG, and δ9’GGGU results in four UAAs per 
ion channel.  Figure created from 2BG9.pdb (15). 
 
 
The β9’ site was mutated to UAG, CGGG, or GGGU.  When mutant mRNA was 
injected into Xenopus oocytes along with 2.5 ng of unligated HSAS or HSFS tRNA, 
which should be aminoacylated with serine by the endogenous seryl-tRNA synthetase, 
significant channel expression was seen.  However, the EC50 values varied depending on 
the incubation time (Table 3.1, A).  This suggested that natural amino acids other than 
serine were being placed at the β9’ site with two-day incubations, because the 
conventional mutant, β9’Ser, shows no change in EC50 (Table 3.1, A).  The variability in 
EC50 between one and two day incubations suggests that the tRNAs are being modified to 
accept other amino acids.  Modification of yeast phenylalanine tRNA in Xenopus oocytes 
has been shown to increase greatly from one-to-two day incubation times (16).  Thus, we 
avoid this complication by incubation for one day.  Amber suppression is highly efficient 
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when the average maximal peak current (Imax) is measured at 1.25 ng of tRNA per oocyte 
and decreases slightly when 2.5 ng is added (Table 3.1, B).  CGGG shows lower 
suppression than GGGU, in agreement with previous in vitro studies (7,17).  CGGG 
suppression is highly nonlinear, with a 330% increase in current when twice as much 
tRNA is injected (Table 3.1, B).  GGGU however shows an almost linear relationship, 
with an increase of 86% in response to doubling (Table 3.1, B).  These data suggest that 
HSFSACCC is a more efficient tRNA at recognizing its cognate quadruplet codon and/or 
has less competition with endogenous triplet tRNA in Xenopus oocytes than HSFSCCCG.  
These experiments establish that frameshift suppression is viable in Xenopus oocytes, and 
that UAA incorporation should be feasible using the appropriate FS tRNA. 
 






nH n EC50 
(2 day)* 
nH n 
AGC (Serine) none 1.5±.04 1.7±.07 5 1.5±.2 1.9±.3 3 
UAG HSAS 1.7±.06 1.7±.09 6 .70±.008 1.9±.07 14 
CGGG HSFSCCCG 2.1±.09 1.7±.1 8 1.3±.1 1.9±.3 13 
GGGU HSFSACCC 1.9±.08 1.5±.08 9 .68±.1 1.7±.04 5 
B 









UAG HSAS -19±2 12 -14±3 11 100% 100% -26% 
CGGG HSFSCCCG -1.3±.3 10 -5.6±1 12 6.8% 40% 330% 
GGGU HSFSACCC -8.6±3 10 -16±3 12 45% 110% 86% 
* Incubation time.  † Avg. Imax (µA) recorded at 50 µM ACh.  ‡ ng of tRNA.  § 1.25 to 2.5 
ng of tRNA. 
 
3.2.2 UAA Incorporation By Frameshift Suppression 
 THG73 is an AS tRNA (cloverleaf structure shown in Figure 3.2, A) (18) used 
extensively for incorporating UAAs into various ion channels expressed in Xenopus 
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oocytes (2).  Initially a FS derived from THG73 recognizing the quadruplet codon CGGG 
(THG73FSCCCG) was tested for UAA incorporation.  Attempts to suppress β9’CGGG 
with THG73FSCCCG-L, where Leu was chemically aminoacylated onto the tRNA, showed 
no current in vivo.  This is consistent with data from Voss and coworkers, who saw very 
little UAA incorporation with THG73FSACCC in Xenopus oocytes (9). 
 Western blots of THG73FSCCCG-W suggested that the tRNA may be stuck on the 
ribosome and stopping translation (Chapter 2).  Uhlenbeck and coworkers have shown 
that nucleotides in the anticodon loop at position 32 and 38 effect ribosome binding of 
tRNAs (19).  THG73FSCCCG and most amber suppressors have C32 and A38 (Figures 3.2 
& 3.4), which is the consensus sequence for optimal suppression by amber suppressor 
tRNAs and is thought to cause tighter binding to the ribosome.  Mutations to tRNAAlaGGC 
at positions 32 and 38 alter ribosome binding where A32-A38 causes tighter binding to 
the ribosome, while C32-G38 and A32-U38 weaken binding to the ribosome (19).  These 
mutations were placed on THG73FSCCCG and shown in Figure 3.4.  Another possibility is 
that THG73FSCCCG could be recognizing multiple codons or even doublet codons, which 
would cause frameshifts and truncation of the gene.  tRNAGly(UCC & CCC) uses the 32nd 
position to discriminate the 3rd nucleotide of the triplet codon (20).  tRNAGlyCCC (similar 
anticodon to THG73FSCCCG) with C32, which is the same as THG73FSCCCG (Figure 3.4), 
promotes doublet decoding of GG over the full triplet codon GGG (21).  Therefore, 
mutations at the 32nd position could alter ribosomal binding and/or decoding of 
THG73FSCCCG to allow for the incorporation of UAAs.  THG73FSCCCG was mutated to 
create the constructs THA32G73FSCCCG, THG38G73FSCCCG, and THA32U38G73FSCCCG 
(shown in Figure 3.4).  Suppression experiments were performed at α149CGGG with the 
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frameshift suppressor tRNAs ligated with Trp and compared to suppression at α149UAG 
by the amber suppressor, THG73-W (Table 3.2).  All mutations resulted in little 




Figure 3.4:  THG73FSCCCG anticodon loop mutations.  The last three base pairs of the 
anticodon stem and the anticodon loop are shown.  The boxed region corresponds to C32-
A38, where mutations were made.  The box on the right shows mutations made (italics).  
On tRNAAlaGGC, A32-A38 increases ribosome binding, while C32-38G and A32-U38 
decrease ribosome binding (19).  C32 on tRNAGlyCCC promotes doublet decoding of GG 
and therefore mutations at the 32nd position may also promote quadruplet decoding (21). 
 
Table 3.2:  THG73FSCCCG and anticodon loop mutations suppression at α149CGGG. 
mRNA tRNA ng tRNA n Imax* ± SE 
α149UAG THG73-W 9.4 12  -2.8 ± .6 
α149CGGG THG73FSCCCG-W 9.4 12  -.019 ± .002 
α149CGGG THA32G73FSCCCG-W 9.4 12  -.013 ± .002 
α149CGGG THG38G73CCCG-W 9.4 12  -.014 ± .003 
α149CGGG THA32U38G73FSCCCG-W 9.4 12  -.024 ± .002 
∗ Avg. Imax (µA) recorded at 1 mM ACh. 
 
We then chose to screen yeast phenylalanine FS (YFFS) tRNAs, which were 
employed successfully by the Sisido group in vitro (7,17).  We studied both YFFSCCCG 
and YFaFSACCC;  Figure 3.2, A, shows cloverleaf structures.  The latter contains acceptor 
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stem mutations (denoted by the “a”) incorporated to reduce glycyl-tRNA synthetase 
recognition (7).  We first evaluated a non-promiscuous position of the nAChR, α149W, 
an agonist binding site tryptophan that makes a cation-π interaction with ACh (22) 
(shown in Figure 3.3).  Wild-type recovery, i.e., suppressing the α149 quadruplet codons 
with YFFSCCCG-W or YFaFSACCC-W, resulted in functional, wild-type channels (Table 
3.3).  To demonstrate UAA incorporation we relied on previous work using the AS 
THG73 that established that 5-fluoro-tryptophan, WF1 (structure in Figure 3.2, B), 
incorporated at α149 decreased the cation-π interaction and caused a ≈ 4-fold increase in 
EC50 (22).  YFFSCCCG-WF1 suppression at α149CGGG resulted in a comparable increase 
in EC50 (Table 3.3), establishing the successful incorporation of the UAA WF1. 
 
Table 3.3:  Wild-type recovery and UAA incorporation by frameshift suppression in  
         vivo. 
mRNA tRNA EC50 (theo)(ref)† nH n 
α149CGGG YFFSCCCG-W* 56±2 (50)(14) 1.8±.07 8 
α149GGGU YFaFSACCC-W* 53±2 (50)(14) 1.6±.03 8 
β9’GGGU YFaFSACCC-Aba 16±.9 (16)(14) 1.3±.08 7 
δ9’GGGU YFaFSACCC-Nval 31±2 (36)(14) 1.6±.1 6 
α149CGGG YFFSCCCG-WF1 190±3 (200)(22) 1.6±.03 10 
* Rescue of wild type recovery by frameshift suppression. 
† EC50 values from THG73-UAA incorporation by nonsense suppression. 
 
We next considered the previously mentioned Leu9’ residue (shown in Figure 
3.3).  Suppression at β9’GGGU and δ9’GGGU with YFaFSACCC-Aba and YFaFSACCC-
Nval (UAA structures shown in Figure 3.2, B), respectively, resulted in reductions in 
EC50 (Table 3.3) that were consistent with previous studies using the same UAAs and the 
AS THG73 (14).  All frameshift suppression experiments had an Imax between -1.6 and    
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-4.4 µA, which is more than adequate for UAA studies in vivo and should allow for the 
incorporation of multiple UAAs.  In all cases, injection of full-length tRNA that had no 
amino acid attached to the 3’ end resulted in no detectable currents in response to added 
ACh, directly showing a lack of aminoacylation by endogenous, Xenopus aaRSs. 
3.2.3 Masking Effects on Frameshift Suppression 
 Experiments with HSFS required the masking of the nAChR subunits in order to 
avoid protein truncation caused by +1 frameshifts.  To demonstrate the effect on UAA 
incorporation, suppression experiments were performed with wild-type and masked 
constructs.  The quadruplet codon GGGU was chosen because there was only one in-
frame quadruplet in the signaling sequence of the nAChR β subunit and none in the α, γ, 
or δ subunits.  Wild-type recovery was performed by suppressing at α149GGGU with 
YFaFSACCC-W and adding either wild-type or masked β mRNA to the injection mixture.  
Table 3.4 shows the dramatic effect of masking one position on frameshift suppression.  
With a 1:1:1:1 ratio of α:β:γ:δ, the masked construct gives a 2.7-fold increase in Imax 
relative to wild type.  As the amount of α subunit (which contains the suppression site) is 
increased, the masking effect decreases to 1.5-fold and 1.2-fold with subunit ratios of 
5:1:1:1 and 10:1:1:1, respectively.  Calculations that assume two, equally efficient 
quadruplet codons reproduce this trend (Table 3.4), suggesting that the α149GGGU and 

















1 : 1 wild type -.14±.02 11 63% 
1 : 1 masked -.38±.1 11 (75%) 
5 : 1 wild type -.35±.1 10 32% 
5 : 1 masked -.52±.2 12 (31%) 
10 : 1 wild type -.71±.3 11 15% 
10 : 1 masked -.83±.3 12 (17%) 
* Avg. Imax (µA) recorded at 1 mM ACh.   
† () are theoretical values = 1 – (P of α suppression)2, where both sites are assumed to 
have the same probability (P) and squared because of 2 α subunits per channel.  
 
3.2.4  Comparison of Frameshift and Nonsense Suppression Efficiencies 
 To compare frameshift and nonsense suppression, the α149 and β9’ sites were 
studied in more detail (shown in Figure 3.3).  Suppression of α149CGGG or GGGU with 
10 ng of YFFSCCCG-W or YFaFSACCC-W resulted in 38% and 48%, respectively, of the 
current from 10 ng of THG73-W suppression at α149UAG (Table 3.5).  Suppression of 
β9’UAG with 2 ng of THG73-L resulted in the largest Imax (Table 3.5).  Suppression at 
β9’CGGG or GGGU with 2 ng of YFFSCCCG-L or YFaFSACCC-L resulted in 14% and 
36%, respectively, of the current from THG73-L (Table 3.5).  We conclude that amber 
suppression is more efficient than frameshift suppression, in agreement with a trend 
previously seen in a eukaryotic cell-free translation system (17).  In particular, the 




Table 3.5:  Comparison of suppression efficiency, aminoacylation, and read-through in  
       vivo. 
mRNA tRNA ng tRNA n Imax*±SE % THG73 
α149UAG THG73-W 10 18 -4.8±2 100% 
α149CGGG YFFSCCCG-W 10 20 -1.8±.3 38% 
α149GGGU YFaFSACCC-W 10 13 -2.3±.9 48% 
β9’UAG THG73-L† 2 15 -6.1±2 100% 
β9’CGGG YFFSCCCG-L† 2 12 -.84±.2 14% 
β9’GGGU YFaFSACCC-L† 2 9 -2.2±.5 36% 
β9’CGGG YFFSCCCG-L† 6 13 -8.8±.9 NA 
β9’GGGU YFaFSACCC-L† 6 13 -16±2 NA 
β9’UAG THG73-dCA 2 13 -4.8±1 100% 
β9’CGGG YFFSCCCG-dCA 2 13 -.42±.8 8.8% 
β9’GGGU YFaFSACCC-dCA 2 13 -.092±.02 1.9% 
β9’UAG THG73-dCA 6 13 -8.2±1 100% 
β9’CGGG YFFSCCCG-dCA 6 12 -1.2±.3 15% 
β9’GGGU YFaFSACCC-dCA 6 11 -.27±.09 3.3% 
     % UAG 
β9’UAG - - 13 -.37±.1 100% 
β9’CGGG - - 13 -.085±.03 23% 
β9’GGGU - - 13 -.078±.02 21% 
∗ Avg. Imax (µA) recorded at 1 mM ACh. 
† Currents in response to 10 µM and 1 mM ACh displayed a ratio of 0.1, as anticipated 
from the Hill equation fit for one, wild-type receptor. 
 
Interestingly, the yield of receptors from frameshift suppression at the β9’ site 
was substantially improved by increasing the amount of tRNA injected.  Suppression 
with 6 ng of YFFSCCCG-L or YFaFSACCC-L gave dramatic increases in Imax, with a % 
change of 950% and 630%, respectively (Table 3.5).  This large change in Imax in 
response to a modest increase in tRNA concentration implicates a competition with 
endogenous triplet tRNA that responds nonlinearly to the amount of injected FS tRNA.  
A comparable increase in the amount of injected THG73-L led to complications due to 
reacylation of the tRNA by endogenous aaRSs (undesired) and incorporation of natural 
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amino acids other than leucine, an issue that is addressed in detail in the following 
section, in the Discussion, and in Chapters 4 and 5. 
3.2.5 Comparison of Aminoacylation of Suppressor tRNA and Read-Through of  
Suppression Sites 
 To evaluate aminoacylation in vivo, which is undesirable for any tRNA used to 
incorporate UAAs, the β9’ site was again studied, because most amino acids produce 
functional receptors when substituted at this position (14).  In all experiments, tRNAs 
that had been ligated to dCA but did not contain an amino acid at the 3’ end were 
injected, in order to more closely mimic the biologically active, full-length tRNA.  In 
order to maximize the potential for aminoacylation by endogenous aaRSs, two-day 
incubations and relatively large mRNA quantities (16.5 ng) were employed.  
Surprisingly, THG73-dCA, which has been used extensively for UAA incorporation in 
Xenopus oocytes, showed significant aminoacylation in vivo, with Imax of -4.8 and -8.2 
µA for 2 and 6 ng tRNA, respectively (Table 3.5).  Note that under other conditions (less 
mRNA; shorter incubations) previous work has found no complications from 
aminoacylation using THG73-dCA in Xenopus oocytes (9,14,18).  Still, the present 
results establish that THG73 is susceptible to aminoacylation by aaRSs, which is 
undesired.  No aminoacylation was seen with 2 ng of THG73-L, suggesting that 
aminoacylation by endogenous aaRSs is more likely when non-aminoacylated THG73 is 
injected, as noted previously (18).  Both FS tRNAs show much lower amounts of 
aminoacylation by aaRSs, as evidenced by the decrease in Imax (Table 3.5).  YFFSCCCG-
dCA shows only 8.8% and 15% of the Imax of THG73-dCA at 2 and 6 ng, respectively.  
The most orthogonal suppressor is YFaFSACCC-dCA with 1.9% and 3.3% of the Imax of 
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THG73-dCA at 2 and 6 ng, respectively.  The orthogonality trend thus follows the order: 
YFaFSACCC-dCA>YFFSCCCG-dCA>THG73-dCA.  YFaFSACCC is the most orthogonal and 
efficient FS tRNA, and it therefore offers a viable replacement for THG73, especially 
when aminoacylation by aaRSs poses a problem in vivo. 
 Read-through at the β9’ site was also assessed by injection of mRNA only (Table 
3.5).  β9’UAG showed the most read-through, presumably because there is only one in-
frame stop codon before desired termination.  β9’CGGG and β9’GGGU show 23% and 
21% read-through relative to the UAG stop codon.  This is consistent with the idea that 
an endogenous triplet tRNA recognizing the first three bases of a quadruplet codon 
causes a -1 frameshift, which then presents multiple stop codons (frameshift suppression 
and competition shown in Figure 2.2).  Again, we designed this experiment to enhance 
signals from read-through by injecting large amounts of mRNA (50 ng).  No current was 
detectable after injection of mRNA containing UAG, CGGG, or GGGU at position α149, 
confirming that this site is much less promiscuous than β9’. 
3.2.6 The Effect of Discriminator and Acceptor Stem Mutations on YFFSCCCG 
 Table 3.5 shows that YFFSCCCG is less orthogonal than YFaFSACCC, which 
contains mutations at the discriminator base (N73) and in the acceptor stem.  In previous 
work the YFaFSACCC mutations were made to avoid glycyl-tRNA synthetase recognition 
for in vitro reactions, and they significantly reduced aminoacylation (7).  In S. cerevisae 
and H. sapiens the glycyl-tRNA synthetase recognizes the discriminator base (A73) and 
acceptor stem recognition includes C2-G71 (23,24).  Both are present in YFFSCCCG.  
Therefore, we mutated A73 to create YFG73FSCCCG, and we mutated the acceptor stem to 
create YFaFSCCCG.  Aminoacylation was determined by injecting 16.5 ng tRNA, not 
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ligated to dCA, and β9’CGGG.  The single A73G mutation resulted in increased 
aminoacylation in vivo as indicated by the increase in Imax relative to YFFSCCCG, but 
incorporating the acceptor stem mutations and A73G resulted in slightly less 
aminoacylation than YFFSCCCG when comparing Imax (Table 3.6).  The orthogonality 
trend was as follows: YFaFSCCCG≈YFFSCCCG>YFG73FSCCCG>THG73.  These results 
suggest that glycyl-tRNA synthetase or another aminoacyl-tRNA synthetase is 
aminoacylating YFFSCCCG, and if the glycyl-tRNA synthetase is aminoacylating the 
YFFSCCCG, the recognition of the discriminator base in Xenopus oocytes differs from the 
other eukaryotes studied.  There was no significant difference between YFaFSCCCG and 
YFFSCCCG by a one-way ANOVA, and we continued to use YFFSCCCG.  However, 
leaving A73 and only incorporating the acceptor stem mutations may create more 
orthogonal variants of YFFSCCCG and YFaFSACCC for the Xenopus oocyte system. 
 
Table 3.6:  The effect of discriminator base and acceptor stem mutations on YFFSCCCG. 
mRNA tRNA Imax*± SE n % THG73 
β9’UAG - 0.026±0.002 5 2.9% 
β9’UAG THG73 0.89±0.4 11 100% 
β9’CGGG - 0.021±0.005 6 2.4% 
β9’CGGG YFFSCCCG 0.29±0.1 14 33% 
β9’CGGG YFG73FSCCCG 0.71±0.2 12 80% 
β9’CGGG YFaFSCCCG 0.23±0.07 10 26% 
* Avg. Imax (µA) recorded at 400 µM ACh. 
 
3.2.7 Incorporation of Two UAAs 
 To investigate the simultaneous incorporation of two UAAs, we again built on 
previous work using THG73 to incorporate UAAs into the nAChR at positions α149, β9’ 
and δ9’ (shown in Figure 3.3).  Importantly, EC50 changes associated with mutations at 
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these sites are independent of one another (22,25).  This allows one to qualitatively 
anticipate the consequences of multiple mutations.  In particular, both β9’Aba and 
δ9’Nval produce predictable reductions in EC50 that should be reproduced when 
combined with mutations at α149 (14).  That is, the previously noted 4-fold increase in 
EC50 seen when the native tryptophan at α149 is replaced by WF1 should persist when in 
combination with β9’Aba or δ9’Nval. 
 Successful incorporation of two UAAs to produce large ACh-induced currents 
could be seen when a 5-fold excess of mutant-to-wild-type mRNA was used.  
Suppression with α149UAG/THG73-W and β9’CGGG/YFFSCCCG-L is a wild-type 
recovery experiment that gave the expected EC50 for ACh of 50 µM (Table 3.7).  
Maintaining β9’CGGG/YFFSCCCG-L, but substituting α149UAG/THG73-WF1 resulted 
in the anticipated 4-fold increase in EC50 (Table 3.7) (22).  For incorporation of two 
UAAs, α149UAG/THG73-W or WF1 was combined with either β9’CGGG/YFFSCCCG-
Aba or δ9’GGGU/YFaFSACCC-Nval (Table 3.7 and Figure 3.5 show representative traces 
and fits to the Hill equation).  The α149 WF1:W EC50 ratios are 4.4 for the both β and δ 
9’ mutants.  These experiments establish that frameshift suppression can be combined 




Table 3.7:  Incorporation of two UAAs. 
Row α149 tRNA β  or δ  tRNA EC50 
(theo)(ref)* 
nH n 
1 UAG THG73-W β9’CGGG YFFSCCCG-Aba 14±.4 
(16)(14) 
1.7±.06 9 
2 UAG THG73-W δ9’GGGU YFaFSACCC-Nval 41±2 
(36)(14) 
1.9±.1 9 
3 UAG THG73-W β9’CGGG YFFSCCCG-L 50±3 
(50)(22) 
1.4±.08 20 
4 UAG THG73-WF1 β9’CGGG YFFSCCCG-Aba 61±3 1.5±.08 7 
5 UAG THG73-WF1 δ9’GGGU YFaFSACCC-Nval 180±7 1.8±.1 6 
6 UAG THG73-WF1 β9’CGGG YFFSCCCG-L 200±7 
(200)(22) 
1.3±.04 9 
* EC50 values from THG73-UAA incorporation by nonsense suppression. 
 
 
Figure 3.5:  Simultaneous incorporation of two UAAs, representative traces and fits to 
the Hill equation.  (A) Representative voltage-clamp current traces from oocytes 
expressing ion channels with two UAAs simultaneously incorporated.  On the top 
α149UAG/THG73-W and β9’CGGG/YFFSCCCG-Aba is shown, which has an EC50 of 14 
µM ACh.  The bottom shows α149UAG/THG73-WF1 and β9’CGGG/YFFSCCCG-Aba 
suppression and represents the incorporation of two UAAs.  The EC50 is 61 µM ACh and 
the ratio of the EC50s (WF1:W) is 4.4. (B) Fits to the Hill equation from (left to right) 
show Row 1 (○), 2 (□), 4 (●), and 5 (■) (Table 3.7).  Row 3 and 6 are left out for clarity 
and have previously been reported (Table 3.3 & (22)). 
 
3.2.8 Incorporation of Three UAAs 
 To demonstrate the incorporation of three UAAs, we combined the two-UAA 
incorporation experiments described above, taking advantage of the knowledge that EC50 
is lowered monotonically by appropriate 9’ mutations at multiple subunits (26).  Thus one 
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expects a lower EC50 when β9’Aba and δ9’Nval are incorporated simultaneously.  
Suppression of α149UAG:β9’CGGG:γ:δ9’GGGU using an mRNA ratio of 5:5:1:5 with 
THG73-W, YFFSCCCG-Aba, and YFaFSACCC-Nval resulted in functional channel 
expression with an EC50 of 4.5 µM ACh (Figure 3.6), which is lower than either of the 
two UAAs (Aba or Nval) incorporated separately.  However, the same conditions with 
THG73-WF1 yielded only small currents.  In order to obtain more expression, α149UAG 
mRNA and THG73-WF1 were initially injected, and 24 hr later β9’CGGG:γ:δ9’GGGU 
(5:1:5) was injected with YFFSCCCG-Aba and YFaFSACCC-Nval (final mRNA ratio 
5:5:1:5).  This resulted in adequate expression and an EC50 of 19 µM ACh (Figure 3.6).  
The ratio of the EC50s (α149 WF1:W) is 4.2, confirming that three different UAAs were 
simultaneously incorporated in vivo, but this is actually four UAAs per ion channel 
because WF1 is incorporated in two α-subunits (Figure 3.3). 
 
 
Figure 3.6:  Simultaneous incorporation of three UAAs.  (A) Representative current 
traces from oocytes incorporating three UAAs.  (B) Dose-response curves showing: 
α149W, β9’Aba, and δ9’Nval (open circles) and α149WF1, β9’Aba, and δ9’Nval 
(closed circles).  EC50 = 4.5±.4, nH = 1.7±.3 and EC50 = 19±2, nH = 1.3±.1, respectively.  




3.3  Discussion 
 The present results establish that frameshift suppression is viable in a eukaryotic, 
vertebrate cell, and that it can be used to incorporate mutiple unnatural amino acids 
(UAAs) in a single experiment.  Previous work in Xenopus oocytes found that UAA 
incorporation using THG73FSACCC was inefficient, and it was proposed that either the 
Xenopus translational machinery was not compatible with frameshift suppression or that 
THG73FSACCC was a poor template for quadruplet recognition (9).  Our results support 
the second rationalization, and a second FS derived from THG73, THG73FSCCCG, is also 
not viable.  Mutation of positions 32 and 38 on THG73FSCCCG did not rescue the 
suppression efficiency (Table 3.2).  It thus appears that THG73-derived FS tRNAs are 
either misfolded, not recognized by EF-Tu, or not accepted by other components of the 
translational machinery. 
Frameshift suppression is viable in the Xenopus oocyte, however, using either 
HSFS or YFFS tRNAs.  We find that in Xenopus oocytes, the quadruplet GGGU is 
suppressed more efficiently by both HSFSACCC and YFaFSACCC than the corresponding 
CGGG/tRNA pairs.  This is seen despite the fact that in Xenopus the GGG triplet is used 
twice as frequently (12.9 per thousand) as the CGG triplet (27).  Frameshift suppression 
must compete with endogenous triplet-recognizing tRNAs.  Codon usage is apparently 
not a perfect predictor of frameshift suppression efficiency. 
We have evaluated three different tRNAs:  the amber suppressor THG73, and the 
frameshift suppressors YFFSCCCG and YFaFSACCC.  For UAA incorporation in the 
Xenopus oocyte, both YFFS tRNAs are less efficient than the AS THG73.  This finding 
parallels results from earlier in vitro studies (17).  Apparently, the competition between 
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release factors and the AS tRNA is less detrimental than the competition between FS 
tRNAs and endogenous, triplet-recognizing tRNA.  This view is supported by the rapid, 
nonlinear rise in suppression efficiency when the amount of YFFS tRNA is increased 
(Table 3.5).  CGGG-recognizing tRNAs are more sensitive to the amount injected than 
GGGU-recognizing tRNAs.  Increasing the amount of FS tRNA for UAA incorporation 
is essential to maximize suppression efficiency. 
The incorporation of UAAs site-specifically into proteins requires the suppressor 
tRNA to be orthogonal to the endogenous, aaRSs.  Read-through of the suppression site 
or aminoacylation of the suppressor tRNA (once the chemically ligated UAA has been 
removed) can result in the undesired incorporation of natural amino acids at the 
suppression site.  The two YFFS tRNAs studied here exhibit much more orthogonality 
than THG73 under the extreme conditions (extended incubation time and increased 
mRNA) used in Table 3.5.  However, THG73 is an orthogonal suppressor tRNA to the 
Xenopus oocyte when used properly; THG73 has been used to successfully incoporate 
over 100 residues at scores of sites in 20 different proteins (1,2).  Even promiscous sites, 
such as the β9’UAG, can be efficiently suppressed by THG73-UAA when using less 
tRNA, mRNA, and incubation time (14).  β9’UAG injected with THG73-dCA shows no 
greater current than mRNA alone with similar conditions.  The small current is less than 
1% of typical UAA incorporation experiments and is caused by read-through of the UAG 
codon (18).  Voss and coworkers found that THG73 incorporated 3 UAAs and Phe with 
efficiencies of 93.5–99.5% (determined by THG73-UAA incorporation relative to natural 
amino acids placed by read-through or aminoacylation of THG73-dCA) using luciferase 
expressed in Xenopus oocytes (9).  The current results show that the YFFS tRNAs are 
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even more orthogonal and so the efficiency of UAA incorporation (relative to natural 
amino acids) should be greater than THG73. 
 An important contributor to our ability to efficiently incorporate two and three 
UAAs is the masking of undesired quadruplets to prevent loss of UAA.  In general, the 
requirement for masking of mRNA to remove undesirable quadruplet codons does 
complicate the frameshift suppression approach.  The only previous examples of UAA 
incorporation in higher eukaryotes were performed by nonsense suppression (1–5,10).  
Frameshift suppression may be limited in vivo to cells that are dormant (such as Xenopus 
oocytes), that express large quantities of the target mRNA, or that come from genetically 
engineered organisms.  Also, suppressor tRNAs may be limited to rare codons, because 
of possible toxicity arising from undesired suppression in other proteins (28). 
 The combination of nonsense and frameshift suppression allows one to incoporate 
multiple UAAs site-specifically into proteins expressed in Xenopus oocytes.  These 
methods are compatible with our entire library of UAAs (2,29) and will allow for 
multiple UAAs to be incorporated into other ion channels for novel structure-function 
studies, cross-linking, and FRET experiments.  In principle, further quadruplet codons 
could be utilized to simultaneously incorporate more than three UAAs. 
 
3.4  Experimental Methods 
3.4.1 Materials 
All oligonucleotides were synthesized by Caltech Biopolymer Synthesis facility 
or Integrated DNA Technologies (IDT, Coralville, IA) (Listed in Table 3.8).  NotI was 
purchased from Roche (Indianapolis, IN).  BamHI, EcoRI, FokI, T4 DNA ligase, and T4 
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RNA ligase were purchased from NEB (Beverly, MA).  Kinase Max, T7 
MEGAshortscript, and T7 mMessage mMachine kits were from Ambion (Austin, TX).  
dCA and NVOC-protected dCA-UAA were prepared as previously reported (14,22,30).  
ACh chloride was purchased from Sigma/Aldrich (St. Louis, MO). 
 









































































All mutated sites are underlined in the oligonucleotide sequence, except for tRNA genes 
where the underline is the anticodon and the flanking regions are italicized.  F—Forward 
& R—Reverse (written 5’ to 3’). 
 
3.4.2 Gene Construction and RNA Preparation 
The α, β, γ, and δ subunits of the nicotinic acetylcholine receptor (nAChR) were 
previously subcloned in the pAMV vector (31).  All four in-frame CGGG were mutated 
(underlined) to degenerate codons (α182CGC, β23AGG, β402AGG, and δ195AGG) and 
one GGGT was mutated at the fourth position (β1AGC), these are known as “masked” 
constructs.  α149TAG, CGGG, GGGT; β9’TAG, CGGG, GGGT; and δ9’GGGT 
mutations were placed on masked constructs by QuikChange Site-Directed Mutagenesis 
(Stratagene, La Jolla, CA).  Mutations were verified by DNA sequencing (Caltech 
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Sequencing/Structure Analysis Facility (SAF)).  Template DNA was linearized with NotI 
and mRNA prepared by T7 mMessage mMachine kit.  mRNA was purified using RNeasy 
Mini kit (Qiagen, Valencia, CA) and quantified by absorption at 260 nm. 
THG73 and HSAS in pUC19 vector were previously made (10,18).  Genes for 
HSFSCCCG, THG73FSCCCG, and YFFSCCCG (sequence from (6)) with flanking EcoRI and 
BamHI overhangs were phosphorylated using Kinase Max kit, annealed, ligated with T4 
DNA ligase into EcoRI and BamHI linearized pUC19 vectors, as previously described 
(30).  A73G; C2G,G3C,G4C; and C69G,C70G,G71C mutations (from (7)) were 
sequentially placed by QuikChange mutagenesis on the YFFSCCCG construct to obtain 
YFaFSCCCG (“a” refers to acceptor stem mutations).  HSFSACCC and YFaFSACCC 
(sequence from (7)) were prepared by replacing the anticodon of HSFSCCCG and 
YFaFSCCCG with ACCC using QuikChange.  All mutations were verified by DNA 
sequencing (Caltech SAF).  Template DNA for tRNA lacking the 3’CA was prepared by 
FokI digestion and tRNA was transcribed using T7 MEGAshortscript kit.  tRNA was 
desalted using CHROMA SPIN™-30 DEPC-H2O columns (BD Biosciences, San Jose, 
CA) and concentration was determined by absorption at 260 nm. 
3.4.3 dCA and dCA-UAA Ligation to Suppressor tRNA 
dCA and NVOC-protected dCA-UAA were coupled to suppressor tRNA using T4 
RNA ligase for 30 min, as previously described (30,32), desalted using CHROMA 
SPIN™-30 DEPC-H2O columns, and quantified by absorption at 260 nm.  tRNA ligation 
efficiency was determined by MALDI mass spectrometry (32) and all tRNA dCA or 
dCA-UAA ligations were greater than 75%. 
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3.4.4 In Vivo Suppression Experiments 
Stage VI oocytes of Xenopus laevis were prepared as previously described (33).  
All tRNA were refolded at 65 ˚C for 2 min and tRNA-UAA were deprotected for 5 min 
by UV irradiation prior to injection (18).  Injection volume for all experiments was 50 nl 
and incubation time was 44–52 hr, unless otherwise noted.  Suppression of HSAS and 
either HSFS 1.25 or 2.5 ng tRNA, with 20 ng mRNA in a subunit ratio 2:5:1:1 
α:β9’(UAG, CGGG, or GGGU):γ:δ was recorded after 1 or 2 days.  THG73-derived FS 
comparison was performed with 30 ng of mRNA in the subunit ratio 10:1:1:1 α149(UAG 
or CGGG):β:γ:δ and 16.5 ng of THG73-W, THG73FSCCCG-W, THA32G73FSCCCG-W, 
THG38G73FSCCCG-W, or THA32U38G73FSCCCG-W.  Single UAA incorporation was 
performed using 20–30 ng of mRNA in a subunit ratio of 10:1:1:1 α149(CGGG or 
GGGU):β:γ:δ; 2:5:1:1 α:β9’GGGU:γ:δ; or 2:1:1:5 α:β:γ:δ9’GGGU with 4.8–16.5 ng of 
YFFSCCCG/YFaFSACCC-UAA.  Comparison of β masked and wild-type suppression 
contained 25 ng total mRNA injected in the subunit ratio listed in Table 3.4 with 1:1 γ:δ 
and 10 ng YFaFSACCC-W.  For comparison of suppression efficiency and aminoacylation 
of tRNA in vivo, all mRNA was normalized to the same concentration and 16.5 ng of 
mRNA was injected in the subunit ratio 10:1:1:1 α149(UAG, CGGG, or GGGU):β:γ:δ or 
2:5:1:1 α:β9’(UAG, CGGG, or GGGU):γ:δ with tRNA amounts listed in Table 3.5.  For 
read-through experiments, 50 ng of mRNA in the ratio 2:5:1:1 α:β9’(UAG, CGGG, or 
GGGU):γ:δ was injected.  Comparison of acceptor stem mutations on YFFSCCCG was 
performed with 20 ng of mRNA in the subunit ratio of α:β9’(UAG or CGGG):γ:δ with 
9.4 ng of THG73, YFFSCCCG, YFG73FSCCCG, and YFaFSCCCG (not ligated to dCA).  Two 
UAAs experiments were performed by injection of 20–30 ng mRNA in a subunit ratio 
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5:5:1:1 α149UAG:β9’CGGG:γ:δ or 5:1:1:5 α149UAG:β:γ:δ9’GGGU with 10–25 ng of 
each suppressor tRNA-UAA.  For three UAAs—α149W, β9’Aba, δ9’Nval—26 ng 
mRNA in a ratio of 5:5:1:5 α149UAG:β9’CGGG:γ:δ9’GGGU was injected with 20 ng 
each suppressor tRNA-UAA, and a second injection of 33 ng each tRNA-UAA was done 
24 h later.  For α149WF1, β9’Aba, and δ9’Nval, 8 ng α149UAG mRNA with 50 ng of 
THG73-WF1 was injected, and a second injection of 18 ng mRNA with subunit ratio of 
5:1:5 β9’CGGG:γ:δ9’GGGU with 25 ng of each YFFSCCCG-Aba and YFaFSACCC-Nval 
was performed 24 h later.  Oocytes were recorded three days after first injection. 
3.4.5 Electrophysiology 
Recordings used two-electrode voltage clamp on the OpusXpress 6000A (Axon 
Instruments, Union City, CA).  ACh was stored at -20 ˚C as a 1 M stock, diluted in Ca2+-
free ND96, and delivered to oocytes by computer-controlled perfusion system.  For 
HSAS & HSFS experiments the holding potential was –60 mV, and all UAA experiments 
were done at either –60 mV or –80 mV.  Dose-response data were obtained from at least 
9 ACh concentrations and comparisons were tested at one drug concentration, except 
β9’(UAG, CGGG, or GGGU) with tRNA-L used two concentrations, 10 µM and 1 mM, 
to check for aminoacylation (Table 3.6).  Dose-response relations were fit to the Hill 
equation to determine EC50 and the Hill coefficient (ηH).  All reported values are 
represented as a mean ± SE of the tested oocytes (number (n) listed with each table). 
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4.1  Introduction 
Incorporation of unnatural amino acids (UAAs) site-specifically in proteins 
biosynthetically is a powerful tool that is increasingly being used.  The primary approach 
has been stop codon (nonsense) suppression using a designed tRNA with an anticodon 
recognizing the stop codon.  In higher eukaryotes, nonsense suppression by a tRNA 
chemically aminoacylated with an UAA (tRNA-UAA) is primarily limited to Xenopus 
oocytes, where microinjection of the mutant mRNA and tRNA-UAA is straightforward, 
and electrophysiology allows for sensitive detection of UAA incorporation (shown in 
Figure 3.1) (1,2).  Recently, site-specific UAA incorporation was performed in Xenopus 
oocytes using frameshift suppression of the quadruplet codons CGGG and GGGU, 
which allowed for the simultaneous incorporation of three UAAs (3). 
 THG73, an amber suppressor tRNA from T. thermophila with a G73 mutation, 
has been used extensively to incorporate over 100 residues in 20 different proteins (1,2).  
With THG73 and any other suppressor tRNAs, a key issue is orthogonality.  An 
orthogonal tRNA is one that is not measurably aminoacylated with natural amino acids 
(aas) by endogenous aminoacyl-tRNA synthetases (aaRSs).  Unlike its mathematical 
counterpart, there can be degrees of orthogonality when referring to tRNAs.  While the 
orthogonality of THG73 has been evaluated using in vitro translation in E. coli (4), 
wheat germ (5), and rabbit reticulocyte lysate (6), the primary application of THG73 has 
been for in vivo translation in Xenopus oocytes, which is the focus of the present work.  
The orthogonality of THG73 is acceptable when injecting low quantities of mutant 
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mRNA and/or tRNA-UAA with incubation times less than 2 d (7,8).  However, 
increasing the amount of mutant mRNA and/or tRNA-UAA, or incubation times of 2 d 
— which we will term “excessive” conditions — led to increased aminoacylation of 
THG73 in vivo with natural aa(s) (3).  This is highly undesirable, because incorporation 
of natural aas at the suppression site leads to a heterogeneous mixture of proteins 
containing an UAA or natural aa(s) and limits the quantity of protein that can be 
produced by UAA incorporation. 
 Previous work from our labs showed that yeast Phe frameshift suppressor tRNAs 
(YFFSCCCG and YFaFSACCC) were aminoacylated much less than THG73 in vivo, but 
suppression of the quadruplet codons was less efficient than with THG73 and varied 
greatly with the amount of frameshift suppressor tRNA injected (3).  Previously, an E. 
coli Asn amber suppressor (ENAS) tRNA was shown to be highly orthogonal in vivo (9) 
and in vitro (4,10,11).  Here we show that ENAS has similar amounts of aminoacylation 
to THG73, suggesting that other well-characterized amber suppressor tRNAs could be 
prone to aminoacylation under excessive conditions. 
 Therefore, we chose to determine the aa that was being placed on THG73 using 
the sensitivity of electrophysiology and a well-characterized mutation site of the 
nicotinic acetylcholine receptor (nAChR), and determined the aa to be Gln.  Using this 
knowledge, we created “Knob” mutations on THG73 previously shown to reduce 
aminoacylation of E. coli tRNA2Gln by the E. coli glutaminyl-tRNA synthetase (GlnRS) 
(12).  The Knob mutations on THG73 resulted in tRNAs that showed drastically reduced 
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suppression efficiency in vivo, making them not viable replacements.  The E. coli GlnRS 
has been shown to interact with the acceptor stem of the tRNA in the crystal structure 
(13), which was subsequently shown to be sensitive to base pairs and/or backbone 
positioning of the tRNA acceptor stem (14–16).  We created seven unique tRNAs with 
mutations in the 2nd to 4th positions of the acceptor stem, and analyzed their function in 
vivo relative to THG73.  Mutations in the acceptor stem decreased aminoacylation 
significantly.  This library of T. thermophila Gln amber suppressor (TQAS) tRNAs can 
be used to screen for orthogonality in other eukaryotic cells.  To show the generality of 
the acceptor stem mutations, we also created T. thermophila Gln opal suppressor 
(TQOpS’ and TQOpS) tRNAs that are also aminoacylated less than THG73.  The 
acceptor stem mutations have general application for the creation of orthogonal 
suppressor tRNAs for UAA incorporation in higher eukaryotic cells, where random 
mutagenesis combined with high-throughput screens is not readily applicable. 
 
4.2  Results 
4.2.1 Schematic for Site-Specific UAA Incorporation and Aminoacylation 
Figure 4.1 shows a schematic for the steps leading to UAA incorporation in vivo.  
Upon injection of the tRNA-dCA-UAA, the tRNA can bind to EF-1α and/or other 
components of the translational machinery in a reversible fashion (Figure 4.1, A).  It has 
been shown that the prokaryotic ortholog EF-Tu can protect tRNA-dCA-UAA from 
hydrolysis in vitro (17) (Figure 4.1, C), thus favoring incorporation of UAA by 
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recognition of the suppressor site on the mRNA (Figure 4.1, B).  If tRNA lacking the 
terminal CA (74mer) is injected, it can be converted to the full-length tRNA by the 
addition of CA in vivo (Figure 4.1, D).  The full-length tRNA, either tRNA-dCA or 
tRNA-CA (76mer), may then be aminoacylated with a natural aa by an endogenous aaRS 
(Figure 4.1, E).  The tRNA-dCA-aa can then bind EF-1α and/or other components of the 
translational machinery (Figure 4.1, F) and lead to the incorporation of a natural aa at the 
suppression site (Figure 4.1, G) in competition with the suppression by tRNA-dCA-UAA 
(Figure 4.1, B), a highly undesirable outcome.  After translation, both UAA and natural 
aa incorporation causes the tRNA-dCA/CA to be released from the ribosome (Figure 4.1, 





Figure 4.1:  Site-specific UAA incorporation.  (A) tRNA-dCA-UAA binds EF-1α 
and/or other components of the translational machinery.  (B) UAA is incorporated at the 
suppression site (XXX(X)), resulting in a protein with an UAA.  (C) Undesired 
hydrolysis and/or aaRS editing results in irreversible loss of the UAA, resulting in 
tRNA-dCA (76mer).  (D) Injection of the tRNA (lacking dCA, 74mer) is converted to a 
76mer in vivo by the addition of CA (tRNA-CA).  (E) Undesired recognition of the 
suppressor tRNA-dCA/CA by endogenous aaRS(s) can result in aminoacylation of the 
tRNA with a natural aa.  (F) tRNA-dCA/CA-aa binds EF-1α and/or other components of 
the translational machinery. (G) Undesired protein translation can occur by placing a 
natural aa at the suppressor site (XXX(X)), rather then termination at the stop codon or a 
frameshift, and this competes with UAA incorporation.  (H) After translation the tRNA-
dCA/CA is released into the cytoplasm and can repeat steps E–H. 
 
4.2.2 Experimental Scheme for Evaluating Aminoacylation and Suppression by  
Electrophysiology 
All experiments were performed on the nAChR, which has been extensively 
studied by the site-specific incorporation of UAAs.  The muscle-type nAChR is a 
pentamer composed of α-, β-, γ-, and δ-subunits in the ratio of 2:1:1:1, respectively 
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(Figure 3.3).  In order to compare experiments from different batches of oocytes, we 
normalized the average maximal current in response to 1 mM ACh for each suppressor 
tRNA to the corresponding average maximal current for THG73.  Wild-type mRNA 
expression would be the most desirable normalization, but injection of 20–60 ng of 
mRNA (as in the aminoacylation experiments) would produce wild-type currents greater 
than 100 µA, resulting in current saturation. 
To evaluate aminoacylation, we chose a Leu site in the second transmembrane 
helix (M2) of the β subunit termed β9’ (shown in Figure 3.3).  This site has been shown 
to tolerate placement of many natural aas and UAAs (18–20), with most causing 
characteristic shifts in ACh EC50.  Previously, THG73 was shown to incorporate natural 
aa(s) at this site under excessive conditions (3).  A possible complication for experiments 
designed to probe aminoacylation is read-through of the stop codon, which can be tested 
for by injecting mRNA only into the Xenopus oocyte.  We find that at the β9’ site, such 
read-through is insubstantial, producing currents that are ≈ 3.5% of those seen when 
THG73 is included. 
During the course of this research, we noticed variations in aminoacylation 
depending on whether the oocytes were acquired from Xenopus Express or Nasco.  
Xenopus laevis frogs from Xenopus Express are caught in Africa, while Nasco frogs are 
bred in a laboratory and are from a similar gene pool (Linda Northey, personal 




4.2.3 Identifying the Natural aa Placed on THG73 Using Electrophysiology 
As noted above, we focus on the β9’ site of the nAChR, which for the wild-type 
β9’L (shown in Figure 3.3) has an EC50 of 50 µM for ACh.  For the well-characterized 
β9’S the EC50 is lowered ≈ 33-fold to 1.5 µM ACh (18), and the lowering of EC50 has 
been shown to scale with the polarity of the residue introduced at the β9’ position (18). 
Injection of β9’UAG + THG73 (74mer) under excessive conditions produces 
receptors with an EC50 of 0.24 µM ACh (Figure 4.2), which is lower than any 
substitution previously tested at the β9’ position.  When β9’UAG + THG73-dCA 
(76mer) was evaluated, an EC50 of 0.88 µM was obtained.  We chose to screen β9’Q 
because THG73 evolved to suppress the amber codon with Gln in T. thermophila (21), 
and many amber suppressor tRNAs are aminoacylated with Gln in vivo (22).  The 
conventional mutant β9’Q has an EC50 of 0.31 µM ACh (Figure 4.2).  While the EC50 of 
β9’Q and β9’UAG + THG73 (74mer) are comparable, there is ≈ 3-fold increase in EC50 
when β9’UAG + THG73-dCA (76mer) is injected (Figure 4.2).  These results suggest 
that the full-length THG73-dCA (76mer) is aminoacylated with amino acids other than 
Gln.  Apparently, this is less important for THG73 (74mer), which must have CA added 
in vivo to become a full-length tRNA (Figure 4.1, D).  From these results, we conclude 




Figure 4.2:  Fits to the hill equation for β9’UAG + THG73 (74mer)/-dCA (76mer) and 
β9’Q.  Filled circles are β9’UAG + THG73 (74mer) [16 ng per oocyte], open squares are 
β9’Q, and filled triangles are β9’UAG + THG73-dCA (76mer) [5 ng per oocyte].  EC50 
values are .24 ± .006, .31 ± .02, and .88 ± .08 µM ACh, respectively.  In each experiment 
n > 3 oocytes. 
 
4.2.4 Testing Knob Mutations on THG73 
Much is known about the recognition of tRNA by the GlnRS, and key 
interactions have been assigned to various “knobs” on the tRNA, termed K1, K2, and K3 
(Figure 4.3).  In a study of aminoacylation of E. coli tRNA2Gln by the E. coli GlnRS (12), 
the mutations that produced the greatest reduction in aminoacylation were K2, K2K3, 
and K1K2K3.  We therefore incorporated these mutations into THG73, and tested for 




Figure 4.3:  THG73 mutations and tRNAs studied.  Circled positions on THG73 
correspond to the Knob mutations from (12), where K1 is C3-G70, K2 is C10-G25, and 
K3 is G17.  The boxed region on THG73 corresponds to the 2nd to 4th positions of the 
acceptor stem (mutations are shown in gray italics in the right box).  Note THG73 K1 
and TQAS-3 are the same mutation.  Other tRNAs studied are shown at the bottom with 
only the 2nd to 4th positions of the acceptor stem shown.  ENAS and TQAS contain the 
same nucleotides at these positions. 
 
 As shown in Figure 4.4, THG73 K2, THG73 K2K3, and THG73 K1K2K3 all 
show less than 20% aminoacylation in vivo when compared to THG73 at β9’UAG 
(Figure 4.4).  However, when each tRNA was chemically ligated with dCA-W and 
injected with α149UAG (a non-permissive site), less than 3% of the current of THG73-
W was seen (Figure 4.4).  Therefore THG73 K2, THG73 K2K3, and THG73 K1K2K3 
are nonfunctional in the Xenopus oocyte and are not viable alternatives for UAA 




Figure 4.4:  THG73 Knob mutations.  Individual tRNA average current were normalized 
by appropriate THG73 average current and bars represent this average ratio. (Total 
number of oocytes tested is 91, where each bar is 15 > n > 5 oocytes.)  Black bars 
correspond to tRNA-W [21 ng per oocyte] suppressing at α149UAG and white bars 
correspond to tRNA (74mer) [17 ng per oocyte] + β9’UAG in Xenopus Express oocytes.  
THG73 Knob mutations are < 20% when suppressing at α149UAG and show they are 
not functional alternatives for UAA incorporation. 
 
We conclude that THG73 is very sensitive to the K2 and K3 mutations in the D-
stem and D-loop, respectively, which make tertiary contacts with the variable loop to 
form the characteristic L-shape, tRNA structure.  Previous replacement of the THG73 
anticodon with ACCC (8) and CCCG (3) also resulted in nonfunctional frameshift 
suppressors in vivo.  THG73 appears to be exceptionally sensitive to mutation within the 
D domain and the anticodon loop, which limits the regions where this tRNA can be 





4.2.5 Testing Aminoacylation of ENAS and ENAS A71 In Vivo 
With the failure of the knob mutations to produce functional tRNAs for UAA 
incorporation, we chose to screen the E. coli Asn amber suppressor (ENAS), which was 
shown to be orthogonal in vitro (4) and in vivo (9).  When analyzing the structure of 
ENAS, we noticed that the 2nd position of the acceptor stem contained the non-Watson-
Crick base pair U2-C71.  We created the variant ENAS C71A to form the canonical pair 
U2-A71 (Figure 4.3) present in the wild-type tRNA (9). 
While injection of ENAS or ENAS A71 (74mer) with β9’UAG resulted in less 
aminoacylation than THG73 in both Xenopus Express and Nasco oocytes, the effect was 
much more pronounced with Nasco oocytes (Figure 4.5).  The EC50s of ENAS  (74mer) 
or ENAS A71 (74mer) with β9’UAG were 2.0 ± 0.1 and 1.5 ± 0.1 µM ACh, 
respectively, in Nasco oocytes.  These EC50s are larger than the 0.31 µM ACh for β9’Q 
(Figure 4.2), suggesting that ENAS and ENAS A71 are aminoacylated by another natural 




Figure 4.5:  ENAS and ENAS A71 aminoacylation tested at β9’UAG.  Individual tRNA 
(74mer) [17 ng per oocyte] average current was normalized to THG73 (74mer) average 
current and bars represent this average ratio. (Total number of oocytes tested is 75, 
where each bar is 22 > n > 5 oocytes.)  Black and white bars correspond oocytes from 
Xenopus Express and Nasco, respectively.  ENAS and ENAS A71 show a large amount 
of aminoacylation in Xenopus Express oocytes after a 2 d incubation, which has not been 
seen in vitro (4) or in vivo (9).  Aminoacylation is drastically reduced when tested in 
Nasco oocytes. 
 
While ENAS and ENAS A71 tRNAs do show improved orthogonality compared 
to THG73, the suppression efficiencies of ENAS-W and ENAS A71-W were less than 
26% of THG73-W in both Xenopus Express and Nasco oocytes (Chapter 5 & (23)).  As 
such, neither ENAS tRNA is a viable replacement for THG73 for UAA incorporation in 
Xenopus oocytes. 
4.2.6 Testing Aminoacylation of THG73 Acceptor Stem Mutations 
The E. coli GlnRS contacts the tRNA acceptor stem in the crystal structure (13), 
and biochemical experiments have shown specific base pairs and/or positioning of the 
backbone affect aminoacylation in vivo (14–16).  As such, we decided to screen various 
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mutations in the 2nd to 4th positions of the acceptor stem (shown in Figure 4.3) to create a 
library of T. thermophila Gln amber suppressor (TQAS) tRNAs (note in this 
nomenclature THG73 would be known as TQAS-0).  The mutation G2C on THG73 
(TQAS-1) results in the 2nd position having C2 C71, which results in a non-functional 
tRNA and serves as a negative control.  The single helix pair mutations C2-G71, C3-
G70, and C4 are named TQAS-2, TQAS-3, and TQAS-4, respectively (Figure 4.3).  We 
then created the double helix pair mutation C3-G70 & C4 (TQAS-5) and the triple helix 
pair mutation C2-G71, C3-G70, & C4 (TQAS’).  Finally we placed the ENAS acceptor 
stem from the 2nd to 4th position, including the U2-C71, on THG73 to create TQAS 
(Figure 4.3). 
 All acceptor stem mutations reduced aminoacylation relative to THG73 in both 
Xenopus Express and Nasco oocytes when tested at β9’UAG (Figure 4.6 & Table 4.1).  
TQAS-1 shows the same amount of current as β9’UAG mRNA injection alone, but due 
to the C2 C71 in the acceptor stem TQAS-1-W is unable to suppress α149UAG in both 
Xenopus Express and Nasco oocytes (Chapter 5 & (23)).  In Xenopus Express oocytes, 
the single helix pair mutations on THG73 all lower aminoacylation, with orthogonality 
following the order TQAS-2 < TQAS-3 < TQAS-4 (Figure 4.6).  Reduction is also seen 
for the single helix pair mutations in Nasco oocytes, but the orthogonality trend is 
TQAS-4 ≈ TQAS-3 < TQAS-2.  These results are consistent with previous biochemistry 
experiments that showed the 2nd and 3rd positions are GlnRS identity elements (14,15), 
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Figure 4.6:  THG73 acceptor stem mutations tested at β9’UAG.  Individual tRNA 
(74mer) [16 ng per oocyte] average current was normalized to THG73 (74mer) average 
current.  Bar colors are the same as in Figure 4.5.  Total number of oocytes tested is 189 
and each bar is 26 > n > 8 oocytes.  All mutations in the acceptor stem lower 
aminoacylation in vivo relative to THG73.  TQAS-1 shows lack of aminoacylation, but is 
not accepted by the translational machinery (Thesis Chapter 5 & (23)).  TQAS’ and 




Table 4.1:  THG73 acceptor stem mutations 
tRNA Xenopus Express a Nasco a Average b 
THG73 1.00 1.00 1.00 
TQAS-1 0.01 0.01 0.01 
TQAS-2 0.52 0.23 0.38 
TQAS-3 0.44 0.59 0.52 
TQAS-4 0.34 0.62 0.48 
TQAS-5 0.30 (0.15) c 0.56 0.43 
TQAS' 0.06 (0.08) c 0.74 0.40 
TQAS 0.55 0.08 0.32 
U2-C71 (TQAS) [4.27] d [0.24] d [1.43] d 
a  Values from Figure 4.6. 
b  Average of Xenopus Express and Nasco aminoacylation from Figure 4.6. 
c  Theoretical values calculated by the multiplication of the single mutations. 
d  Theoretical value for U2-C71 calculated by TQAS/(TQAS-3 X TQAS-5). 
 
 We then combined mutations to reduce aminoacylation further in Xenopus 
oocytes.  In Xenopus Express oocytes, combining the mutations results in a 
multiplicative reduction in aminoacylation for TQAS-5 and TQAS’ (Table 4.1), while 
TQAS, which contains U2-C71, shows the largest amount of aminoacylation (Figure 
4.6).  The overall aminoacylation trend in Xenopus Express oocytes is THG73 >> TQAS 
≈ TQAS-2 > TQAS-3 > TQAS-4 > TQAS-5 >> TQAS’, making TQAS’ the most 
orthogonal tRNA (Figure 4.6).  The same tRNAs tested in Nasco oocytes show no 
logical trend in combining mutations (Table 4.1), and TQAS is the most orthogonal 
tRNA.  Nasco oocytes display the overall aminoacylation trend THG73 >> TQAS’ > 
TQAS-4 ≈ TQAS-3 ≈ TQAS-5 > TQAS-2 >> TQAS (Figure 4.6).  Overall the mutations 
suggest C-G pairs in the acceptor stem reduce aminoacylation in Xenopus Express 
oocytes.  Nasco oocytes prefer the C-G mutation at the 2nd position (TQAS-2, Figure 
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4.3) or the non-Watson-Crick U-C pair at the 2nd position, along with C-G pairs at the 3rd 
and 4th positions (TQAS, Figure 4.3).  While differences in the Xenopus Express and 
Nasco oocytes were unanticipated, Figure 4.6 shows that the TQAS tRNA library 
contained an orthogonal tRNA for each genetic background. 
4.2.7 Aminoacylation Tested at a Highly Promiscuous Site, βA70 
The β9’ site can incorporate many natural aas and UAAs (18–20), but we chose 
to further test aminoacylation of the orthogonal tRNAs selected (TQAS’ and TQAS) at 
another highly permissive nAChR site, βA70.  Structural studies place this residue on a 
highly exposed loop of the receptor (24,25).  Previous work on the aligned αD70UAG 
showed that it can incorporate the large UAA biocytin with little change in the EC50 (26).  
Other work has shown that biocytin is a challenging residue for nonsense suppression 
(11), supporting the notion that αD70 is a promiscuous site.  Therefore we studied the 
αD70-aligned site in the β-subunit, βA70, considering only Nasco oocytes. 
With the injection of β70UAG mRNA only, large amounts of current were 
obtained, indicating that this read-through represents ≈ 30% of the current observed in 
the aminoacylation experiments (Figure 4.7).  This large amount of read-through is not 
typical of most sites studied (β9’UAG discussed above and α145UAG below), and is 
most likely caused by the high promiscuity for aa incorporation.  Injection of THG73-
dCA and TQAS’-dCA with β70UAG in Nasco oocytes resulted in approximately the 
same amount of aminoacylation (Figure 4.7, white bars), which is consistent with 
increased TQAS’ aminoacylation with Nasco oocytes (Figure 4.6).  However, TQAS 
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shows very little aminoacylation compared to THG73 at this site (Figure 4.7), and 




Figure 4.7:  tRNA (74mer/-dCA) aminoacylation tested at a highly promiscuous site, 
βΑ70.  All experiments were performed in Nasco oocytes.  Black bars are tRNA 
(74mer), white bars are tRNA-dCA, and the gray bar is mRNA only.  Average currents 
for TQAS’-dCA and TQAS were normalized to THG73-dCA and THG73, respectively.  
mRNA only was normalized to THG73.  Total number of oocytes tested is 60, where 
each bar is 15 > n > 6 oocytes with 9 ng of tRNA per oocyte.  mRNA only shows 
significant read-through of the UAG stop codon.  THG73, THG73-dCA, and TQAS’-
dCA all show significant aminoacylation when assayed at β70UAG.  TQAS shows 
comparable currents to the injection of mRNA only, showing less aminoacylation of 
TQAS in Nasco oocytes. 
 
The EC50s for mRNA only, THG73, TQAS’-dCA, and TQAS were 71 ± 1, 56 ± 
3, 58 ± 3, and 46 ± 2 µM ACh, respectively, and showed little change from the wild-type 
EC50 of 50 µM ACh.  These studies further show that TQAS is the most orthogonal 
tRNA and that TQAS’ is aminoacylated extensively in Nasco oocytes. 
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4.2.8 LysRS Does Not Aminoacylate THG73, TQAS’, and TQAS 
THG73 was shown to be aminoacylated by Gln at the β9’ site (Figure 4.2).  
However, the 9’ position is a conserved Leu in all of the nAChR subunits and forms the 
hydrophobic gate to the channel (18).  Therefore it is possible that anionic or cationic aas 
such as Asp, Glu, Lys, and Arg may not be incorporated at the β9’ position or may 
produce nonfunctional receptors if they are.  This is concerning because many amber 
suppressor tRNAs have been shown to be aminoacylated by LysRS and/or GlnRS in vivo 
(22), and mutations to the anticodon stem of an amber suppressor tRNATyr have shifted 
the GlnRS or LysRS recognition in vitro (27).  To evaluate this possibility, we studied a 
conserved Lys residue in the α-subunit of the nAChR, αK145, to test if suppressor 
tRNAs were aminoacylated by LysRS and/or GlnRS.  The conventional mutant αK145Q 
gave an EC50 of 144 ± 2 µM ACh (Figure 4.8), a ≈ 3-fold increase relative to the wild-




Figure 4.8:  tRNA aminoacylation tested at αK145.  Total number of oocytes tested is 
36, where each dose-response is 17 > n > 5 oocytes.  EC50 values are 167 ± 14, 165 ± 14, 
134 ± 15, and 144 ± 2 µM ACh in the order listed in the legend with 7.5 ng of tRNA per 
oocyte.  All tRNAs are still aminoacylated by Gln and not Lys (wild-type EC50 = 50 µM 
ACh). 
 
Injection of α145UAG mRNA alone resulted in very small currents, such that 
EC50 could not be determined.  Injection of α145UAG with THG73-dCA, TQAS’-dCA, 
and TQAS resulted in EC50s of 167 ± 14, 165 ± 14, and 134 ± 15 µM ACh, respectively 
(Figure 4.8).  The EC50s for all tRNAs are ≈ 3-fold increased relative to the wild-type 
EC50, and therefore all of the tRNAs are aminoacylated by GlnRS and not by LysRS in 
Xenopus oocytes. 
4.2.9 Analyzing THG73-W and TQAS-W Interactions with the Translational 
Machinery In Vivo 
In Figure 4.1, we outlined the desired events for the incorporation of UAA and 
the undesired possibility of incorporation of natural aas at the suppression site.  THG73 
was previously shown to be orthogonal to the translational machinery in vitro and in vivo 
when using less mRNA and/or tRNA along with incubations less than 2 d (4–8).  We 
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have shown that with increasing all three of the aforementioned conditions, producing 
so-called excessive conditions, THG73 can be aminoacylated in vivo.  Under these same 
conditions, TQAS’ shows ≈ 90% reduction in the aminoacylation product in Xenopus 
Express oocytes (Figure 4.6). 
To analyze interactions with the translational machinery we used the temporal 
control of injection.  By injecting tRNA-W first, we analyze the protection of the tRNA-
W by EF-1α and/or other components of the translational machinery (Figure 4.1, A) 
from the undesired, irreversible loss of the UAA by hydrolysis and/or aaRS editing 
(Figure 4.1, C).  Subsequent injection of mRNA to assay protein production (Figure 4.1, 
B) allows for comparison to what is seen when tRNA-W and mRNA are injected 
simultaneously.  The tRNA-aa bond is highly labile at physiological pH.  In a recent 
study, a sample of dCA-Val at pH 7.8 without translational machinery components was 
69% hydrolyzed after a 1 h incubation (28).  The cytoplasm of a Xenopus oocyte is 
estimated to be between pH 7.3–7.7 (29,30), and therefore some hydrolysis of tRNA-
dCA-W would be expected after 3.5 h, if not protected by other proteins.  EF-Tu has 
been shown to protect YFFSCCCG-UAA from hydrolysis in vitro, but significant loss was 
seen after 1 h (17). 
Simultaneous injection of THG73-W/TQAS’-W (10 ng per oocyte) and 
α149UAG mRNA gave average maximal currents of -3.9 ± 1 and -4.1 ± 1 µA, 
respectively, in Xenopus Express oocytes.  Surprisingly, we see no loss in current from 
either THG73-W or TQAS’-W when injecting mRNA 3.5 h after the tRNA-W, with -3.9 
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± 0.5 and -3.9 ± 1 µA, respectively.  Injection of twice as much THG73-W (20 ng per 
oocyte) resulted in -6.3 ± 2 µA.  This illustrates that the translation system is not 
saturated, but there is not a linear increase in current with twice as much tRNA-W in a 
single injection.  Therefore, interactions with EF-1α and/or other proteins specifically 
protect both suppressor tRNA-Ws from deacylation by aaRS(s) and hydrolysis, which is 
not problematic after 3.5 h in the Xenopus oocytes. 
A double injection protocol, in which a second dose of aminoacyl tRNA is 
injected 24 h after the first, allows us to assay competition between the suppressor 
tRNA-W and tRNA-Q (generated by aminoacylation in vivo) after 24 h (Figure 4.1, B & 
G).  Only aromatic aas can function at α149UAG, and suppressing with tRNA-W results 
in wild-type channels.  If, however, there is competition with tRNA-Q, then, during the 
second 24 h there will be a decrease in the overall protein production, or less than double 
the current.  In the event, a double injection with a 24 h interval of THG73-W/TQAS’-W 
with α149UAG showed currents of -8.9 ± 2 and -8.6 ± 3 µA, respectively, which is 
greater than twice the protein relative to the single injection.  The higher protein 
production is mostly likely due to residual mRNA from the 1st injection, even though 
nonsense-mediated decay in Xenopus oocytes is expected to remove most mRNA with 
premature stop codons after 18 h (31). 
The double injection studies establish that aminoacylation of the tRNA-dCA in 
Xenopus oocytes (Figure 4.1, E–H) is not problematic for the first 24+ h in vivo for 
either THG73 and TQAS’, because there is no reduction in protein and therefore lack of 
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competition for the suppression site.  This is surprising because THG73 is aminoacylated 
≈ 90% more than TQAS’ in Xenopus Express oocytes after 2 d (Figure 4.6).  This does, 
however, agree with previous investigations of THG73 orthogonality in vivo with 
incubations of 24 h or less (7). 
4.2.10 Comparing Aminoacylation of Amber, Opal, and Frameshift Suppressor 
tRNAs 
Increasing the number of UAAs to be simultaneously incorporated site-
specifically requires the use of a unique stop or quadruplet codon for each UAA.  
Previously we screened two yeast Phe frameshift suppressor tRNAs, YFFSCCCG and 
YFaFSACCC, in Xenopus oocytes and found that both tRNAs were aminoacylated much 
less than THG73 when tested at the β9’ site.  However, their suppression efficiency was 
decreased relative to THG73 in vivo, although still adequate for UAA incorporation (3).  
Previous work has established that the opal (UGA) and ochre (UAA) stop codons can be 
suppressed in mammalian cells when using suppressor tRNAs that are aminoacylated by 
endogenous aaRSs (32) or by the import of an exogenous E. coli aaRSs (33).  The opal 
codon has also been used to incorporate an UAA in mammalian cells using a 
tRNA/synthetase pair (34).  Also, an opal suppressor was previously created by replacing 
the anticodon of THG73 with UCA, but this opal suppressor tRNA (not chemically 
ligated to an UAA) is aminoacylated in vitro and results in protein translation, or 
aminoacylation product, > 90% when compared to wild-type translation.  Under the 
same conditions as the opal suppressor tRNA, THG73 and ENAS showed < 5% 
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aminoacylation product (4), suggesting that the opal suppressor derived from THG73 
would be highly aminoacylated in vivo and not viable for nonsense suppression.  In T. 
thermophila, the ochre suppressor has been shown to suppress both the ochre and amber 
codons (21), and so it would not be viable for the simultaneous incorporation of multiple 
UAAs. 
To test the generality of the acceptor stem mutations at reducing aminoacylation 
in vivo, we created T. thermophila Gln opal suppressor tRNAs (TQOpS’ and TQOpS) by 
replacing the anticodon of TQAS’ and TQAS with UCA. 
 All four subunits of the nAChR terminated with the opal (UGA) stop codon, and 
these were all mutated to the ochre (UAA) stop codon to avoid suppression by TQOpS’ 
or TQOpS.  The masked construct had an EC50 of 53 ± 3 µM ACh, comparable to the 
wild-type EC50 of 50 µM.  Injection of β9’UGA with no tRNA resulted in 2.8% of the 
current normalized to THG73 (74mer), vs. 1.7% with β9’UAG.  The opal codon thus 
showed ≈ 1.6-fold greater read-through than the amber codon, which has previously been 
noted in E. coli (35).  Aminoacylation was tested under identical conditions with 
THG73, TQAS’, TQAS, TQOpS’, TQOpS, YFFSCCCG, and YFaFSACCC at the β9’ 
suppression site, stop codon or quadruplet codon, with tRNA (74mer) and tRNA-dCA 
(76mer).  This was done to validate initial screens using only (74mer) and comparisons 
between (74mer) and (76mer) in Figures 4.4, 4.5, 4.6, and 4.7.  Comparison of 
suppressor tRNAs (74mer) and tRNA-dCAs (76mer) show no significant difference for 
each individual suppressor tRNA in Xenopus Express or Nasco oocytes (Figure 4.9).  
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Once again TQAS’ and TQAS showed much less aminoacylation in Xenopus Express 
and Nasco oocytes, respectively, relative to THG73.  TQOpS’ and TQOpS both show 
less than ≈ 40% and ≈ 9% aminoacylation, respectively, compared to THG73 (Figure 
4.9).  This shows that the acceptor stem mutations on THG73 are able to reduce 
aminoacylation for both amber and opal suppressor tRNAs.  YFaFSACCC and YFFSCCCG 
show a similar trend to that previously reported (Chapter 3 & (3)) with average 
aminoacylation product of 19% and 3%, respectively, of THG73.  The orthogonality 
trend is as follows: YFaFSACCC > TQAS’ (Xenopus Express) ≈ TQOpS > YFFSCCCG > 




Figure 4.9:  Amber, opal, and frameshift suppressor tRNAs tested at β9’.  All tRNA 
74mer or -dCA [7.5 ng per oocyte] average currents were normalized to THG73 74mer 
or -dCA average currents, respectively.  Black bars are tRNA 74mer + β9’(UAG, UGA, 
CGGG, or GGGU) and gray bars are tRNA-dCA (76mer) + β9’(UAG, UGA, CGGG, or 
GGGU) in Xenopus Express oocytes.  White and Hatched bars are tRNA 74mer and 
76mer, respectively, in Nasco oocytes.  Total number of oocytes is 276, where 17 > n > 
5.  TQAS’ and TQAS show significantly reduced aminoacylation in Xenopus Express 
and Nasco oocytes, respectively, when compared to THG73.  Both opal suppressor 
tRNAs (TQOpS’ and TQOpS) show less aminoacylation than THG73.  Overall, the 
frameshift suppressor YFaFSACCC is the most orthogonal tRNA in both Xenopus Express 
and Nasco oocytes. 
 
4.3 Discussion 
THG73 is an amber suppressor tRNA that has been used extensively for the 
incorporation of greater than 100 residues in 20 proteins (1,2).  Using conditions such as 
low quantities of mRNA and/or tRNA with incubation times less than 2 d, THG73 has 
been shown to be orthogonal in vitro (4–6) and in vivo (7,8).  However, increasing the 
amount of mRNA and tRNA with incubation of 2 d leads to the aminoacylation of 
THG73 by an endogenous aaRS in vivo (3).  We show that the E. coli Asn amber 
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suppressor (ENAS) and ENAS A71 are both susceptible to aminoacylation by aaRSs of 
the Xenopus oocyte (Figure 4.5), even though aminoacylation has not been observed in 
vitro (4,10,11) or in vivo (9).  This suggests that many well-characterized amber 
suppressor tRNAs may become aminoacylated in vivo when using increased amounts of 
mRNA and tRNA along with incubations of 2 d, which is desirable for increased 
amounts of protein. 
 By using the sensitivity of electrophysiology and the well-characterized β9’ site, 
we have been able to show that the natural aa placed on THG73 is predominantly if not 
exclusively Gln (Figure 4.2).  The THG73 (74mer) and β9’Q show comparable EC50s, 
but THG73-dCA (76mer) shows ≈ 3-fold increase in EC50 (Figure 4.2).  These 
experiments suggest that THG73-dCA (76mer) is more readily aminoacylated by other 
endogenous aaRSs, perhaps due to the unnatural dCA at the 3’ end, but the predominant 
aa is still Gln.  Similar conditions with the THG73 (74mer) resulted in equivalent EC50 
as β9’Q and therefore the active THG73-CA (Figure 4.1, D) appears to be more 
stringently recognized by the GlnRS. 
 Intriguingly, THG73 is very sensitive to the previously discussed “knob” 
mutations meant to disrupt recognition by GlnRS, and the derived tRNAs are not viable 
for UAA incorporation.  The K2 mutation alone destroys activity, and combining it with 
other knob mutations provides little rescue.  The K2 mutation resides within the D 
domain of THG73, which makes tertiary contacts with the variable loop to form the 
characteristic L-shape tRNA structure.  This mutation may result in misfolding of the 
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THG73, but it apparently has little effect on E. coli tRNA2Gln (12).  Interestingly, the K1, 
or TQAS-3, mutation was shown to be functional by itself on THG73 (Chapter 5 & 
(23)), but it is non-functional in combination with K2 and K3 (Figure 4.4).  Replacement 
of the THG73 anticodon with ACCC (8) or CCCG (3) resulted in nonfunctional 
frameshift suppressors in vivo.  THG73 appears to be sensitive to mutation within the D 
domain and the anticodon loop, but tolerates acceptor stem mutations. 
 ENAS and ENAS A71 aminoacylation in Xenopus Express oocytes is 
comparable to THG73, but there is a 40% decrease due to the U2-C71 vs. U2-A71, 
respectively, (Figure 4.5) at the 2nd position of the acceptor stem (Figure 4.3).  ENAS 
A71 is more orthogonal, which suggests that the U-A is not recognized by endogenous 
aaRSs as readily as U-C.  The opposite trend is seen in Nasco oocytes, but orthogonality 
is significantly improved for both ENAS and ENAS A71.  Clearly, the identity of the 2nd 
pair has a strong effect on aminoacylation in vivo. 
We hypothesized that similar mutations on THG73 could result in less 
aminoacylation by the GlnRS, because the identity set includes the 2nd to 4th positions of 
the acceptor stem (13–16).  The acceptor stem mutations (shown in Figure 4.3) greatly 
reduced aminoacylation in vivo (Figure 4.6 & Table 4.1).  In Xenopus Express oocytes, 
the single helix pair mutations could be combined to further reduce aminoacylation in a 
multiplicative manner (Table 4.1).  In contrast, Nasco oocytes showed a strong 
dependence on specific sequences, and there was no logical trend based on the single 
helix pair mutations.  This non-classical identity set has previously been identified on 
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yeast Phe tRNA, where combining mutations could compensate for deleterious single 
mutations to increase aminoacylation in vitro (36).  While variation due to the Xenopus 
Express and Nasco oocytes was unanticipated, the library of six functional TQAS tRNAs 
was able to find an orthogonal suppressor tRNA for each genetic background.  We can 
anticipate that as other workers move the UAA methodology into other cell types, 
different orthogonality issues could arise.  The library of tRNAs created here contains 
diverse mutations in the acceptor stem that should allow for orthogonal tRNA selection 
in other eukaryotic cells, where high-throughput assays for tRNA screening are currently 
lacking. 
 Using the temporal control of injection, we were able to evaluate THG73-W and 
TQAS’-W interactions with the protein translation machinery and competition with the 
suppressor tRNAs aminoacylated with Gln after 1 d.  Shockingly, there is no change in 
suppression efficiency when the mRNA and tRNA-W are injected simultaneously or 
when the mRNA was injected 3.5 h after tRNA-W.  These experiments show that both 
suppressor tRNAs are equally protected by EF-1α and/or other components of the 
translational machinery for at least 3.5 h, which has not been observed in vitro with or 
without EF-Tu (17,28).  Most importantly, this shows that aaRS editing and/or 
hydrolysis (Figure 4.1, C) are not problematic with 10 ng of tRNA-W injected in 
oocytes.  Injection of 20 ng of THG73-W resulted in a 60% increase in current with a 
single injection, establishing the lack of saturation at 10 ng, although the response is non-
linear.  By injecting mRNA and tRNA-W followed by a 2nd injection of the same after 
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24 h, we could see if there was competition for the suppression of α149UAG by tRNA-
Q (Figure 4.1, B & G).  The double injection for both THG73-W/TQAS’-W showed a 
slightly greater than 2-fold increase in current, indicating a lack of competition with 
tRNA-Q slightly after 24 h.  This agrees with previous experiments using less than 24 h 
incubation times (7,8).  Aminoacylation of THG73 therefore takes place after 24 h and is 
not different from TQAS’ in Xenopus Express oocytes in the first 24 h.  However, 
TQAS’ is aminoacylated ≈ 90% less than THG73 after 2 d.  Overall, both THG73 and 
TQAS’ interact with the protein translational machinery similarly in Xenopus Express 
oocytes. 
 In order to simultaneously incorporate multiple UAAs, it is necessary to use a 
unique stop or quadruplet codon for each UAA.  Previously, three UAAs could be 
simultaneously incorporated using amber and frameshift suppression with the UAG, 
CGGG, and GGGU suppression sites (3).  A second nonsense site, either opal (UGA) or 
ochre (UAA), would be valuable for the incorporation of four UAAs.  However, the T. 
thermophila ochre suppressor recognizes both the ochre (UAA) and amber (UAG) stop 
codons (21).  The opal codon has been used to incorporate an UAA in mammalian cells 
using a tRNA/synthetase pair (34) and should be feasible for the UAA incorporation in 
Xenopus oocytes.  Previous work with an opal suppressor created from THG73 by the 
replacement of the anticodon with UCA resulted in a large amount of aminoacylation in 
vitro and production of greater than 90% protein relative to wild-type protein (4).  These 
results suggest that the THG73-derived opal suppressor would be aminoacylated much 
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more than the THG73 amber suppressor and would not be able to be evaluated under the 
conditions tested in this paper.  To test the generality of the acceptor stem mutations at 
reducing aminoacylation, we replaced the anticodon of TQAS’ and TQAS with UCA to 
create TQOpS’ and TQOpS, respectively.  Both TQOpS’ and TQOpS show a great 
reduction in aminoacylation in vivo relative to THG73 (Figure 4.9) and are viable 
suppressor tRNAs for UAA incorporation at the opal codon (Chapter 5 & (23)).  
Intriguingly, there is no significant difference in aminoacylation of TQOpS’ in Xenopus 
Express and Nasco oocytes (Figure 4.9), which suggests the opal suppressor is 
recognized by a different aaRS(s) and variation in aminoacylation is caused by the 
GlnRS, which we have shown recognizes THG73, TQAS’, and TQAS (Figure 4.8); the 
tRNAs show different amounts of aminoacylation depending on the genetic background 
(Figures 4.6 & 4.9). 
 We have shown that acceptor stem mutations have wide applicability for the 
creation of orthogonal suppressor tRNAs for the incorporation of UAAs in higher 
eukaryotic cells.  TQAS’ and TQAS still retain slight aminoacylation by the GlnRS in 
Xenopus Express and Nasco oocytes, respectively.  Mutations in the anticodon stem 
have been shown to decrease GlnRS recognition and may further reduce aminoacylation, 
but these mutations can also lead to increased LysRS recognition (27).  The acceptor 
stem mutations have no adverse effect on the suppression efficiency and can increase the 
suppression efficiency by as much as 40% (Chapter 5 & (23)).  While aminoacylation 
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was shown to be dependent on the genetic background of the oocytes, there is no effect 
on the suppression efficiencies of the TQAS tRNAs (Chapter 5 & (23)). 
In summary, we have created a TQAS tRNA library that will aid in the 
identification of orthogonal tRNAs for use with higher eukaryotic cells.  When combined 
with the evaluation of suppression efficiencies described in Chapter 5 and (23), these 
tRNAs should significantly expand the applicability of site-specific incorporation of 
UAAs by chemically aminoacylated tRNAs. 
 
4.4 Experimental Methods 
4.4.1  Materials 
All oligonucleotides were synthesized by Integrated DNA Technologies 
(Coralville, IA).  NotI was from Roche Applied Science (Indianapolis).  BamHI, EcoRI, 
FokI, T4 DNA ligase, and T4 RNA ligase were from NEB (Beverly, MA).  Kinase Max, 
T7 MEGAshortscript, and T7 mMessage mMachine kits were from Ambion (Austin, 
TX).  ACh chloride and yeast inorganic pyrophosphatase were purchased from Sigma-
Aldrich.  dCA and 6-nitroveratryloxycarbonyl protected dCA-W was prepared as 
reported in (37,38). 
4.4.2 tRNA Gene Preparation and tRNA Transcription 
THG73, YFFSCCCG, and YFaFSACCC subcloned in the pUC19 vector were 
previously made (3,7).  Genes for ENAS (sequence from (4)) with flanking EcoRI and 
BamHI overhangs were phosphorylated using Kinase Max kit, annealed, and ligated with 
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T4 DNA ligase into EcoRI and BamHI linearized pUC19 vector as described (39).  
ENAS A71 (original sequence from (9) with G1-C72 insertion for T7 polymerase 
transcription) was created by QuikChange mutagenesis on ENAS in pUC19.  Knob 
mutations from (12) (K2 is C10-G25; K2K3 is C10-G25 & G17; and K1K2K3 is C3-
G70, C10-G25, & G17) on THG73 were created by QuikChange mutagenesis.  Acceptor 
stem mutations on THG73 were created by QuikChange mutagenesis and shown in 
Figure 4.3.  Replacing the anticodon of TQAS’ and TQAS from CUA to UCA by 
QuikChange mutagenesis created TQOpS’ and TQOpS, respectively.  All mutations 
were verified by DNA sequencing (California Institute of Technology Sequencing / 
Structure Analysis Facility).  Template DNA for tRNA lacking the 3’CA was prepared 
by FokI digestion, and tRNA was transcribed using the T7 MEGAshortscript kit with .5 
µl of yeast inorganic pyrophosphatase (40 U/ml in 75 mM Tris, 10 mM MgCl2, and pH 
7).  tRNA was desalted using CHROMA SPIN-30 DEPC-H2O columns (BD 
Biosciences), and concentration was determined by absorption at 260 nm. 
4.4.3 nAChR Gene Preparation and mRNA Transcription 
The masked α-, β-, γ-, and δ-subunits of the nAChR subcloned in the pAMV 
vector were previously prepared (3).  All four subunits terminate with the opal (UGA) 
stop codon and each UGA was mutated to the ochre (UAA) stop codon to avoid possible 
suppression by TQOpS’ and TQOpS.  α149UAG and β9’(UAG, CGGG, and GGGU) 
were previously prepared on the masked constructs (3).  β70UAG, α145Q, α145UAG, 
and β9’UGA were prepared by QuikChange mutagenesis.  Mutations were verified by 
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DNA sequencing (California Institute of Technology Sequencing / Structure Analysis 
Facility).  DNA was linearized with NotI and mRNA was prepared with the T7 
mMessage mMachine kit with .5 µl of yeast inorganic pyrophosphatase.  mRNA was 
purified by using the RNeasy Mini kit (Qiagen, Valencia, CA) and quantified by 
absorption at 260 nm. 
4.4.4 dCA and dCA-W Ligation to Suppressor tRNAs 
75 µM (used instead of 300 µM because there was no change in ligation 
efficiency) of dCA or 6-nitroveratryloxycarbonyl protected dCA-W were coupled to 
suppressor tRNAs by using T4 RNA ligase for 30 min as previously reported (39,40), 
desalted using CHROMA SPIN-30 DEPC-H2O columns, and quantified by absorption at 
260 nm.  tRNA ligation efficiency was qualitatively determined by MALDI mass 
spectrometry (40), and all tRNA ligations were identical within each prepared group and 
greater than 80%. 
4.4.5 In Vivo Aminoacylation and Suppression Experiments 
Prior to in vivo aminoacylation and suppression experiments, all tRNAs and 
mRNAs were simultaneously made and normalized by UV and densiometric analysis 
using AlphaEaseFC Stand Alone (Alpha Innotech, San Leandro, CA).  Stage VI oocytes 
of Xenopus laevis were prepared as described (41).  All tRNAs were refolded at 65 ˚C 
for 2 min and 6-nitroveratryloxycarbonyl protected dCA-W was deprotected for 5 min 
by UV irradiation before injection (7).  Oocytes were injected with 50 nl of mRNA alone 
or with tRNA and incubated at 18 ˚C for 44–52 h.  For EC50 determination of β9’Q 
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(Figure 4.2), 3 ng of mRNA in the ratio of 2:1:1:1 for α:β9’Q:γ:δ was injected.  20 ng of 
mRNA in a subunit ratio of 2:5:1:1 for α:β9’UAG:γ:δ or 10:1:1:1 for α149UAG:β:γ:δ 
was injected in Figures 4.2, 4.4, and 4.5.  Figures 4.6, 4.7, and 4.8 used the same ratio, 
but 40 ng to 60 ng of mRNA was injected per oocyte.  In Figure 4.9, 40 ng of mRNA 
was injected in a subunit ratio of 2:5:1:1 for α:β9’(UAG, UGA, CGGG, or GGGU):γ:δ.  
The amount of tRNA injected is listed with each figure. 
4.4.6 Electrophysiology 
Recordings employed two-electrode voltage clamp on the OpusXpress 6000A 
(Molecular Devices).  ACh was stored at -20 ˚C as a 1 M stock, diluted in Ca2+-free 
ND96, and delivered to oocytes by computer-controlled perfusion system.  For all 
experiments, the holding potential was -60 mV.  Dose-response data was obtained from 
at least eight ACh concentrations and all tRNA aminoacylation or suppression 
comparisons were tested with a single 1 mM ACh dose.  Dose-response relations were fit 
to the Hill equation to determine the EC50 and Hill coefficient (nH).  All reported values 
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Incorporation of unnatural amino acids (UAAs) site-specifically into proteins is a 
powerful technique that is seeing increased use.  Typically, the UAA is incorporated at a 
stop codon (nonsense suppression) using an orthogonal tRNA with an anticodon 
recognizing the stop codon.  In higher eukaryotes, nonsense suppression by chemically 
aminoacylated tRNAs is mostly limited to the Xenopus oocyte, where injection of the 
mutant mRNA and suppressor tRNA chemically aminoacylated with the UAA is 
straightforward, and electrophysiology allows for sensitive detection of UAA 
incorporation (shown in Figure 3.1) (1,2).  Previously only a single UAA could be 
incorporated into a given protein expressed in Xenopus oocytes, but frameshift 
suppression allows for the simultaneous incorporation of three UAAs, using the amber 
stop codon (UAG) and the quadruplet codons, CGGG and GGGU (3). 
 In developing optimal procedures for nonsense suppression, two key issues must 
be addressed.  The first is “orthogonality”; the suppressor tRNA must not be recognized 
by any of the endogenous aminoacyl-tRNA synthetases (aaRSs) of the expression 
system, as this would lead to competitive incorporation of natural amino acids (aas) at 
the mutation site (Figure 4.1).  In Chapter 4, we developed and evaluated the 
orthogonality of a library of suppressor tRNAs, establishing that several new mutations 
increase the orthogonality of amber suppressor tRNAs (Chapter 4 & (4)).  The second 
issue is suppression efficiency.  In order to produce adequate quantities of protein, 
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optimal use of the chemically aminoacylated tRNA is essential, as this stoichiometric 
reagent is often not available in large quantities.  This is especially true when 
considering incorporation of biophysical probes for fluorescence or cross-linking 
strategies that often require more protein than the much-used electrophysiological 
approaches. 
THG73, an amber suppressor tRNA from T. thermophila with a G73 mutation, 
has been used extensively to incorporate greater than 100 residues in 20 different 
proteins in Xenopus oocytes (1,2).  In the present work, we evaluate a number of tRNAs 
for their suppression efficiency in Xenopus oocytes compared to THG73.  We find that 
an E. coli Asn amber suppressor (ENAS) tRNA that was shown to incorporate UAAs 
better than THG73 in vitro (5) is in fact significantly less efficient than THG73 in 
Xenopus oocytes. 
We also evaluate several other tRNAs that contain mutations in the 2nd to 4th 
positions of the acceptor stem on THG73.  Our study of tRNA orthogonality showed 
such mutations can have interesting consequences on aminoacylation in vivo (Chapter 4 
& (4)).  A number of studies have shown that acceptor stem, anticodon stem, D stem, 
and T stem structure can influence suppression efficiency, often finding that replacement 
of non-Watson-Crick base pairs with canonical pairs increases efficiency (6–8).  We 
therefore created a library of T. thermophila Gln amber suppressor (TQAS) mutants that 
strengthened the acceptor stem with C-G/G-C pairs and replaced the non-Watson-Crick 
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pair U4-G69 with C4-G69.  Many of the mutant tRNAs had increased suppression 
efficiency over THG73, but there was a lack of correlation with the stability of the 
acceptor stem in Xenopus oocytes.  Intriguingly, a mutant tRNA with U2-C71 and 
mutations in the 3rd and 4th positions was found to suppress UAG more efficiently than 
THG73 in Xenopus oocytes.  In contrast, when creating T. thermophila Gln opal 
suppressor (TQOpS) tRNAs, the U2-C71 mutation had an adverse effect on suppression 
efficiency compared to C2-G71 tRNA (TQOpS’).  Thus, in vivo nonsense suppression 
efficiencies of both UAG and UGA stop codons are affected by mutations in the acceptor 
stem of tRNAs.  Overall, we have created a TQAS tRNA library that is functional in 




5.2.1 Electrophysiology Assay 
All experiments were performed by suppression in the nicotinic acetylcholine 
receptor (nAChR), which is a pentameric ion channel composed of α-, β-, γ-, and δ-
subunits in the ratio of 2:1:1:1, respectively (Figure 3.3).  For comparison of the 
suppression efficiency and the incorporation of UAAs, the well-characterized αW149 
site was utilized (Figure 3.3).  This site can only function with the incorporation of 
aromatic aas or aromatic UAAs, because it makes a cation-π interaction with ACh (9).  
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In order to compare suppression efficiencies across different batches of oocytes, we 
normalized the average maximal current for each tRNA to the average maximal current 
for THG73, obtained concurrently.  This ratio allows for comparison of suppression 
efficiencies even if protein expression varies between batches of oocytes. 
During the course of this research, we noticed variations in aminoacylation 
depending on whether the oocytes were obtained from frogs purchased from Xenopus 
Express or Nasco (Chapter 4 & (4)).  Xenopus laevis frogs from Xenopus Express are 
caught in Africa, while Nasco frogs are bred in a laboratory and are from a similar gene 
pool (Linda Northey, personal communication).  We therefore tested the suppression 
efficiency of tRNAs to see if there was any difference between Xenopus Express and 
Nasco oocytes.  When different suppliers are used in experiments, they are explicitly 
labeled with each figure. 
5.2.2 ENAS and ENAS A71 Suppression Efficiency 
The E. coli Asn amber suppressor (ENAS) tRNA has been shown previously to 
have a greater suppression efficiency than THG73 in some instances in an E. coli in vitro 
translation system (5).  ENAS has been used extensively to incorporate UAAs in vitro 
and can also tolerate substitution to the anticodon to suppress quadruplet codons for the 
incorporation of multiple UAAs (10,11).  Therefore ENAS may be a valuable alternative 
to THG73 for the creation of amber and/or frameshift suppressor tRNAs in vivo.  ENAS 
contains the insertion G1-C72 to allow for optimal T7 RNA polymerase transcription 
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and thus has an 8 base pair acceptor stem (5).  THG73 and the yeast Phe frameshift 
suppressor tRNAs (YFFSCCCG and YFaFSACCC) are derived from eukaryotic cells and 
have a 7 base pair acceptor stem (3).  When analyzing the structure of ENAS, we noticed 
that the 2nd position of the acceptor stem contains the non-Watson-Crick base pair U2-
C71, and thus we created the variant ENAS A71 to form the canonical pair U2-A71 
(Figure 5.1) that is present in the wild-type E. coli Asn tRNA (12).  Suppression of 
α149UAG with either ENAS-W or ENAS A71-W resulted in substantially diminished 
suppression efficiency (Figure 5.2), with the best case being only 26% relative to 
THG73-W.  Overall, ENAS is not a viable alternative to THG73 for the incorporation of 
UAAs in Xenopus oocytes. 
 
Figure 5.1:  THG73 mutations and tRNAs studied.  The 2nd to 4th positions of the 
acceptor stem are shown for all tRNAs, with mutations in gray italics.  ENAS and TQAS 
contain the same nucleotides at these positions.  Below each tRNA is the ΔG (kcal/mol) 
of the entire acceptor stem calculated using mfold (13).  TQOpS’ and TQOpS have the 






Figure 5.2:  ENAS-W and ENAS A71-W suppression at α149UAG.  tRNA-W [21 ng 
per oocyte] average current was normalized by THG73-W average current and bars 
represent this average ratio (Total oocytes tested is 40, 17 > n > 11).  Black and white 
bars correspond to Xenopus Express and Nasco oocytes, respectively.  ENAS-W and 
ENAS A71-W produce less than 26% of the THG73-W current when suppressing at 
α149UAG.  Therefore neither ENAS nor ENAS A71 offer improved suppression over 
THG73 in Xenopus oocytes. 
 
 Another option would be to create frameshift suppressors from ENAS.  However, 
previous work has shown that frameshift suppressors derived from amber suppressor 
tRNAs are less efficient in rabbit reticulocyte lysate (14) and in Xenopus oocytes (3), so 
we did not screen frameshift suppressor tRNAs derived from ENAS. 
5.2.3 Testing Suppression Efficiency of THG73 Acceptor Stem Mutations 
We next tested the recently developed T. thermophila Gln amber suppressor 
(TQAS) tRNA library (shown in Figure 5.1) (Chapter 4 & (4)) for suppression efficiency 
at α149UAG.  The mutation G2C on THG73 (TQAS-1) results in the placement of C2 
C71 at the 2nd position of the acceptor stem.  According to a free energy calculation by 
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mfold (13), this causes a distortion in the acceptor stem whereby the base pairs C2-G73 
and G1-C74 are formed, while the CA extension is reduced by two nucleotide lengths.  
Not surprisingly, TQAS-1-W shows only 1% of the suppression efficiency of THG73-W 
in both Xenopus Express and Nasco oocytes (Figure 5.3), a value only slightly greater 
than α149UAG mRNA only. 
 
 
Figure 5.3:  THG73 acceptor stem mutations suppressing at α149UAG.  tRNA-W [9 ng 
per oocyte] average currents were normalized to THG73-W average current, the ratios 
were averaged, and error bars represent the standard error of ≥ 3 normalization 
experiments (17 > n > 8 oocytes per experiment, for a total of 709 oocytes tested).  Bar 
colors are the same as in Figure 5.2.  TQAS-1 is nonfunctional because it represents less 
than 1% of THG73-W.  All other tRNAs show significant current and acceptance by the 
translational machinery.  TQAS-4-W, TQAS-5-W, and TQAS-W all have greater 
average suppression efficiency than THG73-W at α149UAG. 
 
The single helix pair mutations C2-G71 and C3-G70 (TQAS-2 and TQAS-3, 
respectively) show similar suppression efficiency to THG73-W in both Xenopus Express 
and Nasco oocytes (Figure 5.3).  The single mutation U4C (TQAS-4) removes the non-
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Watson-Crick pair at the 4th position and increases suppression efficiency by 55% and 
26% in Xenopus Express and Nasco oocytes, respectively (Figure 5.3). 
Combining the C3-G70 and C4 mutations (TQAS-5) shows an increase in 
suppression efficiency of 26% and 21% in Xenopus Express and Nasco oocytes, 
respectively (Figure 5.3).  Combining all of the functional single helix pair mutations 
created TQAS’, which suppresses equivalently to THG73-W even though there are five 
mutations in the acceptor stem (Figure 5.3).  Placement of the ENAS 2nd to 4th helix pairs 
on THG73 created TQAS (Figure 5.1).  TQAS-W is more efficient in Nasco oocytes 
with 43% increase in suppression efficiency, compared to 9% increase in suppression 
efficiency in Xenopus Express oocytes (Figure 5.3).  The structures of Figure 5.1 
constitute a library of amber suppressor tRNAs containing various acceptor stem 
mutations, which function in vivo comparably or superior to the parent tRNA, THG73. 
5.2.4 Combining Mutations Causes Averaging of the Suppression Efficiency 
While analyzing suppression efficiency, we noticed a trend where combining the 
acceptor stem mutations caused an averaging of the single mutations.  Table 5.1 lists 
values from Figure 5.3 and also shows the average of the two normalization experiments 
for each tRNA-W.  TQAS-5 contains the mutations from both TQAS-3 and TQAS-4 and 
has a suppression efficiency of 1.27 and 1.21, relative to THG73-W, in Xenopus Express 
and Nasco oocytes, respectively.  The average of TQAS-3 and TQAS-4 is 1.28 and 1.14 
in Xenopus Express and Nasco oocytes, respectively (Table 5.1).  TQAS’ contains the 
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mutations from TQAS-2, TQAS-3, and TQAS-4 and has a suppression efficiency of .92 
and 1.00 in Xenopus Express and Nasco oocytes, respectively.  The average of TQAS-2, 
TQAS-3, and TQAS-4 is 1.07 and 1.09 in Xenopus Express and Nasco oocytes, 
respectively (Table 5.1). 
 
Table 5.1:  THG73 acceptor stem mutations. 
tRNA ΔG Xenopus Express a Nasco a Average b 
THG73 -8.9 1.00 1.00 1.00 
TQAS-1 -2.6 0.01 0.01 0.01 
TQAS-2 -8.9 0.67 1.00 0.84 
TQAS-3 -10.9 1.00 1.01 1.00 
TQAS-4 -11.8 1.55 1.26 1.40 
TQAS-5 -13.9 1.27 (1.28) c 1.21 (1.14) c 1.24 (1.20) c 
TQAS' -13.9 .92 d (1.07) c 1.00 (1.09) c 0.96 (1.08) c 
TQAS -10.3 1.09 1.43 1.26 
a  Normalized values from Figure 5.3. 
b  Average of Xenopus Express and Nasco suppression efficiency. 
c  Theoretical values calculated by the average of the single mutations. 
d  Normalized value is larger in Figure 5.4 with 1.15, Average 2 normalizations = 1.04  
   (Theoretical = 1.07). 
5.2.5 Suppression Efficiency of the Acceptor Stem Mutations Does Not Correlate 
With Stability of the Acceptor Stem 
Previous work has shown that non-Watson-Crick mutations within tRNAs have 
an adverse effect on suppression efficiency (6–8), but these mutations would also reduce 
the free energy (ΔG) of the stem regions.  Therefore we calculated the ΔG of the 
acceptor stem using mfold (13).  Mfold does not recognize the U-C pair, and therefore 
we calculated the ΔG as described in the Experimental Methods.  Plotting the TQAS 
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library suppression efficiency as a function of ΔG showed no correlation in Xenopus 
Express or Nasco ooctyes.  TQAS-5 and TQAS’ share the highest ΔG values of the 
library, but suppression efficiency is different due to averaging of single mutations 
(Table 5.1).  Therefore, ΔG of the acceptor stem is not a reliable predictor for tRNA 
suppression efficiency under the conditions currently used. 
5.2.6 Testing Amber, Opal, and Frameshift Suppression Efficiency 
Incorporating multiple UAAs simultaneously requires the use of a unique stop or 
quadruplet codon for each UAA.  Previously we have incorporated three UAAs 
simultaneously using THG73, YFFSCCCG, and YFaFSACCC suppressor tRNAs at the 
corresponding suppression sites, UAG, CGGG, and GGGU (3).  Suppression efficiency 
of the opal (UGA) codon has been shown to be comparable to the amber (UAG) codon 
in mammalian cells when using suppressor tRNAs that are aminoacylated by 
endogenous aaRSs or by the import of exogenous E. coli aaRSs (15,16).  The opal codon 
has also been utilized to incorporate an UAA in mammalian cells using a 
tRNA/synthetase pair (17).  However, when using a chemically aminoacylated tRNA, an 
opal suppressor that efficiently suppresses the opal codon and is adequately orthogonal is 
currently lacking.  Sisido and coworkers tested a yeast Phe opal suppressor in rabbit 
reticulocyte lysate, but the suppression efficiency was only 15% (compared to 65% for 
the yeast Phe amber suppressor) (14).  An opal suppressor created by changing the 
anticodon of THG73 to UCA resulted in large amounts of aminoacylation in vitro (5).  
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We replaced the anticodons of TQAS’ and TQAS with UCA to create TQOpS’ and 
TQOpS, respectively.  Both TQOpS’ and TQOpS show reduced aminoacylation when 
compared to THG73 in Xenopus oocytes (Chapter 4 & (4)). 
 Suppression efficiencies of THG73-W, TQAS’-W, TQAS-W, TQOpS’-W, 
TQOpS-W, YFFSCCCG-W, and YFaFSACCC-W were evaluated at the α149 suppression 
site (Figure 5.4).  All mRNA and tRNAs were normalized to allow for identical 
conditions.  Amber suppression is the most efficient, and the suppression efficiency 
follows the order of TQAS-W > TQAS’-W > THG73-W in Nasco oocytes (Figure 5.4).  
Opal suppression with TQOpS’-W and TQOpS-W has a suppression efficiency of 48% 
and 21%, respectively, relative THG73-W in Nasco oocytes (Figure 5.4).  TQAS-W and 
TQOpS-W were not tested in Xenopus Express oocytes because TQAS was not 
originally selected as an orthogonal tRNA until screening in Nasco oocytes (Chapter 4 & 
(4)), but all other tRNAs show comparable suppression efficiency in both Xenopus 
Express and Nasco oocytes (Figures 5.3 & 5.4).  Overall, TQOpS’-W shows the greatest 
opal suppression efficiency with 54% and 48% in Xenopus Express and Nasco oocytes, 
respectively, and it is a better suppressor tRNA than either frameshift suppressor (Figure 
5.4).  The suppression efficiency trend is thus TQAS-W > TQAS’-W > THG73-W > 




Figure 5.4:  Amber, opal, and frameshift suppressor tRNAs suppression at α149.  
tRNA-W [7.5 ng per oocyte] average current was normalized to THG73-W average 
current.  TQAS’-W, TQOpS’-W, and TQOpS-W were performed twice and error bars 
represent the standard error.  Total oocytes tested is 161 oocytes, where 16 > n > 5 for 
each experiment.  Bar colors are the same as in Figure 5.2.  Amber suppression (THG73-
W, TQAS’-W, or TQAS-W) is the most efficient.  Opal suppression is variable, with 
TQOpS’-W and TQOpS-W suppressing 48% and 21%, respectively, of THG73-W in 
Nasco oocytes.  YFFSCCCG-W suppresses less than YFaFSACCC-W, as previously seen in 
Xenopus oocytes (3).  TQAS’-W and TQAS-W show increased suppression compared to 
THG73-W. 
 
5.2.7 Natural aa and UAA Incorporation With Selected Suppressor tRNAs 
To evaluate incorporation of a natural aa and an UAA using TQAS’, TQAS, 
TQOpS’, and TQOpS, we chose to suppress the well-characterized, non-promiscuous 
site α149.  The Trp at α149 makes a cation-π interaction with ACh, and the 
incorporation of the UAA, 5-F-Tryptophan (WF1), results in ≈ 4-fold increase in the 
EC50 for ACh.  Incorporation of Trp at the α149UAG/UGA site is a wild-type recovery 
experiment because it places the natural aa at the suppression site.  All tRNA-W were 
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injected along with mRNA containing the appropriate codon at site α149, and the EC50 
was determined by fits to the Hill equation (Figure 5.5).  All tRNA-W showed the 
correct EC50 except for TQOpS-W, which showed a slightly higher EC50 than the wild-
type nAChR (Figure 5.5 & Table 5.2).  Injection of α149UGA with TQOpS (74mer) 
resulted in only 3% of the current relative to the injection of α149UGA with TQOpS-W 
and an EC50 for the aminoacylation product could not be determined.  The natural aa 
must be aromatic for functional receptors when suppressing at the α149 site and cannot 
be Trp (EC50 would have been wild-type) and therefore is most likely either Tyr or Phe, 
which are expected to produce substantially higher EC50 values than Trp (9).  However, 
TQOpS-W weakly suppresses the α149UGA site relative to TQOpS’ (Figure 5.4), which 




Figure 5.5:  Fits to the Hill equation for wild-type recovery and UAA incorporation at 
α149.  Suppression of tRNA-W [9 ng per oocyte] at α149(UAG or UGA) places the 
natural aa and results in wild-type EC50 (≈ 50 µM ACh) for all tRNAs tested except 
TQOpS-W (white diamond), which gave the same EC50 in two experiments (see Table 
5.2).  Incorporation of WF1 at α149 results in a 4-fold increase in EC50 (200 µM ACh) 
(9).  All tRNA-WF1 suppressing at α149(UAG or UGA) give similar EC50s and show 
that all tRNAs are able to incorporate an UAA.  All experiments were done in Nasco 
oocytes and give the same EC50s as W or WF1 incorporation in Xenopus Express 
oocytes (3).  EC50s, nH, and n are listed in Table 5.2. 
 
Table 5.2:  Natural aa and UAA incorporation with THG73, TQAS’, TQAS, TQOpS’,  
and TQOpS 
α149 tRNA EC50 (theoretical) a nH n b 
UAG THG73-W 44 ± 1 (50) 1.5 ± 0.05 4 
UAG TQAS’-W 48 ± 1 (50) 1.5 ± 0.05 7 
UAG TQAS-W 49 ± .9 (50) 1.5 ± 0.04 8 
UGA TQOpS’-W 54 ± 5 (50) 1.7 ± 0.2 7 
UGA TQOpS-W 63 ± 2 (50) 1.7 ± 0.07 4 
UAG THG73-WF1 197 ± 9 (200) 1.6 ± 0.09 4 
UAG TQAS’-WF1 201 ± 10 (200) 1.6 ± 0.1 6 
UAG TQAS-WF1 201 ± 10 (200) 1.7 ± 0.2 8 
UGA TQOpS’-WF1 192 ± 12 (200) 1.6 ± 0.1 4 
UGA TQOpS-WF1 200 ± 4 (200) 1.8 ±0.07 5 
a  EC50 values from wild-type nAChR (50 µM ACh) or THG73-WF1 (200 µM ACh) 
incorporation from (9). 
b  n is number of oocytes tested. 
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We then incorporated the UAA, WF1 at the α149 suppression site with the 
injection of tRNA-WF1 and determined the EC50s (Figure 5.5 & Table 5.2).  All tRNAs 
are able to incorporate WF1 at the α149 suppression and show the correct EC50s (Figure 
5.5 & Table 5.2).  All experiments were performed in Nasco oocytes and give the same 
EC50s as W or WF1 incorporation at α149UAG in Xenopus Express oocytes (3).  TQAS’ 
and TQAS are both viable suppressor tRNAs for the incorporation of natural aas and 
UAAs, which suggests that the entire T. thermophila Gln amber suppressor (TQAS) 
tRNA library would also be able to incorporate natural aas and UAAs. 
 
5.3 Discussion 
THG73 is an amber suppressor previously shown to suppress UAAs better than a 
modified yeast Phe amber suppressor (MN3) in Xenopus oocytes (18).  An E. coli in 
vitro translation has shown that ENAS suppresses better than THG73 in some instances 
(5).  We show that in Xenopus oocytes ENAS and ENAS A71 both suppress less than 
26% relative to THG73 (Figure 5.2).  Reduced suppression efficiency may result from 
less acceptance of E. coli derived amber suppressor tRNAs and/or the extra base pair in 
the acceptor stem by the eukaryotic translational machinery.  Therefore neither ENAS 
nor ENAS A71 offer an improvement over THG73.  As a result, frameshift suppressor 
tRNAs derived from ENAS were not screened. 
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 Interestingly, many acceptor stem mutations show no adverse effects on function, 
and there is no statistically significant difference in suppression efficiency in Xenopus 
Express and Nasco oocytes (Figure 5.3), which was seen for aminoacylation (Chapter 4 
& (4)).  Most in vivo assays employ suppressor tRNAs that are aminoacylated in vivo by 
endogenous or exogenous aaRS(s) (6,8,12,15,16,19,20).  By chemically aminoacylating 
mutant suppressor tRNAs, we avoid any bias that may result from suppressor tRNAs 
being differentially aminoacylated.  Therefore, we are able to look at mutant tRNA-W 
interactions with the translational machinery after aminoacylation by evaluating protein 
production, or suppression efficiency.  All mutations to the acceptor stem of THG73, 
excluding the disruptive C2 C71 of TQAS-1, result in functional suppressor tRNAs, and 
many have improved suppression efficiency over THG73 (Figure 5.3).  TQAS-4, TQAS-
5, and TQAS all have increased suppression efficiency (Figure 5.3 & Table 5.1) and 
contain the U4C mutation, which removes a non-Watson-Crick U-G pair at the 4th 
position of the acceptor stem. 
Previous work has established that removing non-Watson-Crick base pairs 
increases suppression efficiency in vitro and in vivo (6–8).  Intriguingly, TQAS contains 
U2-C71 and results in a functional suppressor tRNA with increased suppression 
efficiency relative to THG73 (Figure 5.3 & Table 5.1).  C-U/U-C pairs have been 
identified in the acceptor stems of eukaryotic tRNAs (21).  However, selection schemes 
for orthogonal tRNA/synthetase pairs have not identified such mismatches in E. coli 
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tRNAs, even though ≈ 98.4% of the randomized library would contain a mismatch (22).  
Therefore non-Watson-Crick base pairs are tolerated by the eukaryotic translational 
machinery and may serve some special function in higher eukaryotes, as previously 
suggested (21). 
 Combining the acceptor stem mutations resulted in an averaging of the 
suppression efficiency (Table 5.1).  This result is intriguing because it reflects the 
interactions of the chemically aminoacylated mutant tRNA-W with proteins such as EF-
1α and the ribosome, but not with aaRSs.  All mutations are in the acceptor stem (Figure 
5.1) and maintain the rest of the tRNA body constant.  TQAS-4 contains the single 
mutation U4C, which replaces the non-Watson-Crick base pair U-G, and shows the 
highest average suppression efficiency (Table 5.1).  This mutation most likely increases 
interactions with EF-1α, the ribosome, and/or another protein.  However, this mutation 
combined with other mutations results in reduced suppression efficiency in TQAS-5, 
TQAS’, and TQAS (Table 5.1).  This clearly illustrates that the mutations are not 
additive and no single mutation dominates in influencing the suppression efficiency.  
This suggests there is no dominant protein interaction that strictly influences the 
suppression efficiency, but rather the ensemble of all protein interactions affects the 
overall suppression efficiency. 
 The acceptor stem ΔG does not correlate with suppression efficiency.  Removal 
of non-Watson-Crick base pairs has been shown to increase suppression efficiency in 
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various regions of tRNAs (6–8), which would also increase the ΔG of the tRNA in helix 
forming regions.  Using our TQAS library, we related suppression efficiency as a 
function of ΔG of the acceptor stem and found no overall trend.  The replacement of the 
non-Watson-Crick base pair U4-G69 with C4-G69 (TQAS-4) resulted in increased 
average suppression efficiency, but was not significantly different from the TQAS 
library (Figure 5.3).  TQAS-5 and TQAS’ have the same ΔG (Figure 5.1), but different 
suppression efficiencies (Figure 5.3).  This difference is caused by various combinations 
of single mutations that result in an averaging of suppression efficiency (Table 5.1) due 
to interactions with proteins in the translational machinery.  Therefore, it is difficult to 
predict the tRNA with the best suppression efficiency just by ΔG of the acceptor stem 
under the conditions used in these experiments. 
 An efficient opal suppressor tRNA is highly desirable for the incorporation of 
multiple UAAs in eukaryotic cells.  By replacing the anticodon of TQAS’ and TQAS 
with UCA, we created the opal suppressors TQOpS’ and TQOpS, respectively.  
TQOpS’-W shows suppression efficiency of ≈ 50% relative to THG73-W, while 
TQOpS-W has a suppression efficiency of 21% (Figure 5.4).  Intriguingly, the amber 
suppressor TQAS-W has greater suppression efficiency than TQAS’-W (Figures 5.3 & 
5.4), but the opal suppressors show the reverse trend (Figure 5.4).  Therefore UAG and 
UGA suppression shows differential preference for acceptor stem mutations.  TQOpS-W 
suppresses better than either frameshift suppressor, YFFSCCCG-W and YFaFSACCC-W 
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(Figure 5.4).  TQOpS incorporates W and the UAA, WF1, at α149UGA (Figure 5.5 & 
Table 5.2) and therefore is a viable suppressor tRNA for the incorporation of multiple 
UAAs in vivo. 
 TQAS’ and TQAS can incorporate W and the UAA, WF1, at α149UAG (Figure 
5.5 & Table 5.2).  This suggests that the entire TQAS tRNA library, excluding TQAS-1, 
will be able to incorporate UAAs in vivo.  TQAS’ and TQAS were specifically screened 
because they showed the least amount of aminoacylation in Xenopus Express and Nasco 
oocytes, respectively (Chapter 4 & (4)).  Therefore both orthogonal tRNAs, in their 
respective genetic background, are able to incorporate UAAs.  The TQAS tRNA library 
therefore offers a diverse range of acceptor stem mutations for the selection of 
orthogonal tRNAs (Chapter 4 & (4)).  The TQAS library will be valuable for screening 
in other eukaryotic cells, where screening of randomized libraries may not be feasible. 
 
5.4 Experimental Methods 
5.4.1 Materials 
All oligonucleotides were synthesized by Integrated DNA Technologies 
(Coralville, IA).  NotI was from Roche Applied Science (Indianapolis).  BamHI, EcoRI, 
FokI, T4 DNA ligase, and T4 RNA ligase were from NEB (Beverly, MA).  Kinase Max, 
T7 MEGAshortscript, and T7 mMessage mMachine kits were from Ambion (Austin, 
TX).  ACh chloride and yeast inorganic pyrophosphatase were purchased from Sigma-
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Aldrich.  6-nitroveratryloxycarbonyl protected dCA-W and dCA-WF1 was prepared as 
reported in (9). 
5.4.2 tRNA Gene Preparation and tRNA Transcription 
THG73, YFFSCCCG, and YFaFSACCC subcloned in the pUC19 vector were 
previously made (3,18).  Genes for ENAS (sequence from (5)) with flanking EcoRI and 
BamHI overhangs were phosphorylated using Kinase Max kit, annealed, and ligated with 
T4 DNA ligase into EcoRI and BamHI linearized pUC19 vector as described (23).  
ENAS A71 (original sequence from (12) and containing the G1-C72 insertion for T7 
polymerase transcription) was created by QuikChange mutagenesis on ENAS in pUC19.  
Acceptor stem mutations on THG73 were created by QuikChange mutagenesis and 
shown in Figure 5.1 (gray italics).  Replacing the anticodon of TQAS’ and TQAS from 
CUA to UCA by QuikChange mutagenesis created TQOpS’ and TQOpS, respectively.  
All mutations were verified by DNA sequencing (California Institute of Technology 
Sequencing / Structure Analysis Facility).  Template DNA for tRNA lacking the 3’CA 
was prepared by FokI digestion, and tRNA was transcribed using the T7 
MEGAshortscript kit with .5 µl of yeast inorganic pyrophosphatase (40 U/ml in 75 mM 
Tris, 10 mM MgCl2, and pH 7).  tRNA was desalted using CHROMA SPIN-30 DEPC-





5.4.3 nAChR Gene Preparation and mRNA Transcription 
The masked α-, β-, γ-, and δ-subunits of the nAChR subcloned in the pAMV 
vector were previously prepared (3).  All four subunits terminate with the opal (UGA) 
stop codon and each UGA was mutated to the ochre (UAA) codon to avoid possible 
suppression by TQOpS’ and TQOpS.  α149(UAG, CGGG, and GGGU) were previously 
prepared on the masked constructs (3).  α149UGA was prepared by QuikChange 
mutagenesis.  Mutations were verified by DNA sequencing (California Institute of 
Technology Sequencing / Structure Analysis Facility).  DNA was linearized with NotI 
and mRNA was prepared with the T7 mMessage mMachine kit with .5 µl of yeast 
inorganic pyrophosphatase.  mRNA was purified by using the RNeasy Mini kit (Qiagen, 
Valencia, CA) and quantified by absorption at 260 nm. 
5.4.4 ΔG Calculations of Each tRNA Acceptor Stem 
The entire acceptor stem for each tRNA was used rather than the entire tRNA 
because only secondary interactions are determined by mfold (13) and the correct clover 
leaf structure was not obtained for each tRNA.  The entire acceptor stem—seven helix 
pairs for THG73, TQAS library, YFFSCCCG, and YFaFSACCC, and eight helix pairs for 
ENAS and ENAS A71 (due to the insertion of G1-C72 for T7 RNA polymerase 
transcription) with a U8 linker—was utilized, and default parameters (37 ˚C) of mfold 
were used to calculate ΔGs (13) (values listed for each tRNA acceptor stem in Figure 
5.1).  For TQAS and ENAS, a U-C pair is present in the acceptor stem and this pair is 
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not recognized by mfold (13), even though the U-C pair can form hydrogen bonding 
interactions in RNA helixes (24–26).  Previously, non-Watson-Crick base pair 
thermodynamics (37 ˚C) were obtained by determining the stabilizing/destabilizing 
effect upon placement in a RNA helix (seven base pairs total with mismatch) and 
relating those parameters to a reference RNA helix (six base pairs) (26).  The U-C pair 
was removed to create a reference RNA helix and the ΔG of TQAS(ΔU2-C71) and 
ENAS(ΔU2-C71) with a U8 linker was determined using mfold.  0.26 kcal/mol was 
added to the determined ΔG value to obtain the number listed in Figure 5.1 for TQAS 
and ENAS.  0.26 kcal/mol is the average value of two separate measurements of CU/UC 
pairs in RNA helixes and was used because the exact nucleotide sequence was not 
measured (26).  The ΔG for TQOpS’ and TQOpS are the same for TQAS’ and TQAS, 
respectively. 
5.4.5 dCA-W and dCA-WF1 Ligation to Suppressor tRNAs 
75 µM (used instead of 300 µM because there was no change in ligation 
efficiency) of 6-nitroveratryloxycarbonyl protected dCA-W or dCA-WF1 were coupled 
to suppressor tRNAs by using T4 RNA ligase for 30 min as previously reported (23,27), 
desalted using CHROMA SPIN-30 DEPC-H2O columns, and quantified by absorption at 
260 nm.  tRNA ligation efficiency was qualitatively determined by MALDI mass 
spectrometry (27), and all tRNA ligations were identical within each prepared group and 
greater than 80%. 
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5.4.6 In Vivo Suppression Experiments 
Prior to in vivo suppression experiments, all tRNAs and mRNAs were 
simultaneously made and normalized by UV and densiometric analysis using 
AlphaEaseFC Stand Alone (Alpha Innotech, San Leandro, CA).  Stage VI oocytes of 
Xenopus laevis were prepared as described (28).  All tRNAs were refolded at 65 ˚C for 2 
min and 6-nitroveratryloxycarbonyl protected dCA-W or dCA-WF1 was deprotected for 
5 min by UV irradiation before injection (18).  Oocytes were injected with 50 nl of 
mRNA alone or with tRNA and incubated at 18 ˚C for 44–52 h.  20 ng of mRNA in a 
subunit ratio of 10:1:1:1 for α149UAG:β:γ:δ was injected in Figures 5.2, 5.3, and 5.5 
using the same ratio, but 40 ng and 60 ng of mRNA, respectively, was injected per 
oocyte.  In Figure 5.4, 40 ng of mRNA in a subunit ratio of 10:1:1:1 for α149(UAG, 
UGA, CGGG, or GGGU):β:γ:δ.  Amounts of tRNA injected are listed with the legend of 
each figure. 
5.4.7 Electrophysiology 
Recordings employed two-electrode voltage clamp on the OpusXpress 6000A 
(Molecular Devices).  ACh was stored at -20 ˚C as a 1 M stock, diluted in Ca2+-free 
ND96, and delivered to oocytes by computer-controlled perfusion system.  For all 
experiments, the holding potential was -60 mV.  Dose-response data was obtained from 
at least eleven ACh concentrations and all tRNA suppression experiments were tested 
with a single 1 mM ACh dose.  Dose-response relations were fit to the Hill equation to 
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determine the EC50 and Hill coefficient (nH).  All reported values are represented as a 
mean ± SE of the tested oocytes (number of oocytes (n) is listed with each figure). 
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6.1 Introduction 
 Recent work has established new techniques to specifically label proteins in vitro 
and in vivo using genetically encoded sequences or small molecules with chemical 
functionalities unique from those found in living cells.  These peptide sequences, 
unnatural sugar analogs, unnatural biotin moieties, and unnatural amino acids (UAAs) 
allow for specific labeling by a “bioorthogonal” small molecule reporter through 
enzymatic or chemical reaction (1).  The tetracysteine motif has been utilized to 
selectively react with bisarsenical fluorescent dyes, such as FlAsH and ReAsH (2,3).  A 
15 amino acid sequence has been utilized to attach a biotin or an unnatural biotin that 
contains a ketone moiety to a protein using the E. coli biotin ligase (4,5).  Unnatural 
sugar analogs with ketones, aldehydes, and azides have been incorporated in vivo using 
endogenous enzymes and labeled with biotin for purification or fluorophores for imaging 
(1,6–12).  UAAs have been incorporated in vivo using endogenous aminoacyl tRNA-
synthetases, mutant aminoacyl tRNA-synthetases, or an orthogonal tRNA/synthetase pair 
to incorporate ketones, aldehydes, diketones, azides, and alkynes and labeled with biotin 
and fluorophores (13–22). 
 The ketone functionality has been used extensively to label glycosylated proteins 
containing unnatural sugar analogs and proteins containing UAAs.  The ketone is 
biorestricted in that it is bioorthogonal only on the cell surface because the interior of the 
cell contains acetylated proteins and keto/aldehydic metabolites (1).  The ketone has been 
used extensively to label proteins in vitro that are purified or in crude cell lysates from E. 
coli, HEK 293T cells, and rat neurons (4,6,19,20).  The ketone has also been used to label 
proteins on the cell surface of E. coli, jurkat cells, HL-60 cells, and HeLa cells 
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(4,10,11,13,20).  In this research, we incorporated the UAA p-Acetyl-L-phenylalanine (p-
AcPhe) into the α-subunit of the mouse muscle nicotinic acetylcholine receptor (nAChR) 
expressed in Xenopus oocytes and attempted to site-specifically label with biotin 
hydrazide and cyanine5.5 (Cy5.5) hydrazide. 
 Many membrane proteins form multimeric complexes, and the stoichiometry is 
precisely regulated by the insertion into the endoplasmic reticulum, folding transitions, 
post-translational modification, interactions with other subunits and/or chaperones, 
forming the final oligomeric complex (for many membrane proteins), subsequent 
transport to the golgi (where further oligomerization can take place), and export to the 
cell membrane (where further oligomerization can also occur) (23–29).  To add further 
complexity, many ion channels are heteromeric and contain different subunits.  For 
example, for the nAChRs there are ten α-subunits (α1-α10), four β-subunits (β1-β4), a γ-
subunit, a δ-subunit, and an ε-subunit.  These subunits can form homomeric channels 
(5α7) and heteromeric channels (2α1:β1:γ:δ, α1:β1:γ:δ:ε, 2α3:3β4, 3α4:2β2, and 2α4:3β2) 
(30).  For seventeen genes there is a possibility of 283,985 combinations, but most are not 
biologically relevant. 
 Determining subunit stoichiometry in ion channels can be complicated.  
Classically, macroscopic or single-channel electrophysiology recordings have been used 
to predict the subunit composition when analyzing inactivation or expressing wild-type 
and mutant channels with altered conductances (31–33).  However, electrophysiology 
can’t always accurately predict the subunit stoichiometry of ion channels.  For example, 
cyclic nucleotide-gated (CNG) channels were thought to have a stoichiometry of 
2CNGA1:2CNGA2 (34), but recent FRET experiments (35) and biochemical analysis 
 184 
(36) have shown that the channels have a stoichiometry of 3CNGA1:CNGA2.  Recent 
experiments have attached GFP to ion channels and used time-resolved photobleaching to 
determine the stoichiometry of the NMDAR (2NR1:2NR3B); this was confirmed by 
verification of known stoichiometries of 2NR1:2NR2B and 3CNGA1:CNGA2 (37). 
As the Dougherty and Lester labs have started studying neuronal nAChRs and γ-
aminobutyric acid receptors (GABARs), subunit stoichiometry has become a concern.  In 
this research, we hoped to use the known stoichiometry of the mouse muscle nAChR 
(2α:β:γ:δ) and try to attain this stoichiometry by densiometric analysis of Western blots.  
Using subunits containing the HA tag in the M3-M4 loop, it was hoped that the HA 
antibody would bind similarly to each subunit and insertion of nine amino acids (HA tag) 
would not perturb ion channel function as much as ≈ 240 amino acids for GFP.  Previous 
work has shown that the nAChR subunits degrade rapidly when not assembled in ion 
channel complexes (27,28,38).  We hoped that by using whole cells and looking at the 
total amount of each subunit protein, we would be able to determine the subunit ratio of 











6.2.1 Screening Sites For Aminoacylation of tRNAs, Read-Through, and UAA 
Incorporation 
We chose to screen αD70 and aligned sites in the mouse muscle nAChR (Figure 
6.1).  These sites were chosen because the large UAA biocytin could be incorporated 
efficiently at αD70 and subsequently labeled with streptavidin without a significant shift 
in EC50 (39).  αD70 is part of the main immunogenic region (MIR) of the nAChR, and 
this region binds many antibodies, including those associated with myasthenia gravis (a 
human autoimmune disease) (40,41).  The αD70 site can therefore tolerate a large UAA, 
detection by streptavidin and antibodies shows the region is highly accessible, and should 
be accessible to small molecule, bioorthogonal reporters.  The cryo-EM images of the 
Torpedo nAChR subsequently followed the biochemical work and clearly shows that 
MIR is highly exposed (Figure 6.1) (42).  The αD70 aligned sites were chosen because it 
was hoped that these sites would incorporate UAAs efficiently and allow for multiple 
UAA incorporation for fluorescent resonance energy transfer (FRET) experiments.  The 
βA19’ site was also chosen because mutating this site to Cys allows for labeling when the 
nAChR is in the open state (43) and the site tolerates the incorporation of a large 
fluorescent UAA, Lys(BODIPYFL) (44). 
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Figure 6.1:  α70 and aligned positions in the nAChR.  (A) The α-subunit of the nAChR 
is shown with the lipid bilayer as a reference.  αD70 is shown in the extracellular domain 
in red.  Incorporation of the UAA biocytin allows for labeling with radioactive 
streptavidin (39).  This residue is part of the MIR and accessible to antibodies.  (B) A top 
view of the nAChR with the residues aligned with αD70 shown in red.  The amino acids 
at these positions are as follows: βA70, γK70, and δN70 in the mouse muscle nAChR 
(residues shown are from the Torpedo nAChR).  Image created from 2BG9.pdb (42). 
 
 In order to screen the selected sites, the amber (UAG), opal (UGA), and  
quadruplet (GGGU) codons were utilized to prepare for multiple UAA incorporation.  
THG73 is an amber suppressor tRNA used extensively to incorporate UAAs in Xenopus 
oocytes (45–47).  THG73 is aminoacylated with Gln in Xenopus oocytes when incubated 
for > 1 day and large quantities of tRNA are used (48,49).  TQAS is an amber suppressor 
tRNA created from THG73 by the placement of four mutations in the acceptor stem 
(shown in Figure 4.3), is aminoacylated much less than THG73, and shows similar 
suppression efficiency in Xenopus oocytes from Nasco (48,50).  TQAS’ is an amber 
suppressor tRNA created from THG73 by the placement of five mutations in the acceptor 
stem (shown in Figure 4.3), is aminoacylated comparably to THG73, and shows similar 
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suppression efficiency in Xenopus oocytes from Nasco (48,50).  YFaFSACCC is a 
frameshift suppressor tRNA (shown in Figure 3.2) shown to be the most orthogonal 
suppressor tRNA tested in Xenopus oocytes, but has a suppression efficiency of ≈ 30% 
when compared to the amber suppressor tRNAs (48–50).  TQOpS’ is an opal suppressor 
tRNA created from THG73 by the placement of five mutations in the acceptor stem and 
containing the anticodon UCA (shown in Figure 4.3), is aminoacylated much less than 
THG73, and is capable of incorporating an UAA (48,50). 
Table 6.1 shows aminoacylation of tRNAs, read-through, and UAA incorporation 
experiments at the selected sites (experimental concept discussed in Chapter 4 and shown 
in Figure 4.1).  In the experiments, THG73 was added in large quantities and incubated 
for 2 days in order to obtain aminoacylation with Gln in vivo.  Any site that could 
incorporate a large UAA should also incorporate Gln.  For UAA incorporation, 5-F-
Tryptophan (WF1) (chemical structure in Figure 3.2) was chemically ligated to the 
suppressor tRNA.   
α70UAG shows large aminoacylation product when incubated with THG73, but 
this aminoacylation product is reduced when incubated with TQAS (Table 6.1).  
α70UAG mRNA injected alone shows little read-through of the UAG stop codon (Table 
6.1) and therefore this site is optimal for the incorporation of UAAs.  β70UAG and 
β70GGGU show extremely large read-through when mRNA is injected alone, which is 
very rare, and therefore this site is not useful for UAA incorporation (Table 6.1).  THG73 
is aminoacylated similarly to TQAS’ at β70UAG in Nasco oocytes (Table 6.1).  TQAS 
and YFaFSACCC are aminoacylated much less and close to the β70XXX(X) mRNA alone 
(Table 6.1).  Interestingly, TQAS’-WF1 shows a 180% increase in current compared to 
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THG73 (Table 6.1) and shows that UAA incorporation by the chemically aminoacylated 
tRNA is much more efficient at producing functional channels than THG73 being 
aminoacylated with Gln in vivo, which is in agreement with previous experiments 
(45,48).  The β19’XXX(X) position shows large amounts of read-through with large 
quantities of mRNA injected alone, but much less than the β70 position (Table 6.1).  
THG73 also shows a reduction of ≈ 79% in current when tested at β19’UAG when 
compared to β70UAG (Table 6.1).  TQAS and YFaFSACCC also show larger amounts of 
aminoacylation, relative to THG73, at the β19’ position when compared to the β9’ 
position (see Chapter 4 and (48,49)).  Therefore the β19’ position is not optimal for UAA 
and requires the use of less mRNA to avoid read-through and use of orthogonal tRNAs to 
avoid aminoacylation signals that can be comparable to suppression, which has been 
done experimentally for the incorporation of a fluorescent UAA (44). 
δ69 experiments show little current with suppressor tRNAs that are not 
chemically aminoacylated and with the injection of mRNA only (Table 6.1).  THG73 
injected with δ69UAG is comparable to mRNA only, indicating that the site doesn’t 
tolerate the incorporation of Gln (Table 6.1).  The δ69 position is not useful for the 
incorporation of UAAs.  δ70UGA also shows very little current with the injection of 
TQOpS’, TQOpS’-WF1, and mRNA alone (Table 6.1).  Intriguingly, there is an 80% 
reduction in current when TQOpS’-WF1 is injected relative to TQOpS’, which is not 
chemically aminoacylated, (Table 6.1) and shows that WF1 is not tolerated at δ70UGA.  
The δ70UGA position is not optimal for incorporation of UAAs.  The optimum site 
screened was α70UAG because it showed very little read-through when mRNA alone 
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was injected and low aminoacylation currents were obtained with TQAS.  α70UAG was 
therefore chosen for further experiments. 
 
Table 6.1:  Expression tests at the αD70 aligned positions and βA19’. 
mRNA tRNA Norm n a 
α70UAG THG73 1.0 b 16 
α70UAG TQAS 0.27 15 
α70UAG   0.017 16 
        
β70UAG THG73 1.0 c 16 
β70UAG THG73-dCA 1.0 d 11 
β70UAG TQAS'-dCA 1.1 12 
β70UAG TQAS 0.40 12 
β70UAG TQAS'-WF1 2.8 12 
β70UAG   0.31 14 
β70GGGU YFaFSACCC 0.41 15 
β70GGGU   0.40 16 
        
β19'UAG THG73 1.0 e 16 
β19'UAG TQAS 0.36 15 
β19'UAG   0.23 16 
β19'GGGU YFaFSACCC 0.24 16 
β19'GGGU   0.14 16 
        
δ69UAG THG73 1.0 f 16 
δ69UAG TQAS 0.82 16 
δ69UAG   0.92 16 
δ69GGGU YFaFSACCC 0.64 15 
δ69GGGU   1.0 16 
        
δ70UGA TQOpS'-dCA 1.0 g 7 
δ70UGA TQOpS'-WF1 0.20 7 
δ70UGA   0.54 6 
a  Number of oocytes tested. 
b  Average Imax = -19 µA 
c  Average Imax = -15 µA 
d  Average Imax = -13 µA 
e  Average Imax = -2.9 µA 
f  Average Imax = -0.26 µA 
g  Average Imax = -0.31 µA 
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6.2.2 Suppression of α70UAG with TQAS-Biocytin 
 In order to directly detect an UAA incorporated into the nAChR by Western blot, 
large amounts of protein are needed, which usually requires multiple injections, large 
amounts of tRNA-UAA, choosing only oocytes that are expressing > 10 µA, and 
removing membranes from 10–25 oocytes for each gel lane (51,52).  Multiple injections 
are not optimal because oocyte death increases with the number of injections and requires 
large amounts of tRNA-UAA.  Manually removing membranes from oocytes is also 
tedious and time consuming for a large number of samples and variability can arise from 
incomplete removal of the membrane.  For the following Western blots, saturating 
amounts of TQAS-Biocytin were prepared and only a single injection was performed 
with large amounts of mRNA.  Biocytin is a difficult UAA to incorporate in vitro and in 
vivo (39,53), but the average maximal current obtained from a single injection of 
α70UAG + TQAS-Biocytin was -10.4 µA (23% relative to wild-type current with half 
the mRNA), which is more than sufficient for detection by Western blot.  Whole-cell 
detection of an UAA was also explored because it requires fewer oocytes for each lane, is 
not as time consuming, and there is less variability. 
 Figure 6.2 shows detection of α70Biocytin using four whole oocytes (Figure 6.2, 
A & B) or twenty oocyte membranes (Figure 6.2, C & D).  The Western blots show that 
many endogenous proteins are biotinylated in uninjected Xenopus oocytes (Figure 6.2, A, 
Lanes 2–4, and Figure 6.2, C, Lanes 2–4), but the endogenous proteins don’t overlap with 
the α-subunit of the nAChR (Figure 6.2, B & D).  Using four oocytes per lane, the UAA 
biocytin can be detected in three separate samples (Figure 6.2, A, Lanes 5–7), and no 
band is observed at the same molecular weight for uninjected oocytes (Figure 6.2, A, 
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Lanes 2–4) or wild-type nAChR (Figure 6.2, A, Lanes 8–10).  The α-subunit is clearly 
detected using the HA tag with four whole cells for α70Biocytin and for the wild-type 
nAChR (Figure 6.2, B, Lanes 5–10).  By the whole-cell Western blot, the suppression 
efficiency of TQAS-Biocytin at α70UAG is 8.7% relative to the wild-type nAChR, 
which is not an ideal comparison because the wild-type nAChR has only half the mRNA 
of the suppression experiment. 
 Manually removing the oocyte membranes shows decreased amounts of 
endogenous biotinylated proteins (Figure 6.2, C, Lanes 2–10) and therefore most of the 
biotinylated proteins are not associated with the membrane surface.  α70Biocytin is 
clearly visualized only in the membrane preparation (Figure 6.2, C, Lane 7) and there is 
no α70Biocytin detected in the supernatant (Figure 6.2, C, Lanes 5–6).  The α-subunit is 
clearly visualized in the membrane preparation of both α70Biocytin and the wild-type 
nAChR (Figure 6.2, D, Lanes 7 & 10), but the α-subunit is also visible in the supernatant 
of the wild-type nAChR (Figure 6.2, D, Lanes 8–9).  This is most likely caused by the 
presence of 0.07% SDS in the hypotonic solution used to remove the oocyte membranes 
and may only be visible in the wild-type nAChR due to the large amount of α-subunit 
present.  By manually removing the membrane of the oocytes, the suppression efficiency 
of TQAS-Biocytin at α70UAG is 58% relative to wild-type nAChR, which has half the 
amount of mRNA.  Overall the Western blots of the whole cell homogenization and 
manually removed membranes are comparable, but α70Biocytin shows a stronger signal 
in the whole cell preparation with only four cells (Figure 6.2, A, Lanes 5–7) compared to 
the signal from biocytin from twenty manually removed membranes (Figure 6.2, C, Lane 
7).  Therefore, whole-cell homogenization was used for the remainder of the Western 
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Figure 6.2:  Detection of α70Biocytin by Western blot.  (A) Whole-cell detection of 
α70Biocytin.  (B) Whole-cell detection of HA tag.  (A & B) Lane 1, molecular weight 
maker.  Lanes 2–4, uninjected oocytes.  Lanes 5–7, are αΝΗΑ70UAG + TQAS-Biocytin.  
Lanes 8–10 are αHA and βHA.  Each lane contains four homogenized oocytes.  Blue bands 
in A and B represent pixels saturated by detection with Streptavidin-680.  (C) Membrane 
detection of α70Biocytin.  (D) Membrane detection of HA tag.  (C & D) Lane 1, 
molecular weight marker.  Lanes 2 and 3, supernatant of uninjected oocytes.  Lane 4, 
membrane preparation of uninjected oocytes.  Lanes 5 and 6, supernatant of αNHA70UAG 
+ TQAS-Biocytin.  Lane 7, membrane preparation of αNHA70UAG + TQAS-Biocytin.  
Lanes 8 and 9, supernatant of αHA.  Lane 10, membrane preparation of αHA.  Twenty 
oocyte membranes were manually stripped in a low detergent, hypotonic solution and 
placed in an eppendorf.  Membranes were pelleted by centrifugation and the supernatant 






6.2.3 Analysis of 125I-Streptavidin and 125I-α-Bungarotoxin Binding to Xenopus 
Oocytes Expressing Wild-Type nAChR and UAA Incorporation of Biocytin 
Previous experiments identified significant binding of 125I-Streptavidin to oocytes 
expressing α70UAG + THG73-Biocytin, but there was a lack of significant binding to 
α76UAG + THG73-Biocytin (39).  Using Dr. Justin Gallivan’s lab notebook, I 
reanalyzed all of the experiments performed to gain further insights on the amount of 
endogenous biotinylated protein on the Xenopus oocyte surface and to obtain information 
on unpublished results.  All experiments were performed previously by Dr. Gallivan and 
unfortunately the health of the oocytes and expression of nAChR with different batches 
of oocytes was not always available. 
Figure 6.3 shows the analysis of 125I-Streptavidin and 125I-α-Bungarotoxin binding 
to oocytes expressing wild-type nAChR, mRNA with the amber (UAG) codon at the site 
of interest, incorporation of natural amino acids or UAAs by nonsense suppression, and 
biocytin incorporated at various positions.  Data are given as a ratio of the average signal 
of the tested sample divided by the average signal of the blank.  Figure 6.3 shows there is 
≈ 2-fold increase in signal when 125I-Streptavidin is used to label uninjected oocytes, 
oocytes injected with mRNA only, and mRNA + THG73 (dCA or dCA-X, where X is 
Tyr, p-AcPhe, or ketoTyr).  The suppression of THG73-Biocytin at all positions other 
than α70UAG showed no significant increase in radioactive signal (Figure 6.3, orange 
bar, left), in agreement with published experiments (39).  Only suppression of α70UAG 
+ THG73-Biocytin resulted in significant radioactive signal (Figure 6.3), which is also in 
agreement with published experiments (39).  Therefore, endogenous biotinylated proteins 
may be present on the extracellular membrane of Xenopus oocytes, as shown by the 
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increase in radioactive signal, or this may be due to nonspecific binding of 125I-
Streptavidin to the membrane surface. 
Two 125I-α-Bungarotoxin molecules are expected to bind a single nAChR receptor 
because there are two α-subunits (54).  The labeling of 125I-α-Bungarotoxin and 125I-
Streptavidin is similar on uninjected oocytes (Figure 6.3, red bars) even though ≈ 3 times 
greater concentration was used for 125I-α-Bungarotoxin labeling (39).  Intriguingly, the 
125I-α-Bungarotoxin radioactive signal is increased for all injections and there is a greater 
difference over uninjected oocytes when compared to 125I-Streptavidin labeling (Figure 
6.3).  mRNA only (for all sites tested in (39)) shows an increase in 125I-α-Bungarotoxin 
binding and suggests that the read-through product is accessible on the surface and in 
agreement with electrophysiology data for α70UAG shown in Table 6.1.  mRNA + 
THG73-dCA also shows a significant increase in labeling and is in agreement with 
functional channels on the surface (Table 6.1).  Incorporation of p-AcPhe, ketoTyr, or 
Tyr by THG73 results in the highest labeling and shows the average suppression 
efficiency at various sites is much greater than THG73-Biocytin at various sites (Figure 
6.3, right, light-green bar compared to orange bar).  α70UAG + THG73-Biocytin shows 
robust binding of 125I-α-Bungarotoxin, but suppression of THG73-Biocytin at other sites 
shows little channel expression by electrophysiology (39) and no statistical difference of 
125I-α-Bungarotoxin labeling over uninjected oocytes (Figure 6.3, right, orange bar 




Figure 6.3:  Analysis of 125I-Streptavidin or 125I-α-Bungarotoxin labeling of Xenopus 
oocytes expressing wild-type nAChR and UAA incorporation of biocytin.  
Abbreviations: UI is uninjected oocytes; Strept is 125I-Streptavidin; mRNA refers to any 
other suppression site other than α70UAG; THG73-dCA is the 76mer tRNA; THG73-
dCA-X is THG73 ligated with Tyr, p-AcPhe, or ketoTyr (shouldn’t bind 125I-
Streptavidin); THG73-dCA-Biocytin is THG73-Biocytin; α70 is α70UAG, (Low) is the 
lowest avg. Imax in an oocyte batch; (High) is the highest avg. Imax in an oocyte batch; 
(Avg.) is when oocytes were labeled without determining the avg. Imax; and α-
Bungarotoxin is 125I-α-Bungarotoxin. 
 
6.2.4 Bioorthogonal Labeling of α70p-AcPhe With Biotin Hydrazide 
The incorporation of p-AcPhe at α70 introduces a ketone on the surface of 
Xenopus oocytes (Figure 6.1), which can be labeled with hydrazides.  The ketone is 
bioorthogonal only on the cell surface because the interior of the cell contains acetylated 
proteins and keto/aldehydic metabolites (1).  The desired bioorthogonal reaction of p-
AcPhe with biotin hydrazide, which is membrane impermeant, is shown in Figure 6.4.  p-
AcPhe was incorporated at α70UAG using TQAS and showed an average maximal 
current of -27.3 µA (61% relative to wild-type current with half the mRNA), which is ≈ 
3-fold greater when compared to TQAS-Biocytin incorporation.  To analyze the reaction 
of biotin hydrazide with p-AcPhe, we chose Western blot detection because α70Biocytin 
and α70Biocytin bound to streptavidin showed little shift in EC50 (39) and Western blot 
allows for visualization of all protein bands labeled with biotin hydrazide. 
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Figure 6.4:  Bioorthogonal labeling of p-AcPhe with biotin hydrazide.  p-AcPhe is 
incorporated at α70 and expressed on the extracellular surface of the Xenopus oocyte 
(Figure 6.1).  The cells are labeled with biotin hydrazide, which can’t cross the cell 
membrane unless it is permeabilized.  The hydrazide reacts with the ketone to produce a 
hydrazone and covalently attaches biotin to p-AcPhe. 
 
 Labeling of α70p-AcPhe with biotin hydrazide is shown in Figure 6.5.  Labeling 
of permeabilized, uninjected oocytes and permeabilized, α70UAG + TQAS-p-AcPhe 
with biotin hydrazide results in detection of many proteins with Streptavidin-680 (Figure 
6.5, A, Lanes 4 & 7), which is more intense than non-permeabilized oocytes (Figure 6.5, 
A, Lanes 3 & 6).  α70p-AcPhe shows no labeling above the uninjected oocytes (Figure 
6.5, A, Lanes 3 & 6).  α70p-AcPhe shows greater α-subunit signal (Figure 6.5, B, Lane 
5) than α70p-AcPhe labeled with biotin hydrazide (Figure 6.5, B, Lane 6).  The reaction 
of ketones with hydrazides is pH sensitive and optimum in the range of pH = 4–6.5 
(1,6,10,13,19).  Therefore biotin hydrazide labeling of α70p-AcPhe was tested from pH = 
4–7.5 (Figure 6.5, C).  Biotin hydrazide labeling of α70p-AcPhe shows three distinct 
protein bands when the pH = 4–6.6 (Figure 6.5, C, Lanes 4–9).  Intriguingly, varying pH 
also alters protein translation of the α70p-AcPhe subunit, which is optimum at pH = 6.3–




Figure 6.5:  Detection of α70p-AcPhe labeled with biotin hydrazide.  (A) Whole-cell 
detection of biotin hydrazide labeling of intact and permeabilized oocytes.  (B) Detection 
of the HA tag.  (A & B)  Lane 1, molecular weight marker.  Lane 2, uninjected oocytes.  
Lane 3 is uninjected oocytes labeled with 1 mM biotin hydrazide, pH = 7.5.  Lane 4 is 
uninjected oocytes permeabilized with detergent and labeled with 1 mM biotin hydrazide, 
pH = 7.5.  Lane 5 is αNHA70UAG + TQAS-p-AcPhe.  Lane 6 is αNHA70UAG + TQAS-p-
AcPhe labeled with 1 mM biotin hydrazide, pH = 7.5.  Lane 7 is αNHA70UAG + TQAS-p-
AcPhe permeabilized with detergent and labeled with 1 mM biotin hydrazide, pH = 7.5.  
Lane 8 is uninjected oocytes.  Lane 9 is αHA.  (C) Whole-cell detection of biotin 
hydrazide labeling of intact oocytes with different pH.  (D) Detection of αNHA.  (C & D) 
Lane 1, molecular weight marker.  Lane 2 is uninjected oocytes labeled with 1 mM biotin 
hydrazide, pH = 4.  Lane 3, αNHA70UAG + TQAS-p-AcPhe, pH = 4.  Lane 4, 
αNHA70UAG + TQAS-p-AcPhe labeled with 1 mM biotin hydrazide, pH = 4.  Lane 5, 
αNHA70UAG + TQAS-p-AcPhe labeled with 1 mM biotin hydrazide, pH = 4.6.  Lane 6, 
αNHA70UAG + TQAS-p-AcPhe labeled with 1 mM biotin hydrazide, pH = 5.3.  Lane 7, 
αNHA70UAG + TQAS-p-AcPhe labeled with 1 mM biotin hydrazide, pH = 5.8.  Lane 8, 
αNHA70UAG + TQAS-p-AcPhe labeled with 1 mM biotin hydrazide, pH = 6.3.  Lane 9, 
αNHA70UAG + TQAS-p-AcPhe labeled with 1 mM biotin hydrazide, pH = 6.6.  Lane 10, 
αNHA70UAG + TQAS-p-AcPhe labeled with 1 mM biotin hydrazide, pH = 7.5.  Each lane 
contains four whole oocytes.  Numbers on the left are molecular weight markers (KD). 
 
 Densiometric analysis of α70p-AcPhe labeled with biotin hydrazide at different 
pH is shown in Figure 6.6.  Significant labeling is seen from pH = 4–6.3 (Figure 6.6, A).  
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Labeling at pH = 4.6 is expected to be greater than pH = 5.3 and pH = 5.8 is expected to 
be greater than pH = 6.3.  Labeling may be decreased by variability of labeling, protein 
expression, or oocytes (Figure 6.6, A).  α-subunit expression at different pH shows a 
gradual decrease as acidity increases (Figure 6.6, B).  Even though the α-subunit is 
severely diminished at pH = 4, the greatest labeling is seen at pH = 4 (Figure 6.6, A & B).  
Streptavidin-680 labeling was then normalized by the amount of protein detected by the 
HA antibody to allow for comparison of biotin hydrazide labeling as a function of pH 
alone (Figure 6.6, C).  pH = 7.5 shows virtually no labeling, which is expected of an acid 
catalyzed reaction (Figure 6.6, C).  pH = 4 is the optimum labeling condition, even 
though protein production is decreased significantly (Figure 6.6, C).  All subsequent 
hydrazide labeling experiments were performed at pH = 4. 
 
 
Figure 6.6:  Analysis of p-AcPhe labeled with biotin hydrazide.  Analysis performed on 
Western blots in Figure 6.5, C and D.  (A) Densiometric analysis of biotin hydrazide 
labeling at different pH.  Signals were normalized to the highest labeling (Figure 6.5, C, 
Lanes 2–10).  (B) Densiometric analysis of protein expression as a function of pH.  
Signals were normalized to the highest expression (Figure 6.5, D, Lanes 2–10).  (C) 
Normalization of biotin hydrazide labeling with the amount of protein expressed (value 
from A / value from B and renormalized to the highest value).  Biotin hydrazide labeling 
is optimal at pH = 4, but protein translation is decreased.  Numbers below each graph are 





6.2.5 Attempts to Block Nonspecific Biotin Hydrazide Labeling of Uninjected  
Oocytes 
 The labeling of three bands in Figure 6.5 is undesired because the reaction of 
biotin hydrazide is expected to be specific for the α70p-AcPhe.  Therefore, 
carbohydrazide was added to uninjected oocytes to try and block proteins that are 
reacting with the biotin hydrazide (Figure 6.7, A).  Treatment of uninjected oocytes with 
1 mM or 10 mM carbohydrazide for 1 day (Figure 6.7, A, Lanes 5–10) shows no 
reduction in biotin hydrazide labeling when compared to untreated, uninjected oocytes 
labeled with biotin hydrazide (Figure 6.7, A, Lanes 3–4).  Another possibility is that 
ketones or aldehydes exist on the cell surface by protein modification or glycosylation of 
proteins and these are reacting with the biotin hydrazide.  NaBH4 reduces ketones and 
aldehydes into alcohols, which would not react with biotin hydrazide.  Treatment of 
uninjected oocytes with 1 mM or 10 mM NaBH4 showed no significant reduction in 
biotin hydrazide labeling (Figure 6.7, B Lanes 5–10) when compared to the untreated, 
uninjected oocytes labeled with biotin hydrazide (Figure 6.7, B, Lanes 3–4).  Treatment 
of oocytes with carbohydrazide or NaBH4 showed no reduction in biotin hydrazide 
labeling on uninjected oocytes (Figure 6.7, A & B) and surprisingly showed little effect 
on oocyte health and survival. 
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Figure 6.7:  Uninjected oocytes labeled with biotin hydrazide after treatment with 
carbohydrazide or NaBH4.  (A) Carbohydrazide treatment prior to biotin hydrazide 
labeling.  Lane 1 is molecular weight marker.  Lane 2 is uninjected oocytes.  Lanes 3 and 
4 are uninjected oocytes labeled with 1 mM biotin hydrazide.  Lanes 5–7, uninjected 
oocytes treated with 1 mM carbohydrazide, followed by labeling with 1 mM biotin 
hydrazide.  Lanes 8–10, uninjected oocytes treated with 10 mM carbohydrazide, followed 
by labeling with 1 mM biotin hydrazide.  (B) NaBH4 treatment prior to biotin hydrazide 
labeling.  Lane 1 is molecular weight marker.  Lane 2 is uninjected oocytes.  Lanes 3 and 
4 are uninjected oocytes labeled with 1 mM biotin hydrazide.  Lanes 5–7, uninjected 
oocytes treated with 1 mM NaBH4, followed by labeling with 1 mM biotin hydrazide.  
Lanes 8–10, uninjected oocytes treated with 10 mM NaBH4, followed by labeling with 1 
mM biotin hydrazide.  Each lane contains four oocytes and all labeling was performed at 
pH = 4.  Numbers on the left are molecular weight markers (KD). 
 
6.2.6 Bioorthogonal Labeling of α70p-AcPhe with Cy5.5 Hydrazide 
 Previous labeling experiments used biotin hydrazide, which contains the biotin 
moiety and could possibly be recognized by endogenous proteins and attached to proteins 
in order to sequester free biotin.  Removing biotin from the environment is thought to be 
an antimicrobial mechanism used by avidin in egg whites and streptavidin in S. avidinii 
to inhibit microorganism growth (55).  Therefore, it is possible that the Xenopus oocytes 
are removing the biotin hydrazide in a similar manner to inhibit microorganism growth.  
We then choose to label α70p-AcPhe with Cy5.5 hydrazide (structure shown in Figure 
6.8, A) because the molecule doesn’t resemble biologically active molecules and the 
infrared fluorophore would allow for direct detection by the Li-Cor Odyssey. 
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 Labeling of uninjected oocytes, wild-type nAChR, and α70p-AcPhe with Cy5.5 
hydrazide is shown in Figure 6.8, B.  Permeabilized α70p-AcPhe labeled with Cy5.5 
hydrazide show intense signals from many proteins (Figure 6.8, B, Lane 6), illustrating 
that many proteins within the cell can react with the Cy5.5 hydrazide and similar to biotin 
hydrazide (Figure 6.5, A, Lanes 4 & 7).  Uninjected oocytes and oocytes expressing wild-
type nAChR show three protein bands labeled by Cy5.5 hydrazide (Figure 6.8, B, Lanes 
3 & 5).  Three bands are also seen when labeling α70p-AcPhe (Figure 6.8, B, Lanes 7–8), 
which is similar to the labeling with biotin hydrazide (Figure 6.5, C, Lanes 4–9).  Wild-
type nAChR shows no reduction in protein when labeled with Cy5.5 hydrazide (Figure 
6.8, C, Lanes 4–5).  Labeling of α70p-AcPhe shows greatly diminished protein (Figure 
6.8, C, Lanes 7–8) when compared to the untreated α70p-AcPhe (Figure 6.8, C, Lanes 9–
10).  This suggests covalent attachment of Cy5.5 hydrazide to α70p-AcPhe may be 
occurring and attachment of the large fluorophore is decreasing recognition by the HA 
antibody.  However, there is still labeling of three protein bands and bioorthogonal 




Figure 6.8:  Bioorthogonal labeling of α70p-AcPhe with Cy5.5 hydrazide.  (A) Chemical 
structure of Cy5.5 hydrazide.  Maximal absorbance is 675 nm, maximal emission is 694 
nm, and maximal extinction is 250,000 M-1 cm-1 (Amersham Biosciences product 
manual).  Cy5.5 hydrazide allows for direct detection of labeled proteins.  (B) Detection 
of Cy5.5 hydrazide labeled proteins.  (C) Detection of the HA tag.  (B & C) Lane 1 is 
molecular weight marker.  Lane 2 is uninjected oocytes.  Lane 3 is uninjected oocytes 
labeled with 1 mM Cy5.5 hydrazide.  Lane 4 is αHA and βHA.  Lane 5 is αHA and βHA 
labeled with 1 mM Cy5.5 hydrazide.  Lane 6 is αNHA70UAG + TQAS-p-AcPhe 
permeabilized with detergent and labeled with 1 mM Cy5.5.  Lanes 7 and 8 are 
αNHA70UAG + TQAS-p-AcPhe labeled with 1 mM Cy5.5 hydrazide.  Lanes 9 and 10 are 
αNHA70UAG + TQAS-p-AcPhe.  Each lane contains four oocytes and all labeling and 
incubations were performed at pH = 4.  Numbers on the left are molecular weight 
markers (KD). 
 
6.2.7 Analysis of 125I-Streptavidin Binding to Xenopus Oocytes Labeled with Biotin 
Hydrazide 
Using Dr. Gallivan’s lab notebook, I reanalyzed all experiments involving biotin 
hydrazide labeling (unpublished data).  All experiments were performed previously by 
Dr. Gallivan using published methods (39).  Oocytes expressing α70Biocytin show 
significant radioactive signal when labeled with 125I-Streptavidin (Figure 6.9, black bar).  
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However, oocytes labeled with ≥ 0.5 mM biotin hydrazide (Figure 6.9, pink bar, light 
blue bars, & light green bars) show a similar radioactive signal to α70Biocytin (Figure 
6.9, black bar).  The labeling with biotin hydrazide is concentration dependent and 10 
mM labeling of α70UAG + THG73-dCA or THG73-p-AcPhe/KetoTyr (Figure 6.9) 
shows comparable radioactive signal to nAChRs labeled with 125I-α-Bungarotoxin 
(Figure 6.3).  Therefore, the nonspecific labeling of biotin hydrazide is seen by Western 




Figure 6.9:  Analysis of 125I-Streptavidin binding to Xenopus oocytes treated with biotin 
hydrazide.  Abbreviations: UI is uninjected oocytes, α70 is α70UAG, THG73-dCA is the 
76mer tRNA, THG73-dCA-pAcF/KetoY is THG73-p-AcPhe or THG73-KetoTyr, and 
BIO Hyd is biotin hydrazide, concentration shown in parentheses.  Biotin hydrazide 
labeling is nonspecific and amplified with increasing concentrations. 
 
6.2.8 α-, β-, γ-, and δ-Subunit Detection By Western Blot 
Previously, Dr. Gabriel Brandt prepared the α-, β-, γ-, and δ-subunits containing 
the HA tag in the M3-M4 loop (denoted xHA in contrast to the N-terminal HA tag, αNHA).  
The M3-M4 loop is an intracellular loop that is highly flexible, can tolerate insertion of 
GFP (56), and can tolerate deletion of 108 amino acids in the 5-HT3A receptor and 75 
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amino acids in the GABAρ1 receptor (57).  All subunits showed ≈ 100% expression, 
except the δ-subunit (≈ 90%), as determined by electrophysiology in Xenopus oocytes 
(58).  We hoped that by using these constructs and the sensitivity of the Li-Cor Odyssey, 
we would be able to determine the subunit stoichiometry of the nAChR on whole 
oocytes.  The subunit stoichiometry of the mouse muscle nAChR is known to be 2α:β:γ:δ 
(Figure 6.1) and this would allow for us to assay the feasibility of determining an ion 
channel stoichiometry on whole Xenopus oocytes by Western blot. 
Figure 6.10 shows the expression of the αHA, βHA, γHA, and δHA constructs.  The 
αHA-subunit is clearly visible in all lanes (Figure 6.10, A & B).  The βHA-subunit is clearly 
visible on the 4–15% linear gradient gel (Figure 6.10, A, Lanes 4, 5, & 10), but is slightly 
obscured by the αHA band on the 15% gel (Figure 6.10, B, Lanes 4–5).  The γHA- and δHA-
subunits are only slightly visible and smeared (Figure 6.10, A, Lanes 6–10 and Figure 
6.10, B, Lanes 6–8 & 10).  The δHA-subunit is only clearly visible in one lane (Figure 
6.10, B, Lane 9).  Western blot analysis of these constructs previously showed severely 
decreased signal for the non-α subunits (58), but the βHA-subunit is clearly visible when 







Figure 6.10:  Detection of the αHA, βHA, γHA, and δHA subunits of the nAChR.  (A) Subunit 
detection on a 4–15% linear gradient polyacrylamide gel.  (B) Subunit detection on a 
15% polyacrylamide gel.  (A & B) Lane 1 is molecular weight marker.  Lanes 2 and 3 are 
αHA.  Lanes 4 and 5 are αHA and βHA.  Lanes 6 and 7 are αHA and γHA.  Lanes 8 and 9 are 
αHA and δHA.  Lane 10 is αHA, βHA, γHA, and δHA.  Each lane contains four oocytes.  
Numbers on the left are molecular weight markers (KD). 
 
6.2.9 αHA and βHA Detection After Various Incubation Times 
 In order to gain temporal information on protein translation of the αHA and βHA in 
Xenopus oocytes, the αHA and βHA were injected into oocytes and the whole-cell oocytes 
were homogenized at different time intervals after injection.  Figure 6.11 shows the 
Western blot of different incubation times.  Three hours after injection, only extremely 
little αHA-subunit is seen (Figure 6.11, Lane 2).  Six hours after injection, a slightly 
increased amount of αHA-subunit is seen (Figure 6.11, Lanes 3–4).  Twelve hours after 
injection, the αHA-subunit is clearly visible (Figure 6.11, Lanes 5–6) and the βHA-subunit 
is visible in only one lane (Figure 6.11, Lane 6).  A day after injection, which is the 
typical minimum incubation time before electrophysiology, both the αHA and βHA subunits 
are clearly visible (Figure 6.11, Lanes 7–8).  Two days after injection, there is increased 
amounts of both the αHA and βHA, clearly illustrating that protein translation has not 
saturated after two days. 
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Figure 6.11:  Detection of the αHA and βHA subunits at different incubation times.  Lane 1 
is molecular weight marker.  Lane 2 is αHA and βHA 3 h after injection.  Lanes 3 and 4 are 
αHA and βHA 6 h after injection.  Lanes 5 and 6 are αHA and βHA 12 h after injection.  Lanes 
7 and 8 are αHA and βHA 24 h after injection.  Lanes 9 and 10 are αHA and βHA 48 h after 
injection.  Protein translation shows no saturation after 48 h.  Each lane contains four 
oocytes.  Numbers on the left are molecular weight markers (KD). 
 
6.2.10 αHA and βHA Solubilization of Whole Cells or Insoluble Fraction 
The nAChR is a membrane-associated ion channel and therefore may be difficult 
to solubilize in the presence of cytoplasmic proteins.  In previous Western blots, whole 
cells were homogenized, all protein was solubilized, and samples were centrifuged to 
remove insoluble proteins, lipids, membrane, genomic DNA, etc.  Cytoplasmic proteins 
were removed by homogenizing oocytes in ND96 buffer containing protease inhibitors, 
but no detergent.  The samples were then centrifuged and the insoluble fraction was 
solubilized as done for the whole oocytes.  Solubilization of the insoluble fraction greatly 
increases the yield of the αHA and βHA subunits (Figure 6.12, Lanes 6–9) when compared 
to the whole-cell homogenization (Figure 6.12, Lanes 2–5).  The yield of the αHA is 
increased 142%, while the βHA is increased 108%.  Therefore, homogenization of the 
insoluble fraction is useful for increased solubilization of the nAChR subunits and 
increased signal-to-noise when performing Western blots. 
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Figure 6.12:  Increasing the yield of the αHA and βHA subunits.  Lane 1 is molecular 
weight marker.  Lanes 2 and 3 are αHA.  Lanes 4 and 5 are αHA and βHA.  Lanes 6 and 7 are 
αHA solubilized after cytoplasmic protein removal.  Lanes 8 and 9 are αHA and βHA 
solubilized after cytoplasmic protein removal.  Each lane contains four oocytes.  
Numbers on the left are molecular weight markers (KD). 
 
6.2.11 α-, β-, γ-, and δ-Subunit Stoichiometry Determined By Densiometric 
Analysis 
The densiometric analysis of all experiments is shown in Figure 6.13.  The ratios 
were calculated by dividing the αHA intensity by the intensity of the subunit expressed in 
the same lane.  The expected ratio is 2 for all ratios in Figure 6.13 because the 
stoichiometry of the nAChR is 2α:β:γ:δ.  The α/β average ratio is 2.9 ± 0.13 (Figure 
6.13) and is the best ratio because the βHA is clearly visible and is the average of 30 
Western blot lanes or 120 oocytes.  The α/γ average ratio is 2.9 ± 0.24 (Figure 6.13), 
which is similar to the α/β ratio even though the γHA band has decreased intensity 
compared to βHA.  The α/δ average ratio is 3.5 ± 0.51 (Figure 6.13) and is higher than the 
α/β or α/γ ratio.  All ratios appear to indicate that there are ≈ 3 α-subunits for every β-, γ-
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, and δ-subunit, which is in disagreement with the expected nAChR subunit 
stoichiometry. 
 
Figure 6.13:  Average ratio of the β-, γ-, and δ-subunits relative to the α-subunit.  The 
α/β ratio is an average of 30 lanes or 120 oocytes.  The α/γ ratio is an average of 3 lanes 
or 12 oocytes.  The α/δ ratio is an average of 3 lanes or 12 oocytes.  The expected ratio is 
2 by the nAChR stoichiometry being 2α:β:γ:δ. 
 
6.3 Discussion 
 UAA incorporation is a useful technique for the introduction of novel chemical 
moieties, biophysical probes, and altered amino acid structures.  However, efficient 
incorporation of large, bulky UAAs requires a suppression site that is tolerant, able to 
express well without altering protein folding and function, and doesn’t have large 
amounts of read-through of the suppression site.  Table 6.1 illustrates the differences 
between multiple suppression sites on different subunits of the nAChR.  α70UAG 
incorporates Gln well with THG73 aminoacylated in vivo and shows little read-through 
of the stop codon (Table 6.1).  β70UAG and β70GGGU both show large amounts of 
read-through (Table 6.1), even though a -1 frameshift at the GGGU quadruplet codon 
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presents multiple stop codons.  TQAS’-WF1 shows a 180% increase in current when 
compared to THG73 not chemically aminoacylated (Table 6.1) and clearly illustrates that 
nonsense suppression with an UAA is more efficient that aminoacylation of THG73 in 
vivo.  β19’UAG and β19’GGGU show increased amounts of read-through with large 
amounts of mRNA and less aminoacylation product than both α70UAG and β70UAG 
(Table 6.1).  The β19’ site is suboptimal for UAA incorporation and requires less mRNA 
to avoid read-through.  δ69UAG, δ69GGGU, and δ70UGA all have very little read-
through, but the aminoacylation of the suppressor tRNA doesn’t significantly increase 
current (Table 6.1).  δ70UGA + TQOpS’-WF1 has lower expression than mRNA alone 
or the aminoacylation product, clearly showing that the UAA is not tolerated at this site.  
Overall, the only optimum site is α70UAG for significant UAA incorporation without 
large amounts of read-through. 
 Western blot detection of UAAs has been exceedingly difficult because of the 
need for large amounts of protein on the oocyte surface, multiple injections of large 
quantities of tRNA-UAA, and manual removal of 10–25 oocyte membranes (51,52).  
Whole-cell homogenization of oocytes is a preferable alternative because the lack of 
manual membrane removal, decreased variability, and the need for only four oocytes.  A 
single injection of large quantities of α70UAG + TQAS-Biocytin allowed for significant 
expression for Western blot detection (Figure 6.2, A & C).  Figure 6.2 shows direct 
detection of the UAA biocytin incorporated at α70.  Whole-cell homogenization shows 
increased intensity with four oocytes (Figure 6.2, A, Lanes 5–7) when compared to the 
traditional, manual membrane removal with twenty oocytes (Figure 6.2, C, Lane 7).  
Manual membrane removal requires a small amount of detergent in the hypotonic 
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solution, which causes loss of the αHA-subunit in the supernatant (Figure 6.2, D Lanes 8–
9).  Whole-cell homogenization allows for increased intensity and fewer oocytes for each 
lane, so multiple experiments can be performed in a shorter amount of time.  
Solubilization of the insoluble fraction after removal of cytoplasmic proteins also 
increases the yield of the αHA and βHA subunits (Figure 6.12) and should further increase 
the signal-to-noise ratio in Western blot experiments. 
 Previous work has explicitly shown that there is protein translation saturation for 
luciferase after 3 h (59) or 12 h (60) with mRNA injection in Xenopus oocytes.  However, 
Figure 6.11 clearly shows that protein expression is increasing for both the αHA and βHA 
subunits in the Xenopus oocytes, and no saturation is seen after 48 h.  The experiment 
was performed using whole cell homogenization, which would solubilize αHA and βHA on 
the membrane surface, in vesicles, in the golgi, and in the endoplasmic reticulum.  The 
increase in current with extended incubation time has been seen consistently within our 
lab, but it was unknown whether this was due to increased protein production or whether 
transport of ion channels from the endoplasmic reticulum to the cell surface was causing 
an increase in overall current.  Figure 6.11 clearly shows that the α and β subunits are 
being expressed for at least 48 h from a single injection of wild-type mRNA. 
 α70UAG + THG73 shows large amount of current (Table 6.1) because THG73 is 
aminoacylated in vivo with Gln (48).  TQAS is aminoacylated significantly less than 
THG73 in Nasco oocytes (Table 6.1 & (48)) and is useful for the incorporation of large 
amounts of biocytin and p-AcPhe.  The incorporation of p-AcPhe is ≈ 200% more 
efficient than the incorporation of biocytin, which is most likely due to the large side 
chain of biocytin.  Electrophysiology allows for detection of functional ion channels on 
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the surface of the oocyte membrane, which can often be produced by the desired UAA 
incorporation, or the undesired read-through of the suppression site or aminoacylation of 
the suppressor tRNA in vivo (Table 6.1).  α-bungarotoxin is a snake venom toxin that 
irreversibly and competitively binds to the α-subunit of the nAChR in a region distinct 
from α70 (54,61), and the first 210 amino acids of the α-subunit (with no other subunits) 
is sufficient for α-bungarotoxin binding in Xenopus oocytes (62).  Binding of 125I-α-
Bungarotoxin to oocytes is significant when incorporating biocytin, p-AcPhe, ketoTyr, 
and Tyr, but significant signal is also seen with mRNA only and with mRNA + THG73, 
which is not chemically aminoacylated (Figure 6.3).  The significant radioactive signal 
agrees with large current seen with tRNA that are not chemically aminoacylated (Table 
6.1).  THG73, not chemically aminoacylated, with β9’UAG also produces large current 
(48,49,58) and the β9’Gln (aminoacylation product) has been detected by Western blot 
on the surface of Xenopus oocytes (58).  Therefore, caution should be observed when 
labeling oocytes with α-bungarotoxin, because binding may not be limited to functional 
nAChRs, but also mutants, single α-subunits, and/or aminoacylation by products of UAA 
incorporation that may not be detected by electrophysiology. 
 Labeling of uninjected oocytes, wild-type nAChR, and α70UAG + TQAS-p-
AcPhe with biotin hydrazide (Figure 6.5, C & Figure 6.7) or Cy5.5 hydrazide (Figure 
6.8) show labeling of at least three protein bands that migrate near the α-subunit.  Direct 
labeling of α70p-AcPhe with Cy5.5 hydrazide was not directly observed, but may be 
occurring due to the loss of αΝHA signal after labeling (Figure 6.8, C, Lanes 7–8), which 
was not seen in the unlabeled samples (Figure 6.8, C, Lanes 9–10).  The nonspecific 
labeling with biotin hydrazide couldn’t be prevented by treating uninjected oocytes with 
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carbohydrazide or NaBH4 (Figure 6.7) and suggests that the labeled proteins contain an 
amino acid arrangement and/or glycosylation that is favorable for the reaction with the 
hydrazide chemical moiety.  Previous work has labeled proteins containing the UAAs p-
AcPhe and m-AcPhe with fluorescent hydrazides and biotin hydrazide in vitro and 
expressed in E. coli (13,19,20).  Labeling of E. coli may not have nonspecific covalent 
attachment of hydrazides and/or the quantities of protein produced with UAAs is greater 
and gives a significant signal over background.  In Xenopus oocytes, the ketone moiety 
does not appear to show site-specific labeling of α70p-AcPhe with biotin or Cy5.5 
hydrazide and may only be useful for single ion channels studies involving FRET pairs. 
 Analyzing the subunit stoichiometry of the nAChR from whole oocytes shows ≈ 3 
α-subunits for each non-α-subunit (Figure 6.13).  Intriguingly, solubilizing the insoluble 
fraction gives an α/β ratio of 3.6 compared to whole-cell homogenization having an α/β 
ratio of 2.6 (data from analysis of Figure 6.12).  The α/β ratio is 3.0 after 24 h incubation 
and the α/β ratio is 3.0 after 48 h incubation (data from analysis of Figure 6.11), which 
shows no variability in these two time points (the α/β ratio could not be calculated for 3, 
6, and 12 h incubation because the signal was not above background).  After injection of 
oocytes with α-subunit mRNA only, the α-subunit is expressed on the surface of 
Xenopus oocyte and can be detected by Western blot (58).  Therefore, the oocytes can 
transport single α-subunits to the surface of the Xenopus oocyte that aren’t in fully 
formed ion channels.  The mouse α-subunit of the nAChR can also properly fold and 
have a high affinity α-bungarotoxin binding site when expressed alone in quail fibroblast 
cells (63).  Notably, the α-subunit also has the slowest rate of degradation of all the 
subunits (38,63,64).  The increased αHA signal may also be caused by the injection of 
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mRNA in the subunit ratio of 2α:β:γ:δ, but this has been an established technique for 
many heteromeric ion channels expressed in Xenopus oocytes.   Overall, subunit 
stoichiometry of the mouse muscle nAChR appears inaccurate using whole Xenopus 
oocytes and densiometric analysis of Western blots. 
 
6.4 Experimental Methods 
6.4.1 Materials 
 All oligonucleotides were synthesized by Integrated DNA Technologies 
(Coralville, IA).  NotI and complete, EDTA-free protease inhibitor cocktail was from 
Roche Applied Science (Indianapolis).  T4 RNA ligase and FokI were from NEB 
(Beverly, MA).  T7 MEGAshortscript and T7 mMessage mMachine kits were from 
Ambion (Austin, TX).  ACh chloride, biotin hydrazide, carbohydrazide, NaBH4, and 
yeast inorganic pyrophosphatase were purchased from Sigma-Aldrich.  HA.11 
monoclonal antibody from mouse was from Covance (Berkeley, CA).  Streptavidin 
conjugated to AlexaFluor680 and anti-mouse IgG from goat conjugated to 
AlexaFluor680 was from Molecular Probes (Eugene, OR).  IRDyeTM800CW conjugated 
affinity purified anti-mouse IgG from goat was from Rockland (Gilbertsville, PA).  Cy5.5 
hydrazide was from Amersham Biosciences (Piscataway, NJ).  dCA, 6-
nitroveratryloxycarbonyl protected dCA-WF1, 6-nitroveratryloxycarbonyl protected 
dCA-Biocytin,  and 6-nitroveratryloxycarbonyl protected dCA-p-AcPhe were prepared as 
reported (39,65–67). 
6.4.2 tRNA Transcription and dCA or dCA-UAA Ligation 
THG73, YFaFSACCC, TQAS, TQAS’, and TQOpS’ subcloned in the pUC19 
vector were previously made (45,48–50).  Template DNA for tRNA lacking the 3’CA 
 214 
was prepared by FokI digestion and tRNA was transcribed using the T7 
MEGAshortscript kit with 0.5 µl of yeast inorganic pyrophosphatase (40 U/ml in 75 mM 
Tris, 10 mM MgCl2, and pH 7).  tRNA was desalted using CHROMA SPIN-30 DEPC-
H2O columns (BD Biosciences) and concentration was determined by absorption at 260 
nm.  75 µM of dCA (48,50) or 6-nitroveratryloxycarbonyl protected dCA-
WF1/Biocytin/p-AcPhe were coupled to tRNA by using T4 RNA ligase for 30 min as 
previously reported (68,69), desalted using CHROMA SPIN-30 DEPC-H2O columns, 
and quantified by absorption at 260 nm.  tRNA ligation efficiency was qualitatively 
determined by MALDI mass spectrometry (69), and all tRNA ligations were > 90%. 
6.4.3 nAChR Gene Preparation and mRNA Transcription 
The masked αNHA-, β-, γ-, and δ-subunits (all ending with the ochre (UAA) stop 
codon) of the nAChR subcloned in the pAMV vector were previously prepared (48,50).  
α70UAG, β70UAG, β70GGGU, β19’UAG, β19’GGGU, δ69UAG, δ69GGGU, and 
δ70UGA were prepared by QuikChange mutagenesis.  Mutations were verified by DNA 
sequencing (California Institute of Technology Sequencing / Structure Analysis Facility).  
The αHA (347), βHA (365), γHA (365), and δHA (367) subunits all contain the HA tag in the 
M3-M4 intracellular loop and were previously prepared by Dr. Gabriel Brandt (58).  
DNA was linearized with NotI and mRNA was prepared with the T7 mMessage 
mMachine kit with 0.5 µl of yeast inorganic pyrophosphatase.  mRNA was purified using 
the RNeasy Mini kit (Qiagen, Valencia, CA) and quantified by absorption at 260 nm. 
6.4.4 In Vivo nAChR Expression Experiments 
Prior to in vivo aminoacylation and suppression experiments, all tRNAs and 
mRNAs were simultaneously made and normalized by UV and densiometric analysis 
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using AlphaEaseFC Stand Alone (Alpha Innotech, San Leandro, CA).  Stage VI oocytes 
of Xenopus laevis were prepared as described (70).  All tRNAs were refolded at 65 ˚C for 
2 min and 6-nitroveratryloxycarbonyl protected dCA-WF1/Biocytin/p-AcPhe was 
deprotected for 5 min by UV irradiation before injection (45).  Oocytes were injected 
with 50 nl of mRNA alone or with tRNA and incubated at 18 ˚C for 44–52 h (unless 
otherwise stated in the Figure legends).  20 ng of mRNA in a subunit ratio of 10:1:1:1 for 
α70UAG:β:γ:δ; 2:5:1:1 for α:β70UAG:γ:δ,  α:β70GGGU:γ:δ, α:β19’UAG:γ:δ, 
α:β19’GGGU:γ:δ; and 2:1:1:5 for α:β:γ:δ69UAG,  α:β:γ:δ69GGGU, and α:β:γ:δ70UGA 
was injected in Table 6.1 with 10 ng of tRNA (when listed in Table 6.1).  For TQAS-
Biocytin and TQAS-p-AcPhe incorporation, 30 ng of mRNA (α70UAG:β:γ:δ) in a 
subunit ratio of 10:1:1:1 was injected with 100 ng of tRNA-UAA.  15 ng of mRNA 
(α:β:γ:δ) in a subunit ratio of 2:1:1:1 was injected for the wild-type nAChR. 
6.4.5 Electrophysiology 
Recordings employed two-electrode voltage clamp on the OpusXpress 6000A 
(Molecular Devices).  ACh was stored at -20 ˚C as a 1 M stock, diluted in Ca2+-free 
ND96, and delivered to oocytes by computer-controlled perfusion system.  For all 
experiments, the holding potential was -60 mV.  Suppression comparisons were tested 
with a single 1 mM ACh dose.  Number of oocytes (n) is listed in Table 6.1. 
6.4.6 Oocyte Labeling with Biotin Hydrazide and Cy5.5 Hydrazide 
 A 20 mM stock solution of biotin hydrazide was prepared in DMSO.  1 mM 
biotin hydrazide was prepared by adding 500 µl of 20 mM biotin hydrazide in DMSO 
(5% DMSO in final volume) to 9.5 ml ND96 with Ca2+ with no antibiotics and no horse 
serum added to avoid reaction with biotin hydrazide.  When varying pH, the final 
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solution was adjusted using a pH meter and the pH is listed with each figure legend.  A 
single oocyte (uninjected, α70UAG + TQAS-p-AcPhe, or αHA and βHA) was placed in a 
1.5 ml eppendorf and labeled with 500 µl of 1 mM biotin hydrazide for > 20 h. 
1 mg of Cy5.5 hydrazide was dissolved in 500 µl DMSO and added to 9.57 ml 
ND96 with Ca2+ (no antibiotics and no horse serum) pH = 4 to create 1 mM Cy5.5 
hydrazide labeling solution.  A single oocyte (uninjected, α70UAG + TQAS-p-AcPhe, or 
αHA and βHA) was placed in a 1.5 ml eppendorf and 500 µl of 1 mM Cy5.5 hydrazide 
solution was added.  Oocytes were labeled for 22 h. 
6.4.7 Oocyte Treatment with Carbohydrazide and NaBH4 
Carbohydrazide and NaBH4 was dissolved in ND96 with Ca2+ (no antibiotics and 
no horse serum) pH = 4 to create 1 mM and 10 mM solutions immediately prior to 
treatment of cells.  Single oocytes were placed in 1.5 ml eppendorfs and 500 µl of 1 mM 
or 10 mM of carbohydrazide or NaBH4 was added.  Oocytes were treated with 
carbohydrazide for 45 h and NaBH4 for 24 h.  Oocytes were subsequently labeled with 1 
mM biotin hydrazide (as described in Section 6.4.6). 
6.4.8 Whole Oocyte Homogenization and Membrane Preparation 
 Whole-cell homogenization was preformed by placing four oocytes (either 
immediately from 18 ˚C incubator or after storage at -80 ˚C) in a 1.5 ml eppendorf and 
removing excess ND96.  10 µl of homogenization buffer (100 mM NaCl, 50 mM Tris pH 
= 7.9, 0.6% SDS (w/v), 35 mM n-dodecyl β-D-maltoside (DDM) (Anatrace), and 1 
protease inhibitor tablet) was added to the oocytes and oocytes were lysed manually with 
a pipette tip.  The solution was sonnicated for 10 min and centrifuged for 30 min to 
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remove insoluble debris.  The supernatant was transferred to a new eppendorf and 10 µl 
of 2X loading buffer was added.  Samples were either stored at -80 ˚C or run on a gel. 
 Manual removal of membranes was performed as follows: oocytes were placed in 
hypotonic solution (5 mM NaCl, 5 mM HEPES pH = 7.5, 0.07% SDS (w/v)) and 
incubated for 10 min or until translucent oocyte membrane can be seen.  The membrane 
was manually removed using forceps and placed in a 1.5 ml eppendorf kept on ice.  20 
oocyte membranes were collected and then centrifuged for 10 min at 4 ˚C.  The 
supernatant was removed and saved for Western blotting.  10 µl of smashing buffer (100 
mM NaPhosphate pH = 7.8, 0.5% (w/v) DDM, and 1 protease inhibitor tablet) was added 
to the membranes.  The membranes were sonnicated for 10 min and centrifuged for 10 
min at 4 ˚C.  The supernatant was removed from the insoluble fraction.  10 µl of 2X 
loading buffer was added to 10 µl of sample.  Samples were either stored at -80 ˚C or run 
on a gel. 
6.4.9 Western Blotting of Proteins Expressed in Xenopus Oocytes 
Western blotting was performed as previously described (51).  Briefly 20 µl of 
samples were loaded on a 4–15% linear gradient, polyacrylamide-ready gel Tris-HCl 
(Bio-Rad) or 15% polyacrylamide–ready gel Tris-HCl (Bio-Rad) and run at 150 V for 
1.25 h.  Protein was transferred to nitrocellulose (Bio-Rad) at 30 V for 30 min and 100 V 
for 1.5 h.  Nitrocellulose was blocked overnight using BSA (for biocytin detection) or 
non-fat dairy milk (NFDM) (for subunit stoichiometry determination) in 1X PBS / 0.1% 
Tween.  12.5 µl of 1˚ Ab anti-HA from mouse and 5 µl of Streptavidn-AlexaFluor680 in 
15 ml BSA / 1X PBS / 0.1% Tween was for 1 h, washed 4X with 30 ml 1X PBS / 0.1% 
Tween for 5 min each, placed in 3 µl 2˚ 800CW goat anti-mouse IgG in 15 mL BSA / 1X 
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PBS / 0.1% Tween was for 1 h, and washed 4X with 30 ml 1X PBS / 0.1% Tween for 5 
min each.  For subunit stoichiometry determination, the same procedure was used but 
NFDM replaced BSA and Streptavidin-680 was not used.  Nitrocellulose was visualized 
using two-color infrared dye detection on the Odyssey (Li-Cor, Lincoln, NE) (Hsieh-
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Unnatural Amino Acid Replacement Scanning 




There are many methodologies for the incorporation of unnatural amino acids 
(UAAs) in vivo (1–7).  UAA incorporation by the endogenous translational machinery is 
typically performed in E. coli or other prokaryotes using auxotrophs (reassignment of 
sense codons) or by removing natural amino acids (aas) from growth media (statistical 
UAA incorporation) (8–19).  Recent in vitro techniques identified 90 UAAs (59 
previously unknown) that are substrates of E. coli aaRSs and aminoacylated onto tRNA 
(20).  Of these 90, 71 UAAs were tested and 41 UAAs were accepted by the E. coli 
translational machinery in vitro, allowing for the simultaneous incorporation of 13 UAAs 
(21).  UAA incorporation by the endogenous translational machinery in eukaryotic cells 
hasn’t been studied extensively and experiments cause heterogeneous incorporation of 
UAAs (statistical UAA incorporation) in all proteins translated (22–24).  Site-specific 
UAA incorporation, reassignment of sense codons, or statistical UAA incorporation is 
known to alter the stability, spectral properties, substrate binding, folding, expression, 
pore gating, and function of proteins (2–8,14,16,17,19,25–35).   
 Recently, UAAs have become commercially available for use in eukaryotic cells.  
Azidohomoalanine has been used to identify newly translated proteins in HEK cells and 
neurons (23) and is commercially available from Molecular Probes.  Photoleucine (PLeu) 
and Photomethionine (PMet) (shown in Figure 7.1) are used to identify protein-protein 
interactions in eukaryotic cells (22) and are commercially available from Pierce.  These 
UAAs are heterogeneously incorporated in all translated proteins upon supplementation 
in the growth media, but little is known about the effect (if any) on protein stability, 
folding, expression, and function. 
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Figure 7.1:  Unnatural amino acids used in this research. 
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 In this research, we heterogeneously incorporated UAAs into the nicotinic 
acetylcholine receptor (nAChR) expressed in Xenopus oocytes.  The heterogeneous 
incorporation of UAAs is termed unnatural amino acid replacement scanning (UAARS) 
because of the similarity to alanine scanning mutagenesis, where specific aas are mutated 
to Ala and the functions of proteins are examined.  Because only UAAs that are similar to 
the cognate natural aa will be charged onto a tRNA, UAARS results in less side chain 
perturbation than most conventional mutagenesis.  UAARS does not require DNA 
mutation and creates a large heterogeneous population of protein (discussed in detail 
below).  The nAChR was expressed with UAAs in the incubation media, and changes in 
function were identified by shifts in EC50.  The incorporation of PLeu and PMet was also 
identified by inter-subunit cross-linking of the nAChR.  The expression of functional ion 
channels on the surface of Xenopus oocytes was determined by electrophysiology and 
compared to total protein synthesized by Western blot analysis.  UAARS should be 
useful for identifying UAAs that are recognized by the endogenous translational 
machinery, identifying changes in protein function without the need for DNA 
manipulation, and creation of extremely large populations of chemically unique proteins. 
 
7.2 Results 
7.2.1  Unnatural Amino Acid Replacement Scanning 
 In this research, the αHA His (contains the HA tag in the M3-M4 loop and a 6-His 
tag on the C-terminus) construct was initially used, because it was hoped that the α-
subunit could be purified using the 6-His tag as previously described (36).  The EC50 of 
αHA His nAChR was reported as 25.5 µM ACh (36), but references a paper that has a wild-
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type nAChR EC50 = 47 µM (37).  During the course of this research, the αHA His construct 
gave a variable EC50 ranging from 48–70 µM depending on the batch of oocytes.  The 
αNHA (contains the HA tag at the N-terminus) construct gave EC50 values ranging from 
47–56 µM and is a better construct for reproducible wild-type nAChR values.  Due to the 
variability of the αHA His EC50, the UAARS experiments are compared to the αHA His wild-
type EC50 recorded on the same batch of oocytes. 
 The Xenopus oocyte (stage VI) is a large cell measuring ≈ 1.2–1.3 mm in 
diameter (38,39).  The oocyte starts at stage I and is approximately 0.1 mm in diameter 
(38). Oogenesis is asynchronous, and oocytes of all stages are present in the ovary of a 
Xenopus laevis frog (38).  Complete oogenesis takes ~ 8 months to reach stage VI, and 
oocytes remain in this stage until they are stimulated for maturation or the oocyte is 
absorbed by the ovary (38,39).  During oogenesis, the oocyte accumulates ribosomes, 
yolk, glycogen, lipids, aas, and “maternal mRNA” (39).  Oocytes contain a large pool of 
endogenous aas in preparation for protein synthesis (40).  Heterologous expression of 
protein through injection of DNA or mRNA is an invaluable tool for studying ion 
channels, transporters, and receptors.  Injected oocytes are typically incubated in saline 
solutions lacking any aas and still produce large amounts of protein (39,40). 
 Oocytes maintained in saline solution contain a large pool of aas that is greater 
than the concentration of aas found in Xenopus laevis plasma (40).  The most abundant 
aas are Glu (3.6 mM) and Lys (1.1 mM), which are present in the plasma at 
concentrations of 0.11 mM and 0.29 mM, respectively (40).  Oocytes maintained in 
saline solution have 0.20 mM Val, 0.19 mM Leu, and 0.13 mM Phe, but when incubated 
with saline solutions containing aas that mimic plasma concentrations, the oocytes uptake 
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aas to give 0.72 mM Val, 0.62 mM Leu, and 0.30 mM Phe (40).  Therefore, oocytes 
rapidly import aas, and it was hoped that the same would occur for UAAs.  The large 
endogenous pool of aas is a limiting factor for UAARS.  Based on the determined 
concentration of aas in Xenopus oocytes kept in saline solution (40), Ile is the limiting aa, 
and yet there is enough Ile to make 2.4 X 1011 nAChRs (corresponding to 6.1 X 105 µA), 
which is at least three orders of magnitude greater expression then we ever see in a single 
oocyte.  To incorporate UAAs by the endogenous translational machinery we must get a 
large amount of UAA inside the oocyte in order to compete with the endogenous aas. 
Figure 7.2 schematically shows unnatural amino acid replacement scanning 
(UAARS) in Xenopus oocytes.  Oocytes contain endogenous natural aas and are injected 
with mRNA for the nAChR.  After injection, the oocytes are placed in media containing 
0.5–4 mM UAA (Figure 7.2 A).  The oocytes then begin to translate the nAChR, which 
depletes endogenous aas.  Initially, all nAChRs are wild-type (containing no UAAs).  
Also during this time, UAAs are transported into the oocyte (Figure 7.2 B).  Translation 
of the nAChR causes further depletion of the endogenous aas.  As the concentration of 
UAA increases in the oocyte, an endogenous aminoacyl-tRNA synthetase (aaRS) 
recognizes the UAA and charges the cognate tRNA.  The UAA is then heterogeneously 
incorporated into the nAChR at all positions recognized by the tRNA (Figure 7.2 C).  
Further incubation causes increased UAAs inside of the oocyte and further incorporation 
into the nAChR (Figure 7.2 D).  During the incubation periods, the media is changed 
every 24 h to maintain excess UAA and to increase incorporation into the nAChR.  After 
an incubation period, the oocytes are assayed by electrophysiology to determine shifts in 
EC50 and alterations in functional ion channel expression relative to oocytes not incubated 
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with UAAs.  Electrophysiology only detects channels that are functional (gated by 
acetylcholine (ACh)) and on the oocyte membrane surface.  For the UAAs PLeu and 
PMet (shown in Figure 7.1), oocytes were irradiated with UV to cross-link the subunits 
within an individual nAChR and analyzed by Western blot for increased molecular 
weight bands.  Oocytes can also be analyzed by whole-cell Western blot to determine the 
total amount of protein translated (nAChR that is on the membrane surface, in the 
endoplasmic reticulum, in the golgi apparatus, and in vesicles) relative to oocytes not 
incubated with UAAs. 
 
 
Figure 7.2:  Unnatural amino acid replacement scanning (UAARS).  A) Oocytes are 
injected with wild-type nAChR mRNA, which have endogenous, natural aas.  The 
oocytes are placed in media containing UAAs and lacking the natural aa.  B) After 
incubation; mRNA is translated, endogenous aas are depleted, and UAAs are transported 
inside the oocyte.  C) With further incubation; more mRNA is translated, endogenous aas 
are further depleted, more UAAs are transported inside the oocyte, and UAAs are 
heterogeneously incorporated into the nAChR.  D) Increased incubation time causes 
further mRNA translation, depletion of endogenous aas, increased UAAs inside the 
oocyte, and increased heterogeneous incorporation of UAAs into the nAChR.  Figure 
adapted from (4) and nAChR created from 2BG9.pdb (41). 
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 UAARS creates a large population of nAChRs, which is unprecedented without 
mutating DNA.  For example, there are 251 Leu residues in the mouse muscle nAChR, 
and this is the most abundant aa (Figure 7.3).  There are 37 Leu in the α-subunit, 57 Leu 
in the β-subunit, 65 Leu in the γ-subunit, and 55 Leu in the δ-subunit.  The subunit 
stoichiometry of the nAChR is 2α:β:γ:δ (Figure 6.1).  Treating each of the five subunits 
as chemically distinct, there are 251 possible nAChRs when only a single UAA is 
incorporated.  If a single UAA is incorporated in three of the subunits, there are 1.2 X 106 
possible nAChRs.  A single UAA incorporated in each of the five subunits results in 2.8 
X 108 possible nAChRs.  If all of the 251 sites can contain either Leu or an UAA, there 
are 7.8 X 1016 possible nAChRs, which is 7.8 X 105 times greater than the ~ 1 X 1011 
neurons in an adult human brain.  This example only includes UAARS at Leu but in 




Figure 7.3:  Amino acid composition of the nAChR.  Number on left is the number of 
aas in the Torpedo nAChR (shown in red) and (number) is the number of aas in the 
mouse muscle nAChR.  The α-subunit is shown in yellow and all other subunits are 




7.2.2 Met Derivatives 
There are 58 Met aas in the nAChR (Figure 7.3).  PMet (shown in Figure 7.1) is 
accepted by the translational machinery and incorporated into proteins in COS7 (monkey 
kidney) and HeLa (human cervical cancer) cells (22).  UAARS with PMet showed no 
significant shift in EC50 (Table 7.1).  Nval (shown in Figure 7.1) is accepted by the E. coli 
methionyl-aminoacyl synthetase (MetRS) and aminoacylated on tRNAMet in vitro (20), 
and Nval is also accepted by the E. coli translational machinery in vitro (21).  Nval 
incorporation was also detected in E. coli Met auxotrophs in vivo (13).  UAARS with 
Nval showed no significant shift in EC50 (Table 7.1).  Ppg has been shown to be accepted 
by the E. coli MetRS and aminoacylated on tRNAMet in vitro (20), but was not accepted 
by the E. coli translational machinery in vitro and in vivo (13,21).  UAARS with Ppg 
showed no shift in EC50 (Table 7.1).  While no significant shift was seen in the EC50 for 
these three Met derivatives, UAA incorporation into the nAChR may occur and cause no 
change in function.  Other methods may be necessary for detection or UAARS into other 
ion channels. 
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Table 7.1:  UAARS EC50 determination 
      Incubation  
 UAA EC50 Shifta nH nb Time [UAA]c 
Met Derivatives PMet 64 ± 1 1.05 1.5 ± .04 8 48 h 0.5 mM 
 Nval 49 ± 1 1.02 1.5 ± 1 7 48 h 1 mM 
 Ppg 72 ± 4 1.07 1.5 ± .09 8 48 h 2 mM 
Pro Derivatives Dhp 58 ± 3 1.16 1.4 ± .08 6 48 h 1 mM 
 Dhp 39 ± 2 1.33 1.5 ± .07 5 120 h 4 mM 
 Aze 48 ± 1 1.04 1.4 ± .05 8 48 h 1 mM 
 Aze 38 ± 1 1.37 1.4 ± .08 7 120 h 4 mM 
Val Derivative FVal 81 ± 3 1.65 1.7 ± .09 7 48 h 2 mM 
Leu Derivatives PLeu 18 ± 2 3.72 .93 ± .07 6 48 h 0.5 mM 
 PLeu 17 ± 2 3.94 .99 ± .1 4 48 h 1 mM 
 PLeu 2.5 ± .3 21.2 1.1 ± .1 6 120 h 1 mM 
 F3Leu 25 ± 1 2.12 1.1 ± .05 6 48 h 2 mM 
 F3Leu 11 ± 1 4.82 1.2 ± .1 7 120 h 2 mM 
Phe Derivatives oFPhe 82 ± 3 1.57 1.4 ± .06 6 48 h 1 mM 
 mFPhe 32 ± 1 1.66 1.1 ± .06 7 48 h 1 mM 
 pFPhe 8.2 ± .4 6.46 0.89 ± .03 6 48 h 1 mM 
 3,4-F2Phe 53 ± 0.8 1.26 1.2 ± .01 8 48 h 2 mM 
 3,5-F2Phe 69 ± 1 1.03 1.4 ± .03 8 48 h 2 mM 
 F3Phe 60 ± 2 1.12 1.5 ± .05 8 48 h 2 mM 
 F5Phe 63 ± 0.9 1.06 1.6 ± .03 8 48 h 2 mM 
 2Pyr 74 ± 1 1.35 1.3 ± .02 6 48 h 2 mM 
 3Pyr 41 ± .9 1.22 1.5 ± .04 5 48 h 2 mM 
 4Pyr 51 ± 1 1.08 1.4 ± .05 5 48 h 2 mM 
Trp Derivatives Bth 49 ± 1 1.1 1.4 ± .05 6 48 h 2 mM 
 Thi 52 ± 2 1.06 1.2 ± .05 6 48 h 2 mM 



















a  Shift in EC50 relative to wild-type nAChR EC50 recorded on the same day. 
b  Number of oocytes. 
c  Concentration of UAA in media. 
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7.2.3 Pro Derivatives 
There are 151 Pro aas in the nAChR (Figure 7.3).  Dhp (shown in Figure 7.1) is 
recognized by the E. coli prolyl-aminoacyl tRNA synthetase (ProRS) in vitro (20) and 
accepted by the E. coli translational machinery in vitro (21).  Dhp has also been 
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incorporated into protein expressed in E. coli (10).  UAARS with Dhp shows only a 
slight shift in EC50 with a 2 d incubation (Table 7.1).  UAARS with Dhp shows a 
meaningfully increased shift in EC50 with a 5 d incubation (Table 7.1).  Aze (shown in 
Figure 7.1) is recognized by the E. coli ProRS in vitro (20) and accepted by the E. coli 
translational machinery in vitro (21).  Aze has also been incorporated into protein 
expressed in E. coli (9).  UAARS with Aze shows no shift in EC50 with a 2 d incubation 
(Table 7.1).  With a 5 d incubation, Aze shows a significant shift in EC50 (Table 7.1).  
Both Dhp and Aze show significant shifts in EC50 that are gain of function (GOF) 
phenotypes with 5 d incubations, but are insignificant with 2 d incubations.  Further 
incubation time may be necessary to obtain more efficient incorporation of these Pro 
derivatives. 
7.2.4 Val Derivative 
There are 215 Val aas in the nAChR (Figure 7.3).  FVal (shown in Figure 7.1) is 
recognized by the E. coli valyl-aminoacyl tRNA synthetase in vitro (20) and accepted by 
the E. coli translational machinery in vitro (21).  UAARS with FVal shows a significant 
1.7-fold shift in EC50 (Table 7.1) and causes a loss of function (LOF) phenotype.   
7.2.5 Leu Derivatives 
There are 251 Leu aas in the nAChR, which is the most abundant aa (Figure 7.3).  
PLeu is accepted by the translational machinery and incorporated into proteins in COS7 
and HeLa cells (22).  UAARS shows a 3.7- and 3.9-fold shift in EC50 with 0.5 mM and 1 
mM PLeu, respectively (Figure 7.4 A).  This experiment clearly illustrates that 0.5 mM 
PLeu in the media is sufficient and gives approximately the same EC50 as 1 mM PLeu.  
UAARS shows no shift in EC50 with 0.5 mM and 1 mM PMet (Figure 7.4 A).  In vivo 
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cross-linking experiments typically use both PLeu and PMet (22).  UAARS with PLeu 
and PMet show 5.1-fold shift in EC50 (Figure 7.4 A).  This EC50 is approximately the 
same for PLeu incorporation alone (Figure 7.4 A), showing that changes in nAChR 
function is primarily, if not exclusively, due to PLeu incorporation alone. 
 
 
Figure 7.4:  Fits to the Hill equation for UAARS with PLeu, PMet, and F3Leu.  A) 
UAARS with PLeu, PMet, and PLeu + PMet.  PLeu [0.5 mM] EC50 = 18 ± 2 and nH = 
0.93 ± 0.07.  PLeu [1 mM] EC50 = 17 ± 2 and nH = 0.99 ± 0.1.  Wild-type αHA His nAChR 
EC50 = 67 ± 2 and nH = 1.5 ± 0.06.  PMet [0.5 mM] EC50 = 75 ± 4 and nH = 1.4 ± 0.09.  
PMet [1 mM] EC50 = 64 ± 1 and nH = 1.5 ± 0.04.  PLeu [1 mM] + PMet [0.5 mM] EC50 = 
13 ± 2 and nH = 1.4 ± 0.2.  In each experiment n > 4 oocytes.  B) UAARS with PLeu and 
F3Leu with 2 and 5 d incubations.  PLeu (5 d incubation) EC50 = 2.5 ± 0.3 and nH = 1.1 ± 
0.1.  F3Leu (5 d incubation) EC50 = 11 ± 1 and nH = 1.2 ± 0.1.  PLeu (2 d incubation) 
EC50 = 17 ± 2 and nH = 0.99 ± 0.1.  F3Leu (2 d incubation) EC50 = 25 ± 1 and nH = 1.1 ± 
0.05.  Wild-type αHA His nAChR EC50 = 53 ± 0.7 and nH = 1.5 ± 0.02.  In each experiment 
n > 3 oocytes. 
 
 F3Leu (shown in Figure 7.1) is recognized by the E. coli leucyl-aminoacyl tRNA 
synthetase in vitro (20) and accepted by the E. coli translational machinery in vitro (21).  
F3Leu has also been incorporated in proteins expressed in E. coli auxotrophs in vivo (17).  
UAARS with F3Leu shows a 2.1- and 4.8-fold shift in EC50 with 2 and 5 d incubation, 
respectively (Figure 7.4 B).  UAARS with PLeu shows a 3.9- and 21-fold shift in EC50 
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with 2 and 5 d incubation, respectively (Figure 7.4 B).  Both F3Leu and PLeu show 
increased UAA incorporation with increased time, but the shift in F3Leu (2.3 from 5 d to 
2 d) is not as strong as PLeu (5.4 from 5 d to 2 d) even though these UAAs are both 
replacing Leu. 
 
7.2.6 Phe Derivatives 
There are 123 Phe aas in the nAChR (Figure 7.3).  oFPhe is recognized by the E. 
coli phenylalanyl-aminoacyl tRNA synthetase (PheRS) in vitro (20) and accepted by the 
E. coli translational machinery in vitro (21).  oFPhe, mFPhe, and pFPhe have been 
incorporated into proteins expressed in P. aeruginosa (16).  pFPhe has also been 
incorporated in proteins expressed in E. coli auxotrophs in vivo (8).  UAARS with oFPhe 
shows a 1.6-fold shift in EC50 and causes a LOF phenotype (Figure 7.5 A).  UAARS with 
mFPhe shows a 1.7-fold shift in EC50 and causes a GOF phenotype (Figure 7.5 A).  
UAARS with pFPhe shows a 6.5-fold shift in EC50, causes a GOF phenotype, and causes 
the largest shift with a 2 d incubation of all the UAAs shown in Figure 7.1.  The shifts for 
oFPhe, mFPhe, and pFPhe were observed for two different batches of oocytes.  UAARS 
with oFPhe, mFPhe, and pFPhe shows that the nAChR functions differently when the 
fluorine substituent is moved around the phenyl ring. 
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Figure 7.5:  Fits to the Hill equation for UAARS with oFPhe, mFPhe, pFPhe, 2Pyr, 3Pyr, 
and 4Pyr.  A) UAARS with oFPhe, mFPhe, and pFPhe.  oFPhe EC50 = 82 ± 3 and nH = 
1.4 ± 0.06.  mFPhe EC50 = 32 ± 1 and nH = 1.1 ± 0.06.  pFPhe EC50 = 8.2 ± 0.4 and nH = 
0.89 ± 0.03.  Wild-type αHA His nAChR EC50 = 49 ± 1 and nH = 1.4 ± 0.04.  In each 
experiment n > 5 oocytes.  A) UAARS with 2Pyr, 3Pyr, and 4Pyr.  2Pyr EC50 = 74 ± 1 
and nH = 1.3 ± 0.02.  3Pyr EC50 = 41 ± 0.9 and nH = 1.5 ± 0.04.  4Pyr EC50 = 51 ± 1 and 
nH = 1.4 ± 0.05.  Wild-type αΝHA nAChR EC50 = 55 ± 0.9 and nH = 1.4 ± 0.03.  In each 
experiment n > 4 oocytes. 
 
 2Pyr, 3Pyr, and 4Pyr (shown in Figure 7.1) have been incorporated in proteins 
expressed in E. coli auxotrophs in vivo (15,18).  UAARS with 2Pyr shows a 1.4-fold shift 
in EC50 and causes a LOF phenotype (Figure 7.5 B).  UAARS with 3Pyr shows a 1.2-fold 
shift in EC50 and causes a GOF phenotype (Figure 7.5 B).  Both 2Pyr and 3Pyr show a 
similar phenotypical shift in EC50 to oFPhe and mFPhe, respectively (Figure 7.5 A & B).  
UAARS with 4Pyr shows no shift in EC50 (Figure 7.5).  The lack of EC50 shift for 4Pyr 
suggests that or the loss of hydrogen at the para position has no affect on nAChR 
function.  Overall, the pyridylalanine UAAs show smaller shifts in EC50 when compared 
to the fluorinated Phe UAAs. 
 UAARS with 3,4-F2Phe (shown in Figure 7.1) showed only a slight 1.3-fold shift 
in EC50 (Table 7.1) and further incubation time may be necessary to get increased UAA 
incorporation.  UAARS with 3,5-F2Phe, F3Phe, and F5Phe (shown in Figure 7.1) all 
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showed slight shifts in EC50 (Table 7.1).  F5Phe has been shown not to be accepted by the 
E. coli PheRS and a mutant E. coli PheRS in vivo (15).  It appears that the addition of 
further fluorine substituents on the phenyl ring appears to block recognition by the 
Xenopus PheRS. 
7.2.7 Trp Derivatives 
There are 51 Trp aas in the nAChR (Figure 7.3).  Bth and Thi (shown in Figure 
7.1) are recognized by the E. coli tryptophanyl-aminoacyl tRNA synthetase (TrpRS) in 
vitro (20) and accepted by the E. coli translational machinery in vitro (21).  Bth and Thi 
are both thought to be non-coding or not accepted in vivo (6).  UAARS with Bth and Thi 
show no shift in EC50 (Table 7.1).  Bth and Thi may be incorporated in the nAChR, but 
other methodologies for detection may be necessary. 
FTrp is recognized by the E. coli TrpRS in vitro (20) and accepted by the E. coli 
translational machinery in vitro (21).  FTrp is incorporated into proteins in E. coli (19).  
UAARS with FTrp results in a 2.9-fold shift in EC50 (Figure 7.6 A), and FTrp shows the 
greatest LOF phenotype of the UAAs tested in Figure 7.1.  The UAARS with FTrp EC50 
is close to the EC50 of the site-specific incorporation of FTrp at α149 (Figure 7.6 A), 
which makes a cation-π interaction with ACh (30). 
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Figure 7.6:  Fits to the Hill equation for UAARS with FTrp and nonsense suppression 
experiments.  A) UAARS with FTrp.  Wild-type αNHA nAChR EC50 = 48 ± 2 and nH = 1.5 
± 0.03.  FTrp EC50 = 140 ± 9 and nH = 1.4 ± 0.09.  α149UAG + THG73-FTrp EC50 = 200 
± 7 and nH = 1.3 ± 0.04.  In each experiment n > 5 oocytes.  B) α149UAGβ9’Ser 
nonsense suppression and UAARS with FTrp.  α149UAGβ9’Ser + TQAS-Trp EC50 = 1.7 
± 0.1 and nH = 1.7 ± 0.1.  α149UAGβ9’Ser + TQAS-Trp + 2 mM FTrp EC50 = 3.4 ± 0.4 
and nH = 1.3 ± 0.2.  α149UAGβ9’Ser + TQAS-FTrp EC50 = 14 ± 0.4 and nH = 1.7 ± 0.07.  
α149UAGβ9’Ser + TQAS-FTrp + 2 mM FTrp EC50 = 14 ± 0.7 and nH = 1.7 ± 0.1.  In 
each experiment n > 4 oocytes.  C) α149UAG nonsense suppression and UAARS with 
FTrp.  α149UAG + TQAS-Trp EC50 = 58 ± 2 and nH = 1.7 ± 0.09.  α149UAG + TQAS-
Trp + 2 mM FTrp EC50 = 76 ± 7 and nH = 1.4 ± 0.06.  α149UAG + TQAS-FTrp EC50 = 
230 ± 10 and nH = 1.4 ± 0.07.  α149UAG + TQAS-FTrp + 2 mM FTrp EC50 = 240 ± 10 
and nH = 1.4 ± 0.06.  In each experiment n > 3 oocytes. 
 
 To determine whether the placement of FTrp at α149 was dominating the EC50 
shift in UAARS experiments, we chose to combine site-specific incorporation of Trp or 
FTrp with UAARS with FTrp.  Using nonsense suppression at α149UAG results in either 
0% FTrp when suppressing with TQAS-W or 100% FTrp when suppressing with TQAS-
FTrp.  Initially, the β9’Ser mutation was utilized to lower the EC50 by a factor of ≈ 33, 
and the mutation doesn’t alter the effect of UAAs incorporated at α149 (30,31).  
Suppression of α149UAGβ9’Ser with TQAS-Trp results in an EC50 = 1.7 µM ACh, but 
suppression of α149UAGβ9’Ser with TQAS-Trp and UAARS with FTrp results in a 2-
fold shift in EC50 (Figure 7.6 B).  Suppression of α149UAGβ9’Ser with TQAS-FTrp 
results in an EC50 = 14 µM ACh, but suppression of α149UAGβ9’Ser with TQAS-FTrp 
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and UAARS with FTrp causes no shift in EC50 (Figure 7.6 B).  The EC50 for 
α149FTrpβ9’Ser is expected to be ≈ 6 µM and it is unclear why the EC50 was higher for 
these experiments. 
 We then chose to use the wild-type, β9’Leu nAChR, which had been used in 
previous UAARS experiments.  Suppression of α149UAG with TQAS-Trp results in an 
EC50 = 58 µM ACh, but suppression of α149UAG with TQAS-Trp and UAARS with 
FTrp results in a 1.3-fold shift in EC50 (Figure 7.6 C).  Suppression of α149UAG with 
TQAS-FTrp results in an EC50 = 230 µM ACh, but suppression of α149UAG with 
TQAS-FTrp and UAARS with FTrp causes no shift in EC50 (Figure 7.6 C).  If α149FTrp 
was causing the entire shift in EC50, then both of the suppression experiments (TQAS-Trp 
or TQAS-FTrp) would be expected to show no shift in EC50 from UAARS. 
7.2.8 Cross-Linking the nAChR with PLeu and PMet 
The UAAs PLeu and PMet are used to detect protein-protein interactions in vivo 
(22).  These UAAs are heterogeneously incorporated into all translated proteins and UV 
irradiation is used to convert the diazirine to a reactive carbene intermediate that 
irreversibly cross-links either within a protein or to another protein if the UAA is in close 
proximity.  Cross-linked protein complexes are typically detected by Western blotting as 
an increased molecular weight relative to non-cross-linked protein.  We chose to perform 
Western blots of the αHA His (contains the HA tag in the M3-M4 loop and a 6-His tag at the 
C-terminus) or αNHA (contains the HA at the N-terminus).  By only detecting the α-
subunit, we would expect to obtain four possible dimers α1β, α1γ, α2γ or α2δ; five 
possible trimers α1βδ, α1γα2, γα1β, α2δβ, δα2γ; five possible tetramers α1γα2δ, γα1βδ, 
βα1γα2, α2βδα1, and βδα2γ; and one pentamer α1γα2δβ (note: α1 and α2 are used to show 
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the uniqueness of the different subunit interfaces of the two α-subunits).  Each subunit of 
the nAChR runs at a distinct molecular weight (see Figure 6.10), and therefore different 
subunit combinations may run at different masses.  Also, trimers and tetramers with two 
α-subunits may be detected more readily because there are two HA tags and should bind 
two antibodies (Abs). 
Oocytes that are supplemented with Leu and Met show no increased molecular 
weight bands with or without the exposure to UV light (Figure 7.7 A & B, Lanes 2, 3, 6, 
and 7).  Oocytes that were supplemented with PLeu and PMet showed higher molecular 
weight bands when not irradiated with UV light (Figure 7.7 A & B, Lanes 4 and 8).  
These higher molecular weight bands are most likely caused by ambient light in the lab.  
Oocytes that were supplemented with PLeu and PMet and irradiated with UV light for 40 
min at room temperature show no high molecular weight bands, but there is a loss of the 
α-subunit intensity (Figure 7.7 A & B, Lanes 5 and 9).  A similar reduction in α-subunit 
intensity is seen for oocytes supplemented with Leu and Met (Figure 7.7 A & B, Lanes 3 
and 7).  Ponceau staining of the nitrocellulose membrane shows a loss in total protein for 
oocytes supplemented with PLeu and PMet (Figure 7.7 C & D, Lanes 5 and 9), but there 
is little loss with oocytes supplemented with Leu and Met (Figure 7.7 C & D, Lanes 3 
and 7).  Therefore UV irradiation at room temperature may be resulting in α-subunit and 
total protein loss by heat with 40 min.  Irradiating whole oocytes on the arc lamp (3 min 
on each sides) shows only faint higher molecular weight bands (Figure 7.7 B, Lane 10) or 
nothing (Figure 7.7 A, Lane 10), but there appears to be no loss of α-subunit intensity 




Figure 7.7:  Detecting cross-linking of αHA His with the HA Ab.  (A & B) Gels are the 
same, but with different oocytes.  Lane 1 is molecular weight marker.  Lane 2 is αHA His 
with 1 mM Leu and 0.5 mM Met.  Lane 3 is αHA His with 1 mM Leu and 0.5 mM Met 
irradiated with UV light.  Lane 4 is αHA His with 1 mM PLeu and 0.5 mM PMet.  Lane 5 is 
αHA His with 1 mM PLeu and 0.5 mM PMet irradiated with UV light.  Lane 6 is αHA His 
with 1 mM Leu, 0.5 mM Met, and 0.17 mM 18 other aas.  Lane 7 is αHA His with 1 mM 
Leu, 0.5 mM Met, and 0.17 mM 18 other aas irradiated with UV light.  Lane 8 is αHA His 
with 1 mM PLeu, 0.5 mM PMet, and 0.17 mM 18 other aas.  Lane 9 is αHA His with 1 mM 
PLeu, 0.5 mM PMet, and 0.17 mM 18 other aas irradiated with UV light.  Lane 10 is αHA 
His with 1 mM PLeu, 0.5 mM PMet, and 0.17 mM 18 other aas irradiated with UV light 
on the arc lamp (3 min on each side of the oocyte). (C & D) Ponceau staining of Western 
blots in (A & B).  Staining shows loss of total protein after irradiation with UV light.  UV 
irradiation was done 40 min at room temperature (unless otherwise noted).  Each lane 
contains four whole oocytes.  Numbers on the left are molecular weight markers (KD). 
 
 Cross-linking may hinder detection of the α-subunit because the HA tag is in the 
M3-M4 loop and may form secondary structure during cross-linking, such as a loop.  The 
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HA Ab detects a linear sequence of aas and any structure may not allow for detection.  
We choose to detect the α-subunit with the His Ab because the 6-His tag is at the C-
terminus and is unlikely to cross-link.  The αNHA was also used because the HA tag is in 
the N-terminus and is also unlikely to cross-link.  Using the same amount of His Ab as 
the HA antibody, no α-subunit could be detected (Figure 7.8 A).  After stripping the 
membrane, the membrane was reprobed with the HA, Ab and the α-subunit is clearly 
visible (Figure 7.8 B).  Oocytes injected with αHA His and supplemented with PLeu and 
PMet show faint higher molecular weight bands without UV irradiation (Figure 7.8 B, 
Lanes 3 and 9).  Intriguingly, no higher molecular weight bands are visualized for 
oocytes injected with αHA His and supplemented with only PLeu (Figure 7.8 B, Lane 5 and 
6).  The αNHA didn’t express as well as αHA His, and no higher molecular weight bands are 
seen with or without UV irradiation (Figure 7.8 B, Lanes 7 and 8).  Less UV irradiation 
time (10 min, instead of 40 min as in Figure 7.7) was used to avoid loss of α-subunit and 
total protein.  Oocytes expressing αHA His supplemented with PLeu and PMet only show 
higher molecular weight bands in Figure 7.8 B, Lane 4.  Other oocytes expressing αHA His 
supplemented with PLeu and PMet or only PLeu show no increased molecular weight 




Figure 7.8:  Detecting cross-linking of αHA His with the His Ab and HA Ab.  A) Detection 
of αHA His with the His Ab.  B) Is the same gel as in A, but detected with the HA Ab after 
stripping the membrane.  (A & B)  Lane 1 molecular weight marker.  Lane 2 is αHA His 
with 1 mM Leu and 0.5 mM Met.  Lane 3 is αHA His with 1 mM PLeu and 0.5 mM PMet.  
Lane 4 is αHA His with 1 mM PLeu and 0.5 mM PMet irradiated with UV light.  Lane 5 is 
αHA His with 1 mM PLeu.  Lane 6 is αHA His with 1 mM PLeu irradiated with UV light.  
Lane 7 is αΝHA with 1 mM PLeu and 0.5 mM PMet.  Lane 8 is αΝHA with 1 mM PLeu and 
0.5 mM PMet irradiated with UV light.  Lane 9 is αHA His with 1 mM PLeu and 0.5 mM 
PMet.  Lane 10 is αHA His with 1 mM PLeu and 0.5 mM PMet irradiated with UV light. 
UV irradiation was done for 10 min at room temperature.  Each lane contains four whole 
oocytes.  Numbers on the left are molecular weight markers (KD). 
 
 The loss of α-subunit intensity without increased molecular weight bands is 
concerning, and therefore UV irradiation was performed for 2 h at 4 ˚C.  The lack of high 
molecular weight bands may be due to the minimal amount of nAChR produced in an 
oocyte (pico-femto grams) and therefore oocytes were homogenized and solubilized for 2 
d at 18 ˚C.  Oocytes that were supplemented with Leu and Met show no high molecular 
weight bands (Figure 7.9 A & B, Lane 2).  The large smear running between 75 KD and 
105 KD is an abundant protein in the Xenopus oocyte (see Figure 7.7 C & D), which is 
more abundant in this gel because of the 2 d solubilization and is detected because of 
non-specific HA and/or 2˚ Ab binding.  Oocytes that were supplemented with PLeu and 
PMet either show higher molecular weight bands (Figure 7.9 A, Lane 3) or no higher 
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molecular weight bands (Figure 7.9 B, Lane 3) without UV irradiation, the latter is most 
likely due to minimal protein expression.  Oocytes supplemented with PLeu and PMet 
show higher molecular weight bands with 2 h of UV irradiation (Figure 7.9 A, Lanes 4, 5, 
8, and 9, and Figure 7.9 B, Lanes 4–8), but these are not seen in some lanes with lower 
protein loading (Figure 7.9 A, Lanes 6, 7, and 10, and Figure 7.9 B, 9 and 10).  Some 
lanes also show higher molecular weight bands than a pentamer expected for the nAChR 
(Figure 7.9 B, Lanes 4–7).  Therefore cross-linking of the α-subunit appears to be 
minimal in the Xenopus oocytes and longer UV irradiation at 4 ˚C and solubilization is 
necessary to obtain higher yields of the cross-linked subunits. 
 
 
Figure 7.9:  Detecting cross-linking of αHA His with the HA Ab after extended UV 
irradiation.  (A & B) Gels are the same, but with different oocytes.  Lane 1 molecular 
weight marker.  Lane 2 is αHA His with 1 mM Leu and 0.5 mM Met, half oocyte.  Lane 3 is 
αHA His with 1 mM PLeu and 0.5 mM PMet, half oocyte.  Lane 4 is αHA His with 1 mM 
PLeu and 0.5 mM PMet irradiated with UV light, one oocyte.  Lane 5 is αHA His with 1 
mM PLeu and 0.5 mM PMet irradiated with UV light, half oocyte.  Lane 6 is αHA His with 
1 mM PLeu and 0.5 mM PMet irradiated with UV light, quarter oocyte.  Lane 7 is αHA His 
with 1 mM PLeu and 0.5 mM PMet irradiated with UV light, eighth oocyte.  Lane 8 is 
αHA His with 1 mM PLeu and 0.5 mM PMet irradiated with UV light, one oocyte.  Lane 9 
is αHA His with 1 mM PLeu and 0.5 mM PMet irradiated with UV light, half oocyte.  Lane 
10 is αHA His with 1 mM PLeu and 0.5 mM PMet irradiated with UV light, quarter oocyte. 
UV irradiation was done for 2 h at 4 ˚C.  Numbers on the left are molecular weight 
markers (KD).  Numbers in white are the number of subunits cross-linked. 
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7.2.9 Unnatural Amino Acid Replacement Scanning Expression Determined by  
Electrophysiology and Western Blot 
During the course of the UAARS experiments done in Sections 7.2.2 through 
7.2.7, many UAAs showed unusually low current when compared to wild-type nAChR 
not supplemented with UAAs.  To analyze this phenomenon among different batches of 
oocytes, the average maximal current (Imax) from UAARS experiments were normalized 
to wild-type nAChR Imax, not supplemented with UAAs.  Figure 7.10 shows the variable 
effect that natural aas and UAAs in the incubation media have on functional expression 
of ion channels on the membrane of Xenopus oocytes.  Met, Pro, and Leu are all natural 
aas and when they are supplemented at 1 mM in the media there is ≈ 40% reduction in 
Imax (Figure 7.10).  PMet, Nval, 2Pyr, 3Pyr, 4Pyr, Bth, and Thi all show increased Imax 
(Figure 7.10), but PMet, Nval, 4Pyr, Bth, and Thi show no change in EC50 (Table 7.1 and 
Figure 7.5).  Of the Met derivatives, Ppg shows a decrease in Imax, and PMet and Nval 
show an increase in Imax (Figure 7.10).  Both Pro derivatives, Aze and Dhp, show a 
decrease in Imax equal to the addition of Pro (Figure 7.10).  PLeu shows Imax equivalent to 
oocytes not supplemented with UAAs, but F3Leu shows a severe reduction in Imax (Figure 
7.10).  Intriguingly, oFPhe, mFPhe, and pFPhe all show different Imax profiles (Figure 
7.10).  pFPhe reduces Imax by 94%, while mFPhe is comparable to Met, Leu, and Pro 
(Figure 7.10).  3,4-F2Phe shows only a slight reduction in EC50 (Table 7.1), but shows 
Imax reduction (57%) that is close to the average reduction of Imax for mFPhe and pFPhe 
(62%) (Figure 7.10).  3,5-F2Phe, F3Phe, and F5Phe showed no change in EC50 (Table 
7.1) and the reduction in Imax is similar to Met, Leu, and Pro (Figure 7.10).  FVal and 
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FTrp also cause a reduction in Imax (Figure 7.10).  Overall, fluorinated UAAs appear to 
reduce the functional nAChR on the surface of the oocyte membrane (Figure 7.10). 
 
Figure 7.10:  UAARS effect on functional nAChR expression detected by 
electrophysiology.  Imax for UAARS experiments was normalized to Imax for nAChR 
without UAAs.  WT is wild-type nAChR and natural aas or UAAs (chemical structure 
shown in Figure 7.1) are listed below each bar.  Error bars are standard error. 
 
 To determine whether UAARS causes decreased nAChR translation or increased 
protein degradation, whole cell homogenization and Western blot were utilized to look at 
α-subunit protein.  Figure 7.11 A shows that the α-subunit is translated and present in 
oocytes equally without UAAs in the media (Figure 7.11 A, Lane 2) and in the presence 
of UAAs (Figure 7.11 A, Lanes 3–10).  Densiometric analysis of Figure 7.11 A confirms 
that oFPhe, mFPhe, pFPhe, FTrp, and FVal all have the same amount of α-subunit as 
oocytes not supplemented with UAAs (Figure 7.11 B).  Therefore reduction of Imax for 
these UAAs (Figure 7.10) is not due to decreased translation or protein degradation, but 
rather another mechanism. 
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Figure 7.11:  UAARS effect on nAChR expression detected by Western blot.  A) 
UAARS with oFPhe, mFPhe, pFPhe, FTrp, and FVal.  Lane 1 molecular weight marker.  
Lane 2 is αHA His.  Lanes 3 and 4 are αHA His with 1 mM oFPhe.  Lanes 5 and 6 are αHA His 
with 1 mM mFPhe.  Lanes 7 and 8 are αΝHA with 1 mM pFPhe.  Lane 9 is αHA His with 2 
mM FTrp.  Lane 10 is αHA His with 2 mM FVal.  Each lane contains four whole oocytes.  
Numbers on the left are molecular weight markers (KD).  B) Densiometric analysis of 
Western blot in part A.  Signal intensity was normalized to αHA His not supplemented with 
UAAs (Lane 2).  Error bars are standard error. 
 
7.3 Discussion 
 UAARS requires depletion of the endogenous aas for efficient incorporation of 
UAAs (shown schematically in Figure 7.2).  This is experimentally shown by the 
increased shift in EC50 for PLeu and F3Leu from 2 to 5 d incubations (Figure 7.4 B).  
Injection of PLeu and PMet (final concentration in an oocyte 1 mM and 0.5 mM, 
respectively) caused no shift in EC50 of the nAChR and resulted in ≈ 50% reduction in 
nAChR expression when determined by electrophysiology (data not shown).  Therefore 
the use of excess UAAs in the media is needed for increased UAA concentration in the 
oocyte and for efficient UAARS. 
Many UAAs showed no shift in EC50, which may be due to lack of efficient UAA 
incorporation by the translational machinery, lack of UAA recognition by aaRSs, or no 
change in nAChR function.  Increased incubation times are required to get significant 
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shifts for Aze, which may be required for 3,4-F2Phe (Table 7.1).  F5Phe was not 
recognized in E. coli (15) and therefore may also not be in Xenopus oocytes.  The Met 
derivatives (PMet, Nval, and Ppg) all showed no shift in EC50 (Table 7.1) and other ion 
channels (5HT3A, GABAA, MOD-1, etc.) may be useful to screen for these Met 
derivatives.  With increased research on other ion channels, hopefully UAARS EC50 
shifts can be determined for all 20 canonical aas (or 19 if Gly is omitted) to allow 
efficient screening of all UAA derivatives.  Other methods of detection will also be 
useful, including bioorthogonal labeling of UAAs with fluorophores (23,24,42) and 
detection by total internal reflectance microscopy (TIRF) (43).  TIRF will not only show 
the presence of UAAs, but can also be used to count the number of accessible UAAs of a 
single nAChR and can be used to determine the distribution of UAAs incorporated into 
nAChRs. 
The commercially available PLeu causes a change in the function of the nAChR, 
but no shift is seen with PMet (Figure 7.4 A).  PLeu is hydrophilic compared to F3Leu, 
but both UAAs cause a GOF phenotype in the nAChR (Figure 7.4 B).  This is intriguing, 
because Leu is the most abundant UAA in the nAChR and Leu is a hydrophobic aa 
thought to stabilize the interior of proteins and to interact with the lipid bilayer (Figure 
7.3).  The two UAAs—PLeu and F3Leu—are distinguishable by the number of 
functional ion channels present on the surface.  The hydrophilic PLeu results in 
comparable expression to wild-type nAChR not supplemented with UAAs, but the 
hydrophobic F3Leu results in a 86% reduction in current (Figure 7.10).  This may result 
from differential interactions with chaperones, interactions with lipid bilayers in the 
endoplasmic reticulum and/or golgi, folding by the translocon, change in conductance, or 
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differences in the amount of functional receptors for each UAA.  Val is another 
hydrophobic aa and is present comparably to Leu in the nAChR (Figure 7.3).  The 
incorporation of the more hydrophobic FVal results in a LOF phenotype (Table 7.1), 
which contrasts to the GOF phenotype of PLeu and F3Leu.  Expression of functional ion 
channels is decreased by 56% with FVal and is similar to F3Leu (Figure 7.10).  Further 
research on hydrophobic residues will be intriguing on the nAChR because they are so 
abundant, contact subunit interfaces, and interact with the lipid bilayer (Figure 7.3). 
Phe is the most abundant aromatic aa in the nAChR and forms extensive 
interactions with the lipid bilayer (Figure 7.3).  Fluorination of Phe decreases the cation-π 
binding ability of the phenyl ring (44), but also places a highly eletectronegative 
substituent and increases the hydrophobicity of the side chain.  Intriguingly, fluorination 
of the ortho, meta, and para positions of Phe have different effects on the function of the 
nAChR.  oFPhe causes a LOF phenotype, mFPhe causes a slight GOF phenotype, and 
pFPhe causes the greatest GOF phenotype of UAAs screened (Figure 7.5 A).  The 
pyridylalanine derivatives have decreased cation-π binding ability as well (44), but also 
remove a H atom and increase hydrophilicity of the side chain.  2Pyr results in a LOF 
phenotype similar to oFPhe (Figure 7.5 A & B).  3Pyr results in a GOF phenotype similar 
to mFPhe (Figure 7.5 A & B).  4Pyr shows no shift in EC50 (Figure 7.5 B), which is either 
due to possible protonation of 4Pyr or evidence that the loss of a H atom doesn’t 
influence the function of the nAChR.  Fluorination of the para position on pFPhe causes 
a significant shift in EC50, which greatly alters nAChR function.  These UAAs show 
distinct interactions of the Phe side chain and clearly illustrate that the ortho, meta, and 
para positions have differential interactions within the nAChR and/or the lipid bilayer. 
 256 
Trp is the least used aromatic aa in the nAChR (Figure 7.3), and in proteins in 
general.  UAARS with FTrp results in a LOF phenotype similar to the site-specific 
incorporation of FTrp at α149 (Figure 7.6 A).  4-FTrp and 6-FTrp are accepted by E. coli 
(19) and these derivatives should be intriguing to see if there is a functional difference on 
the nAChR similar to the Phe derivatives.  Differences in EC50 shift have been seen at 
α149 in the nAChR, where site-specific incorporation of 4-FTrp and 6-FTrp cause no 
shift in EC50, but 5-FTrp (FTrp) cause a 4-fold shift in EC50 (30).  Combining site-specific 
UAA incorporation with UAARS allows for a novel experimental technique to remove 
one position from UAARS.  Using α149UAG and suppressing with TQAS-W, 0% of the 
ion channels will contain FTrp at this position and there is still a LOF phenotype seen 
with UAARS with FTrp (Figure 7.6 B & C), although significantly smaller than that from 
simple UAARS.  Intriguingly, suppressing α149UAG with TQAS-FTrp (100% of the ion 
channels will have FTrp at α149) shows no shift in EC50 (Figure 7.6 B & C).  Both 
experiments should show a shift in EC50 if there is a global change in function with 
UAARS with FTrp or no shift if the α149FTrp position is dominating the shift in EC50.  
This difference may be explained by a positional affect near the ACh binding site, known 
as the aromatic box.  α149Trp may show a shift because FTrp at the only other Trp in the 
aromatic box may alter ACh binding, but α149FTrp may dominate the reduction in ACh 
binding and FTrp at the other site has no effect.  Further research is needed to explain this 
phenomenon, but clearly illustrates the utility of combining site-specific UAA 
incorporation with UAARS. 
PLeu and PMet allow for detection of UAA incorporation by cross-linking 
subunits within the nAChR upon UV irradiation and detection of higher molecular weight 
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bands on a Western blot.  Detection of αHA His was not possible with the His Ab (Figure 
7.8 A) and clearly illustrates the difficulty in detecting a low abundance ion channel with 
Abs other than the HA Ab from Covance.  Wild-type nAChR supplemented with Leu and 
Met show no higher molecular weight bands with and without UV irradiation (Figure 7.7 
A & B, Lanes 2, 3, 6, and 7, Figure 7.8 B, Lane 2, and Figure 7.9 A & B, Lane 2).  
nAChR supplemented with PLeu and PMet show higher molecular weight bands without 
UV irradiation, even though the oocytes are kept in an opaque box and only exposed to 
light during media exchange and homogenization (Figure 7.7 A & B, Lanes 4 and 8, 
Figure 7.8 B, Lanes 3 and 9, and Figure 7.9 A, Lane 3).  This suggests that many Leu 
and/or Met positions of the nAChR are in close contact with other subunits.  nAChR 
supplemented with PLeu and PMet sometimes show higher molecular weight bands with 
UV irradiation (Figure 7.8 B, Lane 4, Figure 7.9 A, Lanes 4, 5, 8, and 9, and Figure 7.9 
B, Lanes 4–8).  The detection of higher molecular weight bands is highly variable, but is 
seen more readily with UV irradiation for 2 h at 4 ˚C and solubilization of whole oocytes 
for 2 d at 18 ˚C (Figure 7.9 A, Lanes 4, 5, 8, and 9, and Figure 7.9 B, Lanes 4–8).  When 
the nAChR is supplemented with PLeu only, no higher molecular weight bands are seen 
with or without UV irradiation (Figure 7.9 B, Lanes 5 and 6).  This suggests that PMet is 
critical for cross-linking of the nAChR.  The nAChR is a pentamer, but occasionally 
higher molecular weight bands were seen (Figure 7.9 B, Lanes 4–7).  Cross-linking of the 
nAChR requires highly specialized conditions in order to maximize the yield of the cross-
linked subunits, which are present in extremely low yield and/or difficult to solubilize.  
UAARS with PLeu and PMet can be detected by Western blot, but cross-linking is 
inefficient and highly variable. 
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The supplementation of natural aas and UAAs (0.5–4 mM) effects the functional 
expression of the nAChR.  1 mM of Leu, Met, and Pro all decrease expression by ≈ 40% 
relative to oocytes not supplemented with natural aas (Figure 7.10).  The decrease in 
channel expression may be caused by overwhelming the translation machinery through 
increased concentration of natural aas, which increases aminoacylated tRNAs, 
imbalances the aminoacylated tRNA pool and portion bound to EF-1α, and could cause 
ribosomal stalling, increased frameshifting, and protein truncation.  PMet and Nval both 
increase expression by 77% and 40%, respectively (Figure 7.10).  This suggests that the 
Met concentration in Xenopus oocytes is not optimal for nAChR expression and the 
increase of PMet and Nval may also increase translation and/or initiation of translation.  
This may be useful for increasing nAChR translation and/or site-specific UAA 
incorporation experiments by supplementation of Met (< 1 mM) or Met derivatives.  Dhp 
and Aze result in ≈ 40% decrease in functional channel expression, which is similar to 
Pro (Figure 7.10).  oFPhe and pFPhe show 88% and 93%, respectively, reduction in 
expression, while mFPhe shows 30% reduction (Figure 7.10).  3,5-F2Phe, F3Phe, and 
F5Phe (no shift in EC50 Table 7.1) all show ≈ 20% reduction in functional channel 
expression, while 3,4-F2Phe shows a 57% reduction and suggests incorporation (Figure 
7.10).  2Pyr and 3Pyr show 50% increase in expression, while 4Pyr shows a 100% 
increase in expression (Figure 7.10).  Bth and Thi show an 60% and 80% increase in 
expression (Figure 7.10) even though there is no shift in EC50 (Table 7.1).  Of the UAAs 
that caused a shift in EC50, UAARS with fluorinated UAAs (F3Leu, FVal, FTrp, oFPhe, 
mFPhe, and pFPhe) appears to decrease functional ion channel expression relative to non-
fluorinated UAAs (PLeu, 2Pyr, and 3Pyr) (Figure 7.10).  Intriguingly, there is no change 
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in the total α-subunit when detected by Western blot for oFPhe, mFPhe, pFPhe, FTrp, 
and FVal (Figure 7.11).  Therefore the UAA incorporation doesn’t cause decreased 
translation or increased protein degradation, but most likely the channels are not 
functional, have altered conductance, or are not present on the cell surface (remain 
sequestered in the endoplasmic reticulum, golgi, or vesicles).  Western blots of the 
membrane only can further elucidate where the nAChR is located.  Natural aas and 
UAAs supplemented in the media effect functional nAChR expression, but appear not to 
diminish protein translation for tested fluorinated UAAs. 
UAARS is a useful method for analyzing the global effect of UAA incorporation.  
The commercially available UAA PLeu alters nAChR function and caution should be 
observed when heterogeneously incorporating UAAs.  Further research is necessary to 
extend UAARS to other ion channels to try and attain shifts for the 20 natural aas (or 19 
if Gly is omitted).  UAARS with UAAs not used in this research will further extend 
trends discussed and gain further insight into aa function in the nAChR.  Extension of 
UAARS to charged and polar aas will also be interesting to see the effect on the function 
of the nAChR.  UAARS is a useful technique for evaluating whether the translational 
machinery of the Xenopus oocyte accepts an UAA.  UAAs that are accepted by the 
translational machinery require site-specific incorporation by chemically aminoacylated 
tRNAs, but UAAs that are not accepted can be incorporated by evolved aminoacyl 
synthetase/tRNA pairs for site-specific UAA incorporation.  The use of E. coli mutant 
aaRS can be useful to incorporate UAAs that are not recognized by the endogenous aaRS 
(site-specific or statistical incorporation) and can also be utilized with a specific 
isoacceptor E. coli tRNA to only incorporate UAAs at a subset of triplet codons.  
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UAARS with multiple UAAs will lead to diverse populations of nAChR and can be used 
to look at specific interactions between classes of aas, such as salt bridges (Lys/Arg and 
Glu/Asp).  UAARS combined with site-specific UAA incorporation should be a useful 
technique for analyzing whether specific sites dominate functional changes.  The UAARS 
method is an intriguing technique that should have many applications in Xenopus oocytes 
for many different proteins. 
 
7.4 Experimental Methods 
7.4.1 Materials 
 T7 mMessage mMachine kits were from Ambion (Austin, TX).  ACh chloride 
and yeast inorganic pyrophosphatase were purchased from Sigma-Aldrich.  HA.11 
monoclonal antibody from mouse was from Covance (Berkeley, CA).  IRDyeTM800CW 
conjugated affinity purified anti-mouse IgG from goat was from Rockland (Gilbertsville, 
PA).  Mouse anti-His antibody was from Amersham Biosciences (Piscataway, NJ).  5-
Fluoro-DL-Tryptophan (FTrp) was from Acros (Geel, Belgium).  5,5,5-Trifluoro-DL-
leucine (F3Leu) was from Alfa Aesar (Ward Hill, MA).  H-3,4-Dehydro-L-Proline (Dhp) 
and L-Azetidine-2-Carboxylic Acid (Aze) were from Chem-Impex Int (Wood Dale, IL).  
3-Fluoro-DL-Valine (FVal) was from Fluka (Seelze, Germany).  L-2-Fluorophe (oFPhe), 
L-3-Fluorophe (mFPhe), L-4-Fluorophe (pFPhe), L-3,4-Difluorophe (3,4-F2Phe), L-3,5-
Difluorophe (3,5-F2Phe), L-2,4,5-Trifluorophe (F3Phe), L-Pentafluorophe (F5Phe), L-2-
Pyridylalanine (2Pyr), L-3-Pyridylalanine (3Pyr), L-4-Pyridylalanine (4Pyr), L-
Propargylglycine (Ppg), (R)-2-Thienylglycine (Thi), and L-3-Benzothienylalanine (Bth) 
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were from Peptech (Burlington, MA).  L-Photo-Leucine (PLeu), L-Photo-Methionine 
(PMet), and dialyzed FBS were from Pierce (Rockford, IL). 
7.4.2 nAChR Gene Preparation and mRNA Transcription 
The masked αNHA-, β-, γ-, and δ-subunits (all ending with the ochre (UAA) stop 
codon) of the nAChR subcloned in the pAMV vector were previously prepared (45,46).  
The αHA His in the pAMV vector was previously prepared (36).  DNA was linearized with 
NotI (New England Biolabs) and mRNA was prepared with the T7 mMessage mMachine 
kit with 0.5 µl of yeast inorganic pyrophosphatase.  mRNA was purified using the 
RNeasy Mini kit (Qiagen, Valencia, CA) and quantified by absorption at 260 nm. 
7.4.3 In Vivo nAChR Expression, UAARS, and Site-Specific UAA Incorporation 
Stage VI oocytes of Xenopus laevis were prepared as described (47).  Oocytes 
were incubated at 18 ˚C for 41–56 h (unless otherwise stated in the figure legends).  2 ng 
of mRNA in a subunit ratio of 2:1:1:1 for αHA His or αNHA:β:γ:δ was injected for 2 d 
incubations, and 1 ng of mRNA in the same subunit ratio was injected for 5 d 
incubations.  UAAs were added to ND96 with Ca2+ and 5% FBS immediately prior to 
injection.  After injection, oocytes were divided equally among all dishes containing 
exactly 4 mL of solution.  Media was changed every 24 h after injection.  For α149UAG 
(β9’Ser) nonsense suppression, 40 ng of mRNA in a subunit ratio of 10:1:1:1 
α149UAG:β(or β9'Ser):γ:δ was injected with 7.5 ng of deprotected TQAS-Trp or TQAS-
FTrp (as described in Chapter 5 and (46)).  Prior to nonsense suppression the oocytes 
were incubated in 2 mM FTrp for 24 h and after injection oocytes were incubated for 2 d.  
For PLeu and PMet experiments, oocytes were kept in an opaque box and exposed to 
ambient light only during media exchange and homogenization. 
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7.4.4 Electrophysiology 
Recordings employed two-electrode voltage clamp on the OpusXpress 6000A 
(Molecular Devices).  ACh was stored at -20 ˚C as a 1 M stock, diluted in Ca2+-free 
ND96, and delivered to oocytes by computer-controlled perfusion system.  For all 
experiments, the holding potential was -60 mV.  Dose-response data were obtained from 
at least 12 ACh concentrations.  Dose-response relations were fit to the Hill equation to 
determine EC50 and the Hill coefficient (ηH).  All reported values are represented as a 
mean ± SE of the tested oocytes (number (n) listed with each table). 
7.4.5 UV Irradiation 
 Oocytes were placed in a dish containing ND96 (no FBS or UAAs) and placed on 
an orbital shaker.  Oocytes were UV irradiated with a 100 W Blak-Ray Lamp (UVP Inc.) 
with conditions listed with each figure.  For arc lamp UV irradiation, oocytes were placed 
in a 1.5 ml eppendorf and were irradiated through the open end of the eppendorf. 
7.4.6 Whole Oocyte Homogenization 
 Whole oocyte homogenization was preformed by placing four oocytes (either 
immediately from 18 ˚C incubator or after storage at -80 ˚C) in a 1.5 ml eppendorf and 
removing excess ND96.  10 µl of homogenization buffer (100 mM NaCl, 50 mM Tris pH 
= 7.9, 0.6% SDS (w/v), 35 mM n-dodecyl β-D-maltoside (DDM) (Anatrace), and 1 
protease inhibitor tablet (Roche)) were added to the oocytes, and oocytes were lysed 
manually with a pipette tip.  The solution was sonnicated for 10 min and centrifuged for 
30 min to remove insoluble debris.  The supernatant was transferred to a new eppendorf 
and 10 µl of 2X loading buffer was added.  Samples were either stored at -80 ˚C or run 
on a gel.  For PLeu and PMet 2 d solubilization, the oocytes were homogenized manually 
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as described above, placed in an eppendorf rack covered in aluminum foil, and placed in 
18 ˚C incubator for 2 d. 
7.4.6 Western Blotting of Proteins Expressed in Xenopus Oocytes 
Western blotting was performed as previously described (37).  Briefly 20 µl of 
samples were loaded on a 4–15% linear gradient, polyacrylamide ready gel Tris-HCl 
(Bio-Rad) and run at 150 V for 1.25 h.  Protein was transferred to nitrocellulose (Bio-
Rad) at 30 V for 30 min and 100 V for 1.5 h.  Nitrocellulose was blocked overnight using 
non-fat dairy milk (NFDM) in 1X PBS / 0.1% Tween.  12.5 µl of 1˚ Ab anti-HA from 
mouse (or 14.9 µl, for same µg as HA Ab, of 1˚ Ab anti-His from mouse) was placed in 
15 ml NFDM / 1X PBS / 0.1% Tween for 1h, washed 4X with 30 ml 1X PBS / 0.1% 
Tween for 5 min each, placed in 3 µl 2˚ 800CW goat anti-mouse IgG in 15 mL NFDM / 
1X PBS / 0.1% Tween for 1 h, and washed 4X with 30 ml 1X PBS / 0.1% Tween for 5 
min each.  Nitrocellulose was visualized using two-color infrared dye detection on the 
Odyssey (Li-Cor, Lincoln, NE) (Hsieh-Wilson lab).  Densiometric analysis was 
performed using the Li-Cor Odyssey software package. 
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